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1. List of abbreviations 
A Ampere 
Å Ångström 
Aa Amino acid 
A. dest. Distilled water 
APS Ammonium persulfate 
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bp Base pair 
BDNF Brain-derived neurotrophic factor 
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BSA  Bovine Serum Albumin 
°C Celsius 
CaCl2 Calcium chloride 
C.elegans Caenorhabditis elegans 
Ca(OA2 Calcium acetate 
CD Circular dichroism 
Cdc42 Cell division control protein 42 homolog 
CNS Central nervous system 
comm Commissureless 
C-term C-terminus 
Da Dalton 
DiD Dicarbocyanine 
DNA Deoxynucleic acid 
Dnase Deoxyribonuclease 
dNTP deoxynucleoside triphosphate 
E. coli Escherichia coli 
EDTA Ethylenediaminetetraacetic acid 
EGF Epidermal growth factor 
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GDI Guanine nucleotide dissociation inhibitor 
GppNHp 5’Guanylyl imidodiphosphate 
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2 
 
IMAC Immobilized metal ion affinity chromatography 
IPTG Isopropyl-ß-D thiogalactopyranoside 
K Kilo 
kDa Kilo Dalton 
L Liter 
LB Lysogeny broth 
LRR Leucine-rich repeat 
M Molar 
MABT Maleic acid buffer containing Tween 20 
MAD Multi-wavelength anomalous diffraction 
MB Midbrain 
MgCl2 Magnesium chloride 
MHB Mid-hindbrain boundary 
mM Millimolar 
Min Minute 
M. mus Mus musculus 
µ Micro 
mRNA Messenger RNA 
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2. Abstract 
The Slit-Robo GTPase activating protein family (srGAPs) consists of four members and are 
important multi-domain adaptor proteins, which are involved in axonal pathfinding and various 
other neuronal processes. This thesis explores the function of the human srGAP1 protein as 
well as its zebrafish homolog in three ways: 1) examining of the membrane deforming activity 
of the FBAR domain, 2) analysing the specific activity of the srGAP1 GAP domain towards 
three members of RhoGTPases, and 3) identifying potential novel interaction partners for the 
srGAP1 protein with the intention to determine new pathway involvements for the protein.  
The work presented in this thesis shows that the srGAP1 FBAR domain can induce vesicle 
deformation in vesicle-based in vitro assays. Compared to the results of another FBAR domain-
containing protein, the Carom protein, the srGAP1 FBAR domain is less potent in inducing 
invaginations of giant unilamellar vesicles. Both proteins do not induce formation of tubules as 
seen for classical FBAR domains, but lead to invaginations of the vesicles. Based on these 
results both proteins can be assigned to the recently found inverse FBAR subfamily. This work 
also measures the intrinsic GTP hydrolysis accelerating activity of the srGAP1 GAP domain 
with different NMR approaches. A comparison of the srGAP1 GAP domains of human and 
zebrafish showed species-specific interaction with Cdc42. Cross-interactions between the GAP 
domains and Cdc42 from different organism, namely human and zebrafish, was observed to a 
low extent. Finally, this work identifies possible new interaction partners for the srGAP1 
protein with mass spectrometry analysis, which indicate that the srGAP1 protein might have a 
more complex and diverse role than assumed so far. 
 
Die Slit-Robo GAP Proteinfamilie besteht aus vier Mitgliedern und ist an der Slit-Robo 
vermittelten repulsiven Wegfindung von Axonen und weiteren neuronalen Prozessen beteiligt. 
In dieser Arbeit wurden die Domänen des humanen srGAP1-Proteins sowie dessen Homolog 
aus Zebrafisch funktionell untersucht. Es wurde die membranbindende Aktivität der FBAR 
Domäne mit einem auf Vesikeln basierenden in-vitro System analysiert. Weiterhin wurde die 
Affinität der srGAP1 GAP Domäne zu drei Mitgliedern der RhoGTPase-Familie mit 
verschiedenen NMR-Methoden untersucht. Für die Suche nach neuen Interaktionspartnern für 
srGAP1 wurde ein GST-Pulldown Experiment mit der bis dato wenig charakterisierten C-
terminalen Domäne des Proteins durchgeführt.  
Die Ergebnisse dieser Arbeit zeigen, dass die FBAR Domäne von srGAP1 aktiv zur 
Deformierung von Vesikeln führt. Untersuchungen an einem weiteren FBAR-Domäne 
enthaltenden Protein, dem humanen Carom Protein, zeigen jedoch eine schwächere 
Deformierungsaktivität der srGAP1 FBAR Domäne. Die Interaktion beider Proteine mit den 
Vesikeln führt jedoch nicht zur Bildung von Tubulen, wie bei klassischen FBAR-Domänen, 
sondern zu deren Einstülpung. Deshalb können beide Proteine aufgrund der hier vorliegenden 
Ergebnisse zu der neuen Unterfamilie, den Inversen FBAR-Domänen gezählt werden. Die 
srGAP1 GAP-Domäne zeigt eine starke Affinität zu der RhoGTPase Cdc42. Diese Affinität 
wird auch für die homologen Proteine aus Zebrafisch bestätigt und weist daher auf eine 
entwicklungsgeschichtlich konservierte Interaktion hin. Die vorläufigen Ergebnisse von 
Pulldown-Experimenten zur Identifizierung neuer Interaktionspartner liefern neue Hinweise 
auf die Beteiligung von srGAP1 an anderen Signaltransduktionswegen und weisen somit auf 
eine weitaus komplexere Rolle für das Protein hin. 
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3. Introduction 
3.1 Neuronal development 
The human brain is a complex network of interconnected neurons, which are important for the 
processing and signalling of information. The structure of a neuron is presented in Fig. 3.1 A.  
A neuron is divided into three sectors: the dendrites, the cell body (soma) and the axons. 
Dendrites are the primary target for synaptic input from other neurons. They forward the 
incoming signal to the axon hillock, which combines all incoming inputs and transmits them 
to the axon. After reaching the presynaptic side the signal is transferred to the next neuron. 
Axons, which are not synaptically interconnected, are guided through their growth cone to 
their synaptic target (Purves et al., 2008). The axons end into the growth cone, which can be 
divided into three zones: the central domain, the transition zone and the peripheral domain 
(Fig 3.1 B). The central domain contains bundles of microtubules, which come from the axon 
shaft. The actin arcs in the transition zone form a ring from which the long actin filaments of 
the peripheral domain originate and form filopodia and F-actin networks.  
 
 
 
 
 
 
 
 
 
 
Fig. 3.1: Schematic representation of a neuron 
A) The cell body (soma) of a neuron contains the nucleus. Dendrites are the primary target for synaptic input from other 
neurons. The axon originates in the axon hillock and permits signal transmission over long distances. The growth cone 
contains bundles of microtubules and actin inside, and directs the axon to its synaptic target.  
B) The growth cone can be separated into three zones:  the central domain (white), the transition zone (green) and the 
peripheral domain (purple). The central domain contains bundles of microtubules, which come from the axon shaft. The 
transition zone contains a ring of actin arcs. The peripheral domain has long bundles of actin filaments, which form the 
filopodia and the F-actin networks, which lead to the lamellipodial structures (modified, Lowery and Van Vactor, 2009). 
 
The growth cone explores the environment and determines the direction of the axon growth 
and the recognition of the target. This process is termed migration, an ubiquitous feature of 
development, which guides cells to their appropriate spatial relationships. The motility of the 
(A) 
growth cone 
axon/neurite 
axon hillock 
soma/cell body 
nucleus 
dendrite 
(B) 
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growth cone reflects modulation of the actin and microtubule cytoskeleton through different 
signalling mechanisms, which involve changes in the intracellular Ca2+ concentration (Purves 
et al., 2008). Adhesive, chemotropic, chemo-repulsive and trophic molecules lead to the 
response of the growth cone. These molecules can be found in extracellular matrixes on cell 
surfaces or are secreted to diffuse in extracellular spaces (Fig. 3.2). They ensure that axon 
pathways are formed from one structure to another and inappropriate connections are 
prevented. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2: The way of a growth cone 
The growth cone encounters many different types of cues in its environment. It travels on a ‘road’ that is made of adhesive 
molecules, that are either directly on a cell surface, for example, transmembrane cell adhesion molecules (CAMs) or 
assembled into a complex extracellular matrix (ECM), for example laminin. Repellent molecules such as slits can prohibit 
growth cone advance and thus provide the guards that determine the road boundaries. Diffusible chemotropic cues present 
further instructions to the growth cone and include various diffusible chemotropic molecules such as netrins as well as 
morphogens such as Wnt, sonic hedgehog (SHH) and growth or neurotrophic factors (such as brain-derived neurotrophic 
factor (BDNF), secreted transcription factors 6–9 and neurotransmitters (modified, Lowery and Van Vactor, 2009).  
 
 
There are four families of guidance cues, netrins, semaphorins, ephrins and slits, which are 
divided into attractive and repellent guidance cues. The following chapter gives insight into 
the repellent guidance cue Slit and its involvement with the Roundabout (Robo) receptor. 
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3.2 The Slit-Robo Pathway 
In the central nervous system there are two different interneuron groups described: the 
association neurons and the commissural neurons. Association neurons project axons 
ipsilaterally and never cross the midline, whereas commissural neurons send the axons 
contralaterally and form a commissure across the midline. The latter mentioned neurons need 
repulsive guidance cues to cross the midline (Long et al., 2004). In Drosophila the midline 
repellent, which expels commissural axons and prevents them from re-crossing, is the Slit 
ligand. Slit mediates repulsive effects through the Roundabout receptor family (Kidd et al., 
1998; Kidd et al., 1999). Robo receptors are kept away from the axon surface by the 
commissureless protein when the commissural neuron grows towards the midline. In the 
moment it crosses the midline, the inhibition of Robo is removed and the Robo proteins are 
expressed at the surface of commissural growth cones, which then sense the Slit repellent and 
expel them from the midline (Fig. 3.3) (Kidd et al., 1998). 
 
 
 
 
 
 
 
Fig. 3.3: Model for Slit-Robo function in midline crossing   
The commissureless (comm) protein is the switch, which controls the midline crossing. When comm is on (A), the level of 
the Robo protein is low (grey) and allows crossing of neurons. Once it crosses the midline, comm is turned off and the level 
of Robo is increased (blue), thus inhibiting recrossing (B) (modified, Keleman et al., 2002). 
 
 
3.2.1 The Slit ligand 
Drosophila slit was identified in a screen for embryonic patterning and defects in 
commissural axon pathfinding (Hummel et al., 1999; Nuesslein-Vollhardt et al., 1984; Seeger 
et al., 1993). Invertebrates contain a single Slit, whereas vertebrates have three homologous 
proteins, Slit1, Slit2 and Slit3 (Dickson et al., 2006). The hallmark of the Slit proteins is a 
tandem of four leucine-rich repeats (LRR) at the N-terminus, termed D1-D4. This region is 
(A) (B) 
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followed by six epidermal growth factor like domains (EGF), a laminin G-like domain (either 
one in invertebrates or two in vertebrates), EGF-like domains and a cysteine knot domain at 
the C-terminus (Fig. 3.4).  
 
 
 
 
Fig. 3.4: Domain composition of the mammalian Slit protein 
Schematic drawing of the mammalian Slit protein. The cleavage site of Slit is indicated with a black line. Abbreviations: D1-
D4: Leucine-rich repeat domains, EGF: epidermal growth factor like, LG: laminin G-like domain, CT: C-terminal cysteine 
knot domain (modified Hohenester et al., 2008). 
 
3.2.2 The Roundabout receptor 
Robo is highly conserved in different species, regarding its sequence and function (Kidd et al., 
1998). Caenorhabditis elegans has a single Robo protein (Sax-3), Drosophila has three 
(Robo1, Robo2 and Robo3) and vertebrates have four Robo receptors (Robo1, Robo2, 
Robo3/Rig-1 and Robo4/Magic Roundabout). All Robo receptors, except Robo4, share the 
same domain architecture (Fig. 3.5), containing five immunoglobulin-like 
domains (IG), three fibronectin type 3 repeats (FN3) and four cytosolic 
domains. The cytosolic domains are poorly conserved, besides some 
conserved linear motifs (Hohenester et al., 2008). These motifs named 
CC0-CC3, can occur in different combinations in different Robos 
(Dickson et al., 2006). Previous studies in different embryonic stages of 
rats, mice, zebrafish embryos and human foetuses (Ip et al., 2011; Lee et 
al., 2001) showed that all robo receptors except robo4 are expressed in 
the developing nervous system (Tab. 3.1). robo4, however, shows 
expression mainly in endothelial cells (Huminiecki et al., 2002; Okada et 
al., 2007).  
 
 
 
 
Fig. 3.5: Domain composition of the mammalian Robo receptor 
Schematic drawing of the mammalian Robo receptor. The cytosolic domain is mainly 
unstructured, containing four motifs, here shown as squares, and labelled with CC0-CC3. 
Abbreviations: IG1-5: Immunoglobulin like domain 1-5 (brown), FN1-3: fibronectin type 3 
(blue), CC0-3: cytosolic domain CC0-CC3 (bisque) (modified Hohenester et al., 2008). 
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Tab. 3.1: Expression pattern of Robo receptors in mice, rats, zebrafish embryos and human fetuses 
 zebrafish Mice Rats human 
 
 
 
 
 
 
Expression 
pattern 
of all 
robo 
receptors 
hindbrain 
 
cranial ganglia 
 
olfactory system 
 
visual system 
 
spinal cord 
 
somites 
 
fin buds 
 
 
cortical plate 
 
subventricular zone 
 
intermediate zone 
 
corticospinal axons 
dorsal thalamus 
 
developing 
hippocampus 
 
roof of midbrain 
 
spinal chord 
 
olfactory system 
striatum 
 
cortex 
 
hippocampus 
 
thalamus 
 
hindbrain 
 
olfactory 
system 
 
cortical plate 
 
subventricular 
zone 
 
intermediate 
zone 
 
corticospinal 
axons 
 
 
All four genes show similar expression patterns in neuronal tissues of different organisms, 
indicating a conserved expression pattern.  
Besides their function as repulsive cue both Slit and Robo are involved in neuronal migration, 
cell death, angiogenesis and also have a role in the development of different organs, such as 
kidney, lungs or liver (Avci et al., 2004; Grieshammer et al., 2004; Xian et al., 2004). 
Recently, it was shown that the Slit Robo GTPase activating family 1 (srGAP1) protein binds 
to the cytosolic domain CC3 of the mammalian Robo receptor and leads to Slit-dependent 
inactivation of the RhoGTPase Cell division cycle 42 (Cdc42) (see chapter 3.3) (Wong et al., 
2001).  
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3.3 The discovery of the srGAP family 
The srGAP family consists of three members, srGAP1, srGAP2 and srGAP3. All members 
are multi-domain containing proteins, consisting of a FBAR, GAP, SH3 and C-terminal 
domain. Figure 3.6 shows a scheme of the multi-domain protein with the sequence identities 
of all members. 
 
 
 
Fig. 3.6: Domain composition of the srGAP family 
The srGAP family contains a FBAR domain, a GAP domain, a SH3 domain and a C-terminal domain. The 
sequence identities between the three members of the srGAP family vary between 70-79 % for the FBAR 
domain, 67-78 % for the GAP domain, 86-96 % for the SH3 domain and 30-40 % for the C-terminus, containing 
PxxP motifs. 
 
Recently, a new member was added to the srGAP family on the basis of its function, 
ARHGAP4, also termed srGAP4. ARHGAP4 has the same domain composition, though the 
sequence identity between the domains is low: FBAR domain 46-48 %, GAP domain 53-
59 %, SH3 domain 55-56 % and the C-terminus 8-11 %. 
 
3.3.1 The Domains of the srGAP proteins 
3.3.1.1 The srGAP FBAR domain 
The srGAP FBAR domain belongs to the BAR superfamily, which not only induce membrane 
deformation, but link the membrane to the cytoskeleton, thus becoming regulators of cell 
morphology and function (Lee et al., 2007; Scita et al., 2008; Suetsugu et al., 2006; Tsujita et 
al., 2006; Yamagishi et al., 2004). The BAR superfamily can be divided into three 
subfamilies: the classical BAR/N-BAR proteins, the Fer-CIP4 Homology (FBAR) proteins 
and the inverse BAR (I-BAR) proteins. In Fig. 3.7 the characteristic curvature of each 
subfamily is displayed.  
 
 
 
 
 
 
FBAR GAP SH3 PxxP 
70-79 % 67-78 % 86-96 % 30-40 % 
1 1099 
11 
 
  
 
 
 
 
 
Fig. 3.7: The BAR domain superfamily 
Structures of the three subfamilies of the BAR superfamily: the Amphiphysin N-BAR domain (PDB: 1URU, Peter et al., 
2004), the FBP17 FBAR domain (PDB: 2EFL, Shimada et al., 2007) and the IRSp53/missing-in-metastasis I-BAR domain 
(PDB: 1Y2O, Millard et al., 2005). The membrane-binding surface is directed to the bottom, emphasizing the classical 
banana-shaped appearance of the BAR domain and the different characteristic curvature of the FBAR and I-BAR domains 
(Moravcevic et al., 2012). 
 
 
3.3.1.1.1 The classical BAR/NBAR domain 
The classical BAR domain consists of three anti-parallel α-helical bundles in each monomer, 
which form crescent-shaped dimers, consisting of 6 α-helices (Suetsugu et al., 2009). 
Positively charged residues can be found on the concave surface of the BAR domain, which 
allows it to directly interact with negatively charged PI(4,5)P2 containing membranes via 
electrostatic interaction (Fig. 3.8). It has been reported that the dimers oligomerize to induce 
membrane invagination (Itoh et al., 2005; Shimada et al., 2007).  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.8: Schematic models for membrane deformation by BAR domains 
BAR domains bind to the negatively charged membrane with their concave surface through electrostatic interaction and lead 
to membrane invaginations, like caveolae or clathrin-coated pits. 
 
The N-BAR domains contain an additional N-terminal amphipathic α-helix, which can insert 
into the membrane, thus increasing membrane curvature (Itoh et al., 2006). Various proteins, 
which contain a BAR or N-BAR domain, such as amphiphysin or endophilin, have been 
BAR/N-BAR 
FBAR I-BAR 
cytosol cytosol 
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implicated in membrane deforming activities related to synaptic vesicle formation (Di Paolo 
et al., 2002; Schuske et al., 2003).  
 
3.3.1.1.2 The FBAR domain 
FBAR domains contain a FCH domain which is followed by a coiled-coil domain. This C-
terminal coiled-coil domain has been predicted to fold in a similar way to BAR domains 
(Frost et al., 2007). FBAR dimers consist of 5 α-helices and are longer and shallower curved 
in comparison to “classical” BAR domains, though they still exhibit the banana-shaped form. 
This difference in length and curvature of the FBAR domain, leads to a larger diameter of the 
induced tubules (Henne et al., 2007). In vitro assays with FBAR domains showed deformation 
of liposomes (Couthino-Budd et al., 2012; Henne et al., 2007). To understand the ability of 
the FBAR domains to induce membrane tubules, structural information of the protein have 
been combined with cryo-electron microscopy (Frost et al., 2008; Shimada et al., 2007;). 
These studies report that FBAR dimers can bind with their tips end-to-end and form strings of 
oligomers (Fig. 3.10). Most of the FBAR containing proteins, like formin-binding protein 17 
(FBP17) or Cdc42-interacting protein (CIP4), are involved in endocytosis, regulation of the 
actin cytoskeleton and signalling (Itoh and De Camilli, 2006).     
 
3.3.1.1.3 The I-BAR domain 
I-BAR domains contain three anti-parallel α-helices, like classical BAR domains. But instead 
of the familiar banana-shape, I-BAR domains show a zeppelin-shaped appearance, with 
positive amino acids located on their convex surface (Millard et al., 2005). Hence, this 
subfamily was named inverse BAR (Fig. 3.9).  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.9: Schematic models for membrane deformation by I-BAR domains 
I-BAR domains bind to the negatively charged membrane with their convex surface through electrostatic 
interaction and lead to membrane protrusions, such as filopodia or lamellipodia. 
cytosol cytosol 
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In contrast to BAR and FBAR domains, I-BAR domains induce filopodia-like membrane 
protrusions (Mattila et al., 2007; Millard et al., 2005; Saarikangas et al., 2008; Saarikangas et 
al., 2009). Figure 3.10 shows the putative mechanism of how the BAR/FBAR/I-BAR dimers 
deform membranes. BAR/FBAR dimers bind to the surface of the membrane, while I-BAR 
dimers are predicted to bind to the inner side of the protruding membrane. This theory has 
been confirmed with the help of molecular dynamic simulations by Yu and Schulten in 2013.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.10: Putative mechanism of membrane deformation for BAR, FBAR and I-BAR domains 
(A) The BAR/FBAR dimer spiral is located on the surface of the invaginating membrane. The end-to-end interaction between 
the homo-dimers can be observed. This interaction facilitates the sensing of the membrane curvature. (B) The I-BAR dimer 
binds to the inner surface of the protruding membrane (modified, Suetsugu et al., 2010). 
 
  
Little was known about the FBAR domains of the srGAP family until recently. Studies from 
the Polleux lab showed for the first time, that the srGAP2 FBAR domain leads to outward 
membrane protrusions and thereby negatively regulates neuronal migration and induces 
neurite outgrowth and branching. It was also shown that methylation of srGAP2 plays an 
important role in cell spreading and cell migration (Guo et al., 2010). Studies on the srGAP3 
FBAR domain indicated that it has an inhibitory effect on actin dynamics specifically on 
lamellipodia formation (Endris et al., 2011). In Cos7 fibroblasts, expression of the full-length 
FBAR domain of srGAP2 and srGAP3, induce filopodia formation. The deletion of the last 49 
amino acids abolishes the effect, though the protein is still located at the cell membrane 
(Carlson et al. 2011; Guerrier et al., 2009). A more recent study, provided the information that 
the FBAR domains of the three srGAP family members show a diverse ability to induce 
filopodia-like protrusions in neuronal and non-neuronal cells. The FBAR domain of srGAP3 
induces filopodia in Cos7 cells and in cortical neuron cells, though less potent than the FBAR 
domain of srGAP2. The FBAR domain of srGAP1 though, prevents filopodia formation in 
(A) 
BAR/FBAR domains I-BAR domains 
(B) 
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cortical neuron cells and reduces plasma membrane dynamics. Overall, all results obtained 
until now point to a unique function of the FBAR domains of the srGAP family through their 
ability to control membrane deformation (Couthino-Budd et al, 2012). 
 
3.3.1.2 The srGAP GAP domain 
The srGAP GTPase activating protein (GAP) domain belongs to the RhoGAP family as it 
binds and inactivates small GTPases by increasing their intrinsic GTP hydrolysis rate (Schulte 
and Der, 2006).  
 
3.3.1.2.1 The RhoGTPases 
RhoGTPases are a distinct subfamily in the superfamily of Ras-related small GTPases. They 
are known for their role in actin cytoskeleton regulation, cell growth and differentiation as 
well as endocytosis (Moon and Zheng, 2003; Threadgill et al., 1997). So far, 22 human 
members for the RhoGTPase family have been identified (Wennerberg and Der, 2004). 
Cdc42, RhoA and Rac1 are the best characterized members of this GTPase family (Etienne-
Manneville and Hall, 2002). Rac1 has been shown to lead to the formation of lamellipodial 
protrusions through actin networks, Cdc42 forms filamentous actin bundles, which regulate 
filopodia formation and RhoA leads to actin depolymerisation (Hall et al., 1994). GTPases act 
in general as binary switches by cycling between an active and inactive state. In the active 
state, guanine triphosphate (GTP) is bound to the GTPase. This leads to the association with 
downstream effectors, which then activate a range of downstream signalling cascades (Bishop 
and Hall, 2000; Burridge and Wennerberg, 2004). During the inactive state guanine 
diphosphate (GDP) is bound. The cycle is regulated by GTPase activating proteins (GAPs), 
which increase the intrinsic GTP hydrolysis rate of the GTPase, and guanine exchange factors 
(GEFs), which exchange the bound GDP to GTP. Guanine nucleotide dissociation inhibitors 
(GDIs) bind to prenylated GDP-bound GTPase to control the cycling between the membranes 
and the cytosol (Schmidt and Hall, 2002) (Fig. 3.11).  
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Fig. 3.11: General regulation of RhoGTPases by GEFs, GAPs and GDIs 
The RhoGTPases are activated by the GDP/GTP exchange with the help of GEFs (pink) and inactivated by the accelerated 
GTP hydrolysis by GAPs (yellow). The switch from cytosol to membrane or vice versa is regulated by GDIs (green), 
(modified, Cherfils and Zeghouf, 2013) 
 
All RhoGTPases are composed of six-stranded β-sheets, which are surrounded by five α-
helices, referred as G-domain (Cherfils and Zeghouf, 2013). They contain a guanine 
nucleotide binding site, which recognizes the guanine base with the N/TKXD motif, in which 
X stands for any amino acid. The β- and γ-phosphate interact with the phosphate binding loop 
(P-Loop). Various motifs around these specific regions are also involved in the GTP 
hydrolysis reaction, for example Switch I and Switch II (Cherfils and Zeghouf, 2003; Vetter 
and Wittinghofer, 2001). In Fig. 3.12 human Cdc42 with bound GDP is shown as a 
representative of the three most described members of this GTPase family. The main binding 
sites are highlighted. 
 
 
 
 
 
 
 
Fig. 3.12: Crystal structure of human GDP-bound Cdc42 
Ribbon representation of the human Cdc42 with bound GDP. Switch I (residues 30-38) is highlighted in light 
blue, Switch II (residues 57-72) is shown in dark blue, the P-loop (residues 9-16) is presented in red and the 
bound GDP in yellow (PDB: 1GRN, Nassar et al., 1998). 
P-Loop 
GDP 
Switch I 
Switch II 
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The regulator GEF and GAP proteins are supposed to bind to the Switch I/ Switch II region 
and stabilize this region (Hakoshima et al., 2003), whereas the nucleotide binds near the P-
Loop and is surrounded by the switch regions.  
 
3.3.1.2.2 The RhoGAP family 
GTPases have a very slow intrinsic GTPase activity, which is accelerated by its specific GAP 
protein. GAPs are abundant in eukaryotes ranging from yeast to human. Human genome 
analysis resulted in 80 RhoGAPs, which outnumber the RhoGTPases comprising 20 members 
(Moon and Zheng, 2003). This suggests individual roles for the members of the RhoGAP 
family, while regulating specific RhoGTPases in their activity and function. RhoGAP proteins 
consist of nine α-helices (Gamblin et al., 1998) and negatively regulate the biological activity 
of RhoGTPases. Some down-regulate their specific RhoGTPase, while others facilitate the 
effective cycling of RhoGTPases between the GTP- and the GDP-bound conformation. It is 
proposed that GAP actively participates in the GTP hydrolysis process by contributing a 
catalytic residue to the active site (Scheffzek et al., 1998). An important step in solving the 
mechanism of the GTPase accelerating process came from studies using aluminium fluoride 
(AlFx). AlFx (x represents either aluminium trifluoride (x=3) or aluminium tetrafluoride 
(x=4)) has been suggested to activate heterotrimeric G-proteins in their GDP-bound inactive 
state by binding into the γ-phosphate pocket (Chabre et al., 1990). This hypothesis was 
confirmed by crystal structures of Gα-AlFx complexes. The data supported the idea that GDP-
AlFx mimics the transition state of the GTPase reaction. This gives more insight into the 
mechanism of most GAPs. The formation of a stable GTPase/GAP complex in the presence of 
GDP and AlFx is used as a reference assay to demonstrate the activity of a GAP domain 
(Mittal et al., 1996; Wittinghofer et al., 1997). The studies revealed that the GAP domain 
contains a highly conserved arginine residue, which stabilizes the GTPase stimulation by 
inserting the arginine residue into the active site (Gamblin and Smerdon et al., 1998; Kosloff 
and Selinger, 2001; Scheffzek et al., 1998; Vetter and Wittinghofer, 2001). The GAP domain 
positions the crucial residue Gln61/Gln63 (in RhoA) of the RhoGTPases towards a 
nucleophile water molecule, which hydrolyses GTP and neutralizes developing negative 
charges on the leaving group during the phosphoryl-transfer reaction (Ahmadian et al., 1997; 
Nassar et al., 1998). This has been confirmed with mutation approaches (Li et al., 1997, 
Nassar et al., 1998). Three binding sites are mentioned in the literature for the RhoGAP 
domain: the Switch I, the Switch II and the P-Loop region (Dvorsky et al., 2004; Moon and 
Zheng, 2003).  
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A previous study in HEK cells reported, that srGAP1 specifically inactivates Cdc42 and 
RhoA (Wong et al., 2001), whereas srGAP2 and 3 inactivate Rac1 (Guerrier et al., 2009; 
Soderling et al., 2002). ArhGAP4 can act on both Cdc42 and Rac1 (Vogt et al., 2007). 
Structurally the srGAP GAP domains are assumed to resemble classical GAP domains, 
containing nine α-helices, packed together in an anti-parallel arrangement (Dvorsky et al., 
2004). In Fig. 3.13 a model of the regulation of the RhoGTPases by the srGAP GAP domain 
is shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.13: Model for the regulation of the RhoGTPase activity by the srGAP GAP domain  
Activation of the GAP domain leads to the inactivation of the RhoGTPase through the increasing intrinsic GTP hydrolysis 
rate. This leads to the inhibition of downstream effectors, like N-WASP and Arp2/3 complex, which results in less actin 
polymerization. GEFs activate the RhoGTPases again (modified, Wong et al., 2001). 
 
3.3.1.3 The srGAP SH3 domain 
SH3 domains are found in multiple intracellular proteins 
in living cells. They are ubiquitous protein-interaction 
modules, which have roles in many aspects of complex 
signalling networks. The peptide recognition surface 
contains a hydrophobic cleft, which has variable loops 
that contribute to the recognition specificity and also 
determine ligand orientation (Mayer et al., 2001; Li et al., 
2006). SH3 domains recognize proline- rich sequence 
motifs with a PxxP motif, which is classified into class I, 
RKxxPxxP and class II, PxxPxR motifs. The structure of 
Fig. 3.14: Crystal structure of the srGAP1 
SH3 domain 
Ribbon representation of the monomer structure 
of the srGAP1 SH3 domain, containing five β-
strands. This figure was drawn using PyMOL 
(http://www.pymol.org/). (PDB: 2GNC, Li et al., 
2006) 
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the srGAP1 SH3 domain (Li et al., 2006) and the srGAP2 SH3 domain (Qin et al., 2006) were 
solved, showing a classical SH3 domain (Fig. 3.14), containing five β-strands arranged as two 
orthogonal β-sheets and forming a compact anti-parallel β-sheet (Li et al., 2006). So far, it is 
known that the SH3 domain of srGAP1 binds to the CC3 of Robo1, hence involving the 
protein in the Slit-Robo pathway (Fig. 3.15). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.1.4 The srGAP C-terminal region 
So far, not much is known about the C-terminal region of the srGAP family. It seems to be 
mainly unstructured, containing a short coiled-coil domain, which is conserved in all 
organisms. Functionally the C-terminal region is assumed to be involved in protein-protein 
interaction. In vitro studies indicate that the members of the srGAP family play a crucial role 
in neurological processes during the development of the human brain. srGAP1 transduces Slit 
signalling in neuronal migration by inactivating Cdc42 (Wong et al., 2001). srGAP2 was 
shown to be involved in axon regeneration (Madura et al., 2004). Recently, it has also been 
implicated in a severe neurodevelopmental syndrome, which causes early infantile epileptic 
encephalopathy and profound psychomotor delay (Saitsu et al., 2011). srGAP3 is suggested to  
be involved in a severe form of X-linked mental retardation, the 3p- syndrome, giving 
srGAP3 the alternate name of mental-disorder associated GAP protein (MEGAP) (Endris et 
al., 2002). Furthermore, a role for srGAP3 in long term memory has been shown with mice 
Fig. 3.15: Binding of the srGAP1 SH3 domain to the Robo receptor 
The D2 domain of the Slit ligand binds to the IG1 domain of the Robo receptor, hence enhancing its binding to the 
SH3 domain of srGAP1 via its cytosolic domain 3. Abbreviations: D1-D4: Leucine-rich repeat domains, EGF: 
epidermal growth factor, LG: laminin G-like domain, CT: C-terminal cysteine knot domain, IG1-5: 
Immunoglobulin like domain 1-5, FN1-3: fibronectin type 3, CC0-3: cytosolic domain 0-3 (modified, Hohenester 
et al., 2008). 
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behaviour tests such as novel object recognition, water maze and passive avoidance (Carlson 
et al. 2011). Figure 3.16 shows a summary of the known roles for the individual domains of 
the srGAP family. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.16: Summary of the individual roles of each domain of srGAP family in the cell 
The members of the srGAP family contain a FBAR, GAP, SH3 and C-terminal domain. The SH3 domain (orange circle) 
binds to the cytosolic domain of the Robo receptor, thus activating the srGAP protein and involving it in the Slit-Robo-
pathway. Activation of the srGAP protein leads to an increasing activity of its GAP domain (yellow box), which specifically 
binds to members of the RhoGTPase family and increases their intrinsic GTP hydrolysis rate, thus inhibiting all downstream 
processes. The FBAR domain is responsible for membrane binding and bending (blue half moon). The C-terminal domain 
contains PxxP motifs and is assumed in protein-protein interaction and for involving the srGAP proteins in new pathways 
(modified, Wong et al., 2001; Hohenester et al., 2008).   
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3.4 The FCH and double SH3 domain family-
another member of the I-FBAR containing 
proteins 
Intracellular trafficking needs several membrane-shaping proteins, which work together to 
induce membrane invagination, tubules or vesicle formation. Many of these proteins contain 
BAR domains, such as the FCH and double SH3 domain family containing a N-terminal 
FBAR domain. It can be found in various organisms ranging from yeast to mammals and has 
an evolutionary conserved protein domain composition. 
 
3.4.1 Nervous wreck 
Nervous wreck (Nwk) is an FCH and SH3 domain-containing neuronal adaptor protein (Fig. 
3.17 A), which localizes to the periactive zone of presynaptic terminals and is able to bind to 
Wsp, the Drosophila orthologue of WASP, which is an important regulator of actin 
polymerization. Nwk was assumed to be a member of a family of adaptor proteins, which 
include the human srGAP proteins. It is proposed that Nwk controls the endosomal traffic and 
signalling output of synaptic growth receptors at the presynaptic terminus of the Drosophila 
neuromuscular junction (Coyle et al., 2004; O’Connor-Giles et al, 2008; Rodal et al., 2011). 
As mentioned above Nwk contains a N-terminal FBAR domain, which is followed by two 
canonical SH3 domains, recognizing proline-rich consensus sequences (Fig. 3.17 A). The C-
terminal domain of Nwk contains additional proline-rich motifs, with five possible SH3 
binding sites (Coyle et al., 2004). There are 11 related proteins in yeast, worms and mammals, 
which include the three members of the human srGAP family (Fig. 3.17 B). In some protein 
families one of the SH3 domains has been replaced by a GAP domain. Though the sequence 
identity is not high, Nwk and its 11 homologs share an approximately 60 aa long sequence in 
the FBAR domain, which is unique for this family. This sequence is referred to as ARNEY 
domain, for which no relevant function has been described until now (Coyle et al., 2004). 
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Fig. 3.17: Domain composition of Nervous Wreck  
(A) The Drosophila protein Nwk contains a FBAR domain (blue) and two SH3 domains (orange). 
(B) Table with the 11 homologs of Nwk. Sequence identities of the individual domains are shown in percentages. Dashes 
mean either insufficient similarity in BLAST alignment or in case of the first SH3 domain, replacement by a GAP domain. 
FCHSD1 and FCHSD2 are the human Nwk proteins. The F12F6.5 protein from C. elegans shows no specific similarity in 
domain composition, though it contains the ARNEY domain, which has a sequence identity of 37 %. Abbreviations: C. 
elegans: Caenorhabditis elegans, H. sp.: Homo sapiens, M. mus.: Mus musculus, S. cer.: Saccharomyces cerevisiae 
 
The similar domain composition of Nwk and its homologs suggests that all 12 proteins belong 
to a distinct family of adaptor proteins, which interact with cytoskeletal regulators. Recently, 
it has been shown that the FBAR domain of Nwk has a membrane deforming activity, which 
is different from the previously described FBAR proteins. Instead of classical membrane 
tubules, the Nwk FBAR creates ridges and scallops in in vitro assays by assembling into 
zigzags. In S2 cells, these structures develop into plasma membrane protrusions by actin 
polymerization, thus showing a negative membrane deforming activity, which is similar to 
Homologs FBAR SH3 SH3 
H. sap. FCHSD1 - 55 % 53 % 
H. sap. FCHSD2 30 %  47 %  50 % 
srGAP1 29 % - 31 % 
srGAP2 32 % - 30 % 
srGAP3 26 % - 31 % 
srGAP4 27 % - 28 % 
M. mus. Nwk 40 % 55 % 53 % 
M. mus. RhoGAP4 30 % - 28 % 
M. mus. RhoGAP14 26 % - 31 % 
C. elegans F12F6.5 - - - 
S. cer. Bzz1p 46 % 35 % 38 % 
1 1000 
FBAR SH3 SH3 
(A) 
(B) 
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that of the srGAP family. Analysis of mutations localized in the concave surface indicate, that 
Nwk exhibits a conventional concave FBAR domain structure. The results of this study 
suggests that there are unique modes of higher-order assembly, which can define how FBAR 
proteins sculpt the membrane (Becalska et al., 2013).  
 
3.4.2 The human Nwk homolog-the FCHSD2 protein 
The human Nervous wreck protein, known as FCHSD2 or Carom, shares the same domain 
composition of Nwk. So far, it is known that the murine FCHSD1 and FCHSD2 form 
abundant protrusions in S2 cells. Further experiments in HEK293T cells also resulted in F-
actin containing protrusions to which the FBAR domains localized. This similar protrusion- 
generating activity of the Drosophila and murine Nwk proteins indicate an evolutionary 
conserved mechanism (Becalska et al., 2013). The observed membrane deforming activity 
shows some similarity to that of the srGAP family.  
In addition to the information about the FBAR domain, the structures of both SH3 domains 
have been solved (Qin et al., 2006). Not much is known about their possible interaction 
partner whereas it is clear that the Drosophila Nwk binds to Wsp with its first SH3 domain, 
and is therefore, involved in actin polymerization (Coyle et al., 2004). Furthermore, it has 
been shown that Carom interacts with the calcium/calmodulin-dependent serine protein kinase 
(CASK), which targets junctional components and links them to the cytoskeleton and with 
myelin-associated glycoprotein 1 (MAGI-1), which is assumed to play a role in the 
transmission of regulatory signals from the cell surface to the nucleus (Dobrosotskaya et al., 
1997; Ohno et al., 2003). Both proteins bind to distinct regions of the C-terminal domain of 
Carom, whereby CASK inhibits the binding of Carom to MAGI-1. The in vivo significance of 
this interaction is not solved yet, though it is assumed that Carom might be associated with the 
cytoskeleton and linkage of other proteins to the cytoskeleton (Ohno et al., 2003).  
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4. Goals of the project 
 
 
 
The goal of this work is to analyse the structural and functional properties of the srGAP1 
protein to gain new insight into the characteristics of the srGAP family.  
srGAP1 belongs to a novel GTPase activating protein family and is part of the BAR domain 
superfamily, containing a N-terminal FBAR domain, which belongs to a new class of FBAR 
domains, termed I-FBAR domains. Characteristic for this new subfamily is the formation of 
membrane protrusions upon binding of the FBAR domain to the membrane, instead of the 
classical membrane invagination. This was shown with several in vivo experiments with Cos7 
and cortical neuron cells. Like many BAR domain containing proteins, the srGAP1 protein 
has additional protein domains, a GAP and a SH3 domain, as well as several protein binding 
motifs in its C-terminal region.  
To understand the function of the I-FBAR subfamily and their differential behaviour upon 
membrane binding, the FBAR domain of srGAP1 and the FBAR domain of Carom were 
analysed with giant unilamellar vesicle based in vitro assays for their membrane deforming 
activity. Furthermore, the affinity of the GAP domain to three members of the Rho family of 
GTPases was examined using different NMR approaches to gain insight into the structural 
properties of the acceleration of the intrinsic hydrolysis reaction of the GTPase by the srGAP1 
GAP domain. The C-terminal domain, which is rich in protein binding motifs was used to 
identify potential new interaction partners for the srGAP1 protein, to gain insight into new 
functions for the protein within the complex protein network. 
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5. Contributions 
All experiments were discussed with my supervisor Dr. Yvonne Groemping. 
 
7.1.1 Bioinformatical cluster analysis of the srGAP family 
The setup and the results of the bioinformatical analysis were discussed with Dr. Moritz 
Ammelburg. The analysis was carried out by myself with the bioinformatic toolkit of the MPI 
for Developmental Biology, Tuebingen.  
 
7.1.2 Developmental and tissue-specific expression analysis of srgap1 in zebrafish 
embryos 
The experimental outline for the analysis of the expression pattern of srgap1 was discussed 
with Dr. Christian Soellner and Horst Geiger. Zebrafishes were provided by the fish facility of 
the Department of Genetics, MPI Tuebingen.  I cloned the srgap1 construct for the in-situ 
hybridization and carried out the in-situ experiments by myself. The images of the single in-
situ experiments were taken by myself. The images of the double in-situ experiments were 
taken together with Dr. Christian Soellner and the results of the analysis were discussed with 
him as well. 
 
7.1.3 Structural analysis of the srGAP1 FBAR domain 
I performed the cloning of all FBAR domain constructs, except the SRGAP1 FBAR domain 
from Pristionchus pacificus, which was done by Martin Schuekel. I carried out all 
purifications as well as the biochemical analysis of the different srGAP1 FBAR domains. The 
crystallization screens for the zebrafish srGAP1 FBAR domain were set up by Dr. Reinhard 
Albrecht and Kerstin Bär.  
 
7.1.4 Functional characterization of the srGAP1 FBAR domain of zebrafish 
The liposome mixes for the EM assays were generated by Silvia Wuertenberger. I carried out 
the EM assays and the images were taken together with Dr. Matthias Floetenmeyer in the 
beginning, later I took the images by myself. The GUV assays were performed in the research 
group of Dr. Wolfram Antonin together with Dr. Nathalie Eisenhardt. 
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7.1.5 Comparison of the binding specificity of the human srGAP1 GAP domain and its 
zebrafish homolog to three members of the RhoGTPases 
I cloned the GAP domains, as well as the zebrafish Cdc42. The human RhoGTPase constructs 
were already available and were cloned before by Dr. Yvonne Groemping. Dr. Murray Coles 
conducted all NMR measurements and provided me with the figures, which we discussed 
together. The mapping of the binding sites on Cdc42 was suggested by my TAC committee 
members Professor Dr. Andrei Lupas, Professor Dr. Thilo Stehle and Dr. Christian Soellner. 
 
7.1.6 Possible new interaction partners for the human srGAP1 protein and its zebrafish 
homolog 
The C-terminal domain of the human srGAP1 was cloned by Beatrice Laudenbach. I 
performed the purification and further characterization of the domain. The setup of the rat 
brain pulldown was discussed with Silvia Wuertenberger. The mass spectrometry analysis of 
the rat brain pulldown as well as the zebrafish embryo pulldown were carried out by Johannes 
Madlung from the Proteome Center in Tuebingen. I carried out further analysis of the mass 
spectrometry results. The selection of the potential interaction partners were discussed with 
Dr. Yvonne Groemping. 
 
7.2.1 Biochemical characterization of the FBAR domain of the human Carom protein 
Beatrice Laudenbach and Martin Schueckel cloned the human Carom construct. I performed 
the purification and further biochemical analysis of the protein. Crystallization screens were 
set up by Dr. Reinhard Albrecht and Dr. Marcus Hartmann analysed the diffraction data. 
Further variation of the crystallization screens were carried out by myself. 
 
7.2.2 Membrane deforming activity of the human Carom FBAR domain 
The GUV assays in chapter 7.2.2.1 and 7.2.2.3 were performed by Dr. Aleksander Czogalla, 
Dresden. The GUV assays in chapter 7.2.2.2 were performed by me under the supervision of 
Dr. Nathalie Eisenhardt.  
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6. Materials and Methods 
 
6.1 Materials 
6.1.1 Chemicals and Enzymes 
All chemicals and enzymes which were used in this project were ordered from the following 
companies: AppliChem GmbH (Darmstadt), Carl Roth GmbH & Co KG (Karlsruhe), 
Fermentas/Life Technologies Co. (Franfurt/Main), Merck AG (Darmstadt) and Sigma-Aldrich 
Chemical GmbH (Steinheim). 
 
6.1.2 Used bacterial strains 
Tab. 6.1: Escherichia coli (E. coli) strains 
Name Genotype Reference 
BL21 (DE3) F– ompT gal dcm lon hsdSB(rB-
 mB-) λ(DE3 [lacI lacUV5-T7 
gene 1 ind1 sam7 nin5]) 
Novagen 
Rosetta F-ompT gal [dcm] [lon] hsdSB 
(rB-,mB-) λ(DE3)  
pRARE(CmR)  
Novagen 
Lemo21 (DE3)  fhuA2 [lon] ompT gal (λ DE3) 
[dcm] ∆hsdS/ pLemo(CamR) 
New England Biolabs 
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6.1.3 Plasmids 
Tab. 6.2: Cloned plasmids 
Name Characteristics Source 
pET28b_FBAR_DR_21-475 srGAP1 FBAR domain of 
zebrafish with C-terminal 6His-
tag in pET-28b, kanamycin 
resistance 
Anitha Jeyanthan 
pET47b_FBAR_1-469 human srGAP1 FBAR domain 
with N-terminal 6His-tag in 
pET-47b, kanamycin resistance 
Anitha Jeyanthan 
pET28b_FBAR_PP_20-460 SRGAP1 FBAR domain of 
Pristionchus pacificus with C-
terminal 6His-tag in pET28b, 
kanamycin resistance 
Martin Schueckel 
 
 
 
 
pGEX6P1_GAP_496-695 human srGAP1 GAP domain in 
pGEX6P1 with N-terminal 
GST-tag, ampicillin resistance 
Anitha Jeyanthan 
 
 
 
pGEX6P1_GAP_DR_492-676 srGAP1 GAP domain from 
zebrafish in pGEX6P1 with N-
terminal GST-tag, ampicillin 
resistance 
Anitha Jeyanthan 
pGEX6P1_Cterm_799-1085 human srGAP1 C-terminal 
domain in pGEX6P1 with N-
terminal GST-tag, ampicillin 
resistance 
Beatrice Laudenbach 
pGEX6P1_Cterm_DR_782-
1073 
srGAP1 C-terminal domain, 
from zebrafish in pGEX6P1 
with N-terminal GST-tag, 
ampicillin resistance 
Anitha Jeyanthan 
pET28b_Carom_FBAR Human Carom FBAR domain 
in pET-28b with C-terminal 
6His-tag, kanamycin resistance 
Beatrice Laudenbach, Martin 
Schueckel 
pGEX4T1_Cdc42_Hs_1-178 human Cdc42 in pGEX4T1 
with N-terminal GST-tag, 
ampicillin resistance 
Yvonne Groemping 
pGEX6P1_Cdc42_DR_1-191 Cdc42 from zebrafish in 
pGEX6P1 with N-terminal 
GST-tag, ampicillin resistance 
Anitha Jeyanthan 
pGEX4T1_Rac1_Hs human Rac1 in pGEX4T1, with 
N-terminal GST-tag, ampicillin 
resistance 
Yvonne Groemping 
pGEX4T1_RhoA_Hs human RhoA in pGEX4T1, 
with N-terminal GST-tag, 
ampicillin resistance 
Yvonne Groemping 
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6.1.4 Oligonucleotides 
Tab. 6.3: Used oligonucleotides for cloning of the FBAR, GAP and the C-terminal constructs 
Name Sequence Reference 
srGAP1_FBAR_1_fw CATGCCATGGGAATGTCCACCCCGAGCCGATTCAAG MWG 
srGAP1_FBAR_469_rv CCGCTCGAGTCATTCTCCCAGGGTCCTCTGCAGCAAGTC MWG 
srGAP1_FBAR_L1_fw CAGGGACCCGGTATGTCCACCCCGAGCCGATTCAAG MWG 
srGAP1_FBAR_L469_r
v 
GGCACCAGAGCGTTATTCTCCCAGGGTCCTCTGCAGCAA
GTC 
MWG 
sr1_ GAP_496_fw CGGGATCCCGCTCACAGTATAATACTAAGTTGTTTAATG MWG 
sr1_GAP_695_rv GCGCTCGAGTCATGGGAAAATAGTCTCATGGTGGATGAT
G 
MWG 
srGAP1_L799_fw CAGGGACCCGGTGTGCAGGATATGGATGATACG MWG 
srGAP1_L1085_rv GGCACCAGAGCGTTACATTGTGCATGACTTGTCTGTTG MWG 
SrGp1_DR_1fw CCAGTTTGTAAACACTCTCATAAC MWG 
SrGp1_DR_2fw CATGCCATGGTGAAGATGTCGAATCCTCCTGTGAAG MWG 
SrGp1_DR_3fw CATGCCATGGTCAAAGAGATTCGAGCTCAAC MWG 
SrGp1_DR_1rv ATAGTTTAGCGGCCGCGTCACCGAGGGTTCTCTTCAGTAG MWG 
SrGp1_DR_2rv ATAGTTTAGCGGCCGCGGTGCAGGATTTGTCCAATG MWG 
SrGp1_DR_3rv GAAATGACTCTGGCTCTGACTG MWG 
SrGP1_DR_insitu_fw CAAAATTAACCCTCACTAAAGGGGTCAAAGAGATTCGAG
CTAA 
MWG 
SrGP1_DR_insitu_rv TTGTTAACTCCCTATAGTGAGTCGTATTAGCAGCCGGATC
TCAG 
MWG 
sr1drGAPfw1 GAACCGGGCATTGCGGACCTAC MWG 
sr1drGAPrv1 TGAGATGGGTGGACGAGGCAGTG MWG 
sr1drGAPfw2 CGCGGATCCAGACATCAGGACTCTGGTCAAG MWG 
sr1drGAPrv2 CCGCTCGAGAGGAAAGATGGTTTCGTGGTG MWG 
sr1drCtermflfw1 GAGGATGAGGGAGAGCCCATTGAAG MWG 
sr1drCtermflrv1 TACCAAGAGGTTCAAAGCCTGTTTGAG MWG 
sr1drCtermflfw2 CCGGAATTCTATGGACGACACGTTCTCAGACACTTTG MWG 
sr1drCtermflrv2 CCGCTCGAGTCACATGGTGCAGGATTTGTCCAATG MWG 
Carom fw CGGGATCCATGCAGCCGCCGCCGAG MWG 
Carom rv ATAGTTTAGCGGCCGCTTAGCGGGCCCATCGCTCATTTTC MWG 
 
 
6.1.5 Cloning vectors 
6.1.5.1 pET-28b 
 
 
 
 
 
 
 
Fig. 6.1: Multiple cloning site of pET-28b from Novagen  
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6.1.5.2 pET-47b 
 
 
 
 
 
 
Fig. 6.2: Multiple cloning site of pET-47b from Novagen  
 
6.1.5.3 pGEX4T1 
Fig. 6.3: Multiple cloning site of pGEX4T1 from GE Healthcare 
 
6.1.5.4 pGEX6P1 
Fig. 6.4: Multiple cloning site of pGEX6P1 from GE Healthcare 
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6.1.6 Media and Additives 
Tab. 6.4: Media composition and concentrations of additives 
Name Contents/Use Concentration 
LB-Medium Trypton 
yeast extract 
NaCl 
H2O  
10 g 
5 g 
5 g 
ad to 1 l 
M9 minimal medium 5x M9 Salt* 
1 M MgSO4 
1 M CaCl2 
20 % glucose 
1 % thiamin 
amino acids 
DL-Selenomethionine 
200 ml 
2 ml 
0.1 ml 
20 ml 
0.2 ml 
each 50 mg 
50 mg 
M9 minimal medium for NMR 5x M9 Salt* 
15NH4Cl 
1 M MgSO4 
1 M CaCl2 
20 % glucose (13C) 
200 ml 
1 g 
2 ml 
0.1 ml 
1.25 g 
ad to 1 l  
IPTG (1M) for induction of bacterial 
expression 
0.1-1 mM 
Rhamnose (1M) for tuning of protein 
expression with lysozyme 
level 
0.75 mM  
Kanamycin sulfate (10 mg/ml) for resistance 10 µg/ml 
Ampicillin (50 mg/ml) for resistance 50 µg/ml 
Chloramphenicol (100 mg/ml) for resistance 100 µg/ml 
 
* 5x M9 Salt: 64 g Na2HPO4 x 7H2O, 15 g KH2PO4, 2.5 g NaCl, 5 g NH4Cl. For M9 minimal 
medium labelled 15NH4Cl was added instead of unlabelled NH4Cl. 
All additives were filtered and stored at -20 °C or for Rhamnose at room temperature. 
 
6.1.7 Buffers 
6.1.7.1 Agarose gel buffer 
Tab. 6.5: Buffer with components for Agarose gel electrophoresis 
Name Components  
TAE-Buffer (50x) Tris/HCl pH 7.9 
acetic acid 
0.5 M EDTA  
H2O  
Serva Stain G 
242 g 
1 ml 
100 ml 
ad 1 l 
2 µg/ml 
Agarose-gel  agarose in 1x TAE buffer 1 % (w/v) 
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6.1.7.2 SDS-gel buffer 
Tab. 6.6: Buffers for SDS-gel electrophoresis 
Name Components  
Separating-gel buffer 1.5 M Tris/HCl pH 8.8 
0,4 % SDS 
H2O  
181.7 g 
20 ml (from 20 % stock) 
ad 1 l 
Stacking-gel buffer 0.5 M Tris/HCl pH 6.8 
H2O  
60 g 
ad 1 l 
Running-buffer (10x) Tris/HCl pH 8.3  
SDS  
glycerol 
H2O  
151.4 g 
50 g 
720.6 g 
ad 5 l 
Loading-buffer (4x)  100 mM Tris/HCl pH 6.8  
SDS  
glycerol 
Bromphenolblue 
β-ME  
H2O  
1.2 g 
4  % (w/v) 
20  % (v/v) 
0.02 % 
30 µl/ml 
ad 100 ml 
Staining solution Coomassie Brilliant Blue R-250 
ethanol 
acetic acid 
H2O  
2.5 g 
400 ml 
100 ml 
ad 1 l 
Destaining solution ethanol 
acetic acid 
H2O  
300 ml 
100 ml 
ad 1 l 
 
 
Tab. 6.7: Components for six 10 % SDS gels 
Name Components  
Separation gel  H2O 
separation gel buffer 
30 % Acrylamide 
APS 
TEMED 
12.3 ml 
7.5 ml 
10 ml 
250 µl 
25 µl 
Stacking gel H2O 
stacking gel buffer 
30 % acrylamide 
APS 
TEMED 
8.9 ml 
3.8 ml 
2.3 ml 
150 µl 
15 µl 
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6.1.7.3 Western Blot 
Tab. 6.8: Buffers for Western blotting 
Name Components  
Transfer buffer 20 mM Tris 
150 mM glycine  
0.1 mM SDS 
20 % methanol 
H2O  
30 g 
10.5 g 
1 g 
200 ml 
ad 1 l 
Blocking buffer PBS 
Tween 
BSA 
ad 10 ml 
1 % (v/v) 
5 % (v/v) 
Wash buffer Tween 
PBS 
1 % (v/v) 
ad 10 ml 
Detection solution Tetramethylbenzidine 1 ml 
 
 
6.1.7.4 Buffers for silver staining of SDS-gels 
Tab. 6.9: Buffers for silver staining 
Name Components  
Fixation buffer 50 % MeOH 
12 % Acetic acid 
1/2000 37 % Formaldehyde 
H2O 
100 ml 
24 ml 
0.1 ml 
ad 200 ml 
Post-fixation buffer 0.2 g/l Na2S2O3 x 5H2O 
H2O 
0.1 g 
ad to 500 ml 
Developer 60 g/l Na2CO3 
1/2000 37 % formaldehyde 
1/50 post-fixing 
H2O 
12 g 
0.1 ml 
4 ml 
ad to 200 ml 
Stop II solution 50 mM EDTA 
H2O 
9.3 g 
ad to 500 ml 
Staining solution 2 g/l AgNO3 
H2O 
0.2 g 
ad to 100 ml 
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6.1.7.5 Buffers for protein purification 
6.1.7.5.1 srGAP1 FBAR domain 21-469 of Homo sapiens 
Tab. 6.10: Buffers for purification of the srGAP1 FBAR domain of Homo sapiens  
Name Components for 
detergent-applied 
purification 
Components for 
Refolding 
Lysis buffer 20 mM Tris pH 8.0 
300 mM NaCl 
3x protease inhibitor tablets 
2 % N-Laurylsarcosine (sarcosyl; 
added after cell lysis)  
2 mM β-Mercapto ethanol (β-ME) 
20 mM Tris pH 8.0 
300 mM NaCl 
3x protease inhibitor tablets 
2 mM β-ME 
 
Wash buffer I 20 mM Tris pH 8.0 
750 mM NaCl 
10 mM MgCl2 
50 mM KCl 
2 mM ATP 
1 % sarcosyl 
2 mM β-ME 
20 mM Tris pH 8.0 
750 mM NaCl 
10 mM MgCl2 
50 mM KCl 
2 mM β-ME 
 
Wash buffer II 20 mM Tris pH 8.0 
300 mM NaCl 
10 mM imidazole 
0.5 % sarcosyl 
2 mM β-ME 
20 mM Tris pH 8.0 
300 mM NaCl 
10 mM imidazole 
2 mM β-ME 
 
Elution buffer 20 mM Tris pH 8.0 
300 mM NaCl 
150 mM imidazole 
0.2 % sarcosyl 
2 mM β-ME 
20 mM Tris pH 8.0 
300 mM NaCl 
150 mM imidazole 
2 mM β-ME 
 
Dialysis buffer 20 mM Tris pH 8.0 
300 mM NaCl 
0.2 % sarcosyl 
2 mM β-ME 
20 mM Tris pH 8.0 
300 mM NaCl 
4 M urea/2 M urea 
2 mM β-ME 
 
Gelfiltration buffer 20 mM Tris pH 8.0 
300 mM NaCl 
0.2 % sarcosyl 
2 mM β-ME 
20 mM Tris pH 8.0 
300 mM NaCl 
2 mM β-ME 
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6.1.7.5.2 srGAP1 FBAR domain 20-460 of Pristionchus pacificus 
Tab. 6.11: Buffers for purification of the srGAP1 FBAR domain from Pristionchus pacificus 
Name Components  
Lysis buffer 20 mM Tris pH 7,5 
400 mM NaCl 
2 mM MgCl2 
2 mM imidazole 
1.0 % CHAPS  
2 mM β-ME 
Wash buffer I 20 mM Tris pH 7,5 
800 mM NaCl 
2 mM MgCl2 
20 mM KCl 
2 mM ATP 
0.5 % CHAPS 
2 mM β-ME 
Wash buffer II 20 mM Tris pH 7,5 
300 mM NaCl 
10 mM imidazole 
0.5 % CHAPS 
2 mM β-ME 
Elution buffer 20 mM Tris pH 7,5 
300 mM NaCl 
250  mM imidazole 
0.5 % CHAPS 
2 mM β-ME 
Dialysis buffer 20 mM Tris pH 7.5 
300 mM NaCl 
0.5 % CHAPS 
2 mM β-ME 
Gelfiltration buffer 20 mM Tris pH 7,5 
300 mM NaCl 
0.5 % CHAPS 
2 mM β-ME 
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6.1.7.5.3 srGAP1 FBAR domain 21-475 of zebrafish 
Tab. 6.12: Buffers for purification of the srGAP1 FBAR domain from zebrafish 
Name Components  
Lysis buffer 20 mM Tris pH 8.0 
400 mM NaCl 
5 mM imidazole 
1.0 % n-Dodecyl β-D-maltoside 
(β-DDM) 
2 mM β-ME 
Wash buffer I 20 mM Tris pH 8.0 
800 mM NaCl 
2 mM MgCl2 
20 mM KCl  
2 mM ATP 
2 mM β-ME 
Wash buffer II 20 mM Tris pH 8.0 
300 mM NaCl 
10 mM imidazole 
2 mM β-ME 
Elution buffer 20 mM Tris pH 8.0 
300 mM NaCl 
250 mM imidazole 
2 mM β-ME 
Dialysis buffer 20 mM Tris pH 8.0 
75 mM NaCl 
2 mM β-ME 
Mono Q buffer 1 20 mM Tris pH 8.0 
75 mM NaCl 
2 mM β-ME 
Mono Q buffer 2 20 mM Tris pH 8.0 
1 M NaCl 
2 mM β-ME 
Dialysis buffer 20 mM Tris pH 8.0 
300 mM NaCl 
2 mM β-ME 
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6.1.7.5.4 Purification buffers for GST-tagged proteins 
Tab. 6.13: Buffers for purification of GST-tagged proteins 
Name Components 
Lysis buffer 20 mM Tris pH 7.5 
300 mM NaCl 
3x protease inhibitor tablets 
2 mM DTT 
Wash buffer I 20 mM Tris pH 7.5 
750 mM NaCl 
10 mM MgCl2 
50 mM KCl 
2 mM ATP 
2 mM DTT 
Wash buffer II 20 mM Tris pH 7.5 
300 mM NaCl 
2 mM DTT 
Elution buffer 20 mM Tris pH 7.5 
300 mM NaCl 
75 mM GSH 
2 mM DTT 
Dialysis buffer 20 mM Tris pH 7.5 
300 mM NaCl 
2 mM DTT 
Gelfiltration buffer 20 mM Tris pH 7.5 
300 mM NaCl 
2 mM DTT 
 
The final salt concentration was reduced to 150 mM according to the protein stability. 
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6.1.7.5.5 Carom FBAR 
Tab. 6.14: Buffers for purification of the human Carom FBAR domain 
Name Components 
Lysis buffer 20 mM Tris pH 8.0 
300 mM NaCl 
3x Proteaseinhibitor tablets 
2 mM β-ME 
Wash buffer I 20 mM Tris pH 8.0 
750 mM NaCl 
10 mM MgCl2 
50 mM KCl 
2 mM β-ME 
Wash buffer II 20 mM Tris pH 8.0 
300 mM NaCl 
2 mM β-ME 
Elution buffer 20 mM Tris pH 8.0 
300 mM NaCl 
250 mM imidazole 
2 mM β-ME 
Dialysis buffer 20 mM Tris pH 8.0 
300 mM NaCl 
2 mM β-ME 
Gelfiltration buffer 20 mM Tris pH 8.0 
300 mM NaCl 
2 mM β-ME 
 
 
6.1.7.6 Buffer for rat brain tissue and zebrafish embryos pulldown 
Tab. 6.15: Lysis buffer for rat brain and zebrafish embryos  
Name Components 
Lysis buffer 20 mM Tris pH 8.0 
150 mM NaCl 
1 % (v/v) NP-40 
2 mM EDTA 
1 mM Na2HPO4 
5 mM NaF 
3 mM Na4P2O7 
1 mM Na3VO4 
2x proteaseinhibitor tablets 
PMSF (only in homogenizing buffer 
2 µl/ml) 
1 mM DTT 
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6.1.7.7 Buffers for single and double in-situ hybridization 
Tab. 6.16: Used buffer and their components for single and double in-situ hybridization 
Name Components 
PBST pH 7.4 500 ml PBS 
0.1 % Tween 20 
20x SSC pH 7.0 3 M NaCl 
0.3 M Na3-citrate 
2x SSCT 20x SSC 
0.1 % Tween 20 
ad 500 ml H2O 
0.2x SSCT 20x SSC 
0.1 % Tween 20 
ad 500 ml H2O 
4 % PFA 20 g Paraformaldehyde 
ad 500 ml pre-warmed PBS 
proteinase K 10 µg/ml proteinase K in PBST 
HYB- pH 6 50 % Formamide 
5x 20x SSC 
0.1 % of 10 % Tween 20 
HYB+ 5 mg yeast RNA 
50 µg/ml Heparin 
100 ml HYB- 
Western blocking buffer 500 ml PBS 
1 % Tween 20 
Blocking bufffer 5 g blocking reagent 
50 ml MABT 
Glycin 0.05 g glycin 
50 ml PBST 
 
 
6.2 Methods 
6.2.1 Methods in molecular biology 
6.2.1.1 Polymerase Chain Reaction (PCR) 
The target DNA was amplified by PCR with the help of specific oligonucleotides (see chapter 
6.1.4). As templates genomic or plasmid DNA were used (Tab. 6.17 and 6.18) 
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Tab. 6.17: Components of a PCR reaction 
 concentration Volume 
template  5-8 ng 
 
1-2 µl 
MgCl2 1 mM 1 µl 
dNTPs 0.5 mM 1 µl 
5x HF Buffer (New England 
Biolab, Ipswich, USA) 
 10 µl 
primer fw 1 µM 1 µl 
primer rv 1 µM 1 µl 
Phusion High Fidelity DNA 
Polymerase (New England 
Biolab, Ipswich, USA) 
- 1µl 
 
 Tab. 6.18: PCR programme 
 
 
      
        
 
 
The amplified product was analysed via agarose gel (see chapter 6.1.7.1) and purified either 
by gel extraction (Qiagen gel extraction kit, Qiagen, Hilden) or with PCR purification (Qiagen 
PCR purification kit, Qiagen, Hilden).  
 
6.2.1.2 Restriction Digest 
The purified PCR product and the specific vector were cut with restriction enzymes (Fast 
Digest, Fermentas GmbH, Germany) (Tab. 6.19). Vectors were cut for 1 h and PCR products 
for 30 min at 37 °C. The digested samples were then purified with the gel extraction kit. 
Ligation independent cloning (LIC) was applied for two constructs. The LIC method uses the 
3'→5' exonuclease activity of the T4 DNA polymerase to create 15-base single stranded 
overhangs in the LIC vector. PCR products with complementary overhangs are created by 
building appropriate 5' extensions into the primers. The purified PCR product is treated with 
LIC-qualified T4 DNA polymerase in the presence of dATP to generate specific vector-
compatible overhangs. The desired product is formed by annealing.  
Steps Time Temperature 
initiation 2 min 98 °C  
denaturation 1 min 98 °C 
annealing 30 sec 55 °C 
elongation 2 min 72 °C 
final elongation 1 min 72 °C 
Hold - 8 °C 
30x 
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Tab. 6.19: Target genes with restrictions sites 
 
 
 
 
 
 
 
 
6.2.1.3 Ligation 
For the ligation of the target insert into the multiple cloning site of a specific vector a ratio of 
1:3 was taken. The ligation reaction was set up overnight at room temperature (Tab. 6.20). 
Tab. 6.20: Components of the ligation reaction 
 
 
 
 
 
 
6.2.1.4 Competent E. coli cells 
For the transformation, competent E. coli cells were used. For making competent cells a 5 ml 
overnight culture was set up with the required strain from a glycerol stock. 50 ml LB medium 
were then inoculated with 1:200 of the overnight culture and grown till an OD600 of 0.5. Cells 
were cooled on ice for 30 min and centrifuged at 6000 rpm for 10 min at 4 °C. Then they 
were resuspended in 10 ml of cold CaCl2 (100 mM) and incubated one hour at 4 °C. This was 
followed by another centrifugation step at 6000 rpm for 10 min at 4 °C. Then the cells were 
resuspended in 2 ml cold CaCl2 and 416 µl glycerol (to have an end concentration of 15 % of 
glycerol) and aliquoted à 50 µl.  
Construct Restriction sites 
srGAP1_FBAR_DR NcoI, NotI 
srGAP1_GAP_DR BamHI, XhoI 
srGAP1_Cterm_DR BamHI, XhoI 
srGAP1_FBAR_Hs LIC 
srGAP1_GAP_Hs BamHI, XhoI 
srGAP1_ Cterm_Hs LIC 
srGAP1_FBAR_PP NcoI, NotI 
Carom_Hs_FBAR NheI, NotI 
Component Volume 
insert DNA 5 µl 
vector DNA 12 µl 
10x T4 Ligase buffer  
(Fermentas GmbH, Germany) 
1 µl 
T4 Ligase (Fermentas GmbH, Germany) 1 µl 
H2O ad 20 µl 
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6.2.1.5 Transformation of competent E. coli cells 
One 50 µl aliquot of competent cells was thawed on ice. 5 µl of the ligation or plasmid DNA 
were added and incubated for 12 min on ice. This step was followed by a heat shock at 42 °C 
for 30 sec. The cells were cooled on ice for 5 min and then 1000 ml of LB medium was added 
and incubated for 1 h in a 37 °C shaker (Thermomixer compact, Eppendorf AG, Hamburg). 
After a centrifugation step at 13000 rpm for 10 min, the cells were plated on LB plates with 
the corresponding antibiotic and incubated overnight in a 37 °C incubator (Heraeus Incubator, 
Fellbach). 
 
6.2.1.6 Preparation of plasmid DNA 
For the isolation of plasmid DNA colonies were picked and grown in 5 ml LB medium 
containing tubes overnight in a 37 °C shaker. The isolation itself was carried out with a spin 
column kit containing a silica membrane, which binds DNA in the presence of a high 
concentration of chaotropic salt and elutes with low-salt buffer. For small scale preparation 
the QIAprep Spin Miniprep (Qiagen, Hilden) and for large scale preparation the Qiagen 
Plasmid Midi Kit (Qiagen, Hilden) was used.  
 
6.2.1.7 Sequencing of target DNA 
Positive clones were selected and confirmed with DNA sequencing of the target region. For 
that 150 ng of DNA was mixed with 1 µl of the T7 forward and T7 reverse primer (10 
pmol/µl), 0.5 µl BDT mix, 1.9 µl of 5x sequencing buffer (both provided from the sequence 
facility in house) and H2O to a total volume of 10 µl. The sequencing reaction was then 
analysed with the ABI 3730 XL sequencer (Applied Biosystems GmbH, Darmstadt) in the 
sequence facility of the institute. 
 
6.2.2 Methods in protein biochemistry 
6.2.2.1 Overexpression of the proteins in E. coli in LB-Medium 
The expression of each protein construct was carried out in E. coli strains. Table 6.21 shows 
the used E. coli strains, antibiotics and the temperature after induction for each protein 
construct. 
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Tab. 6.21: Overexpression of the different protein domain constructs 
Name Line Antibiotics Temperature 
after 
induction 
srGAP1_DR_FBAR  BL21 (DE3),  
Lemo21 (DE3) 
kanamycin 
kanamycin + chloramphenicol 
28 °C 
srGAP1_DR_GAP BL21 (DE3) Ampicillin 28 °C 
srGAP1_DR_Cterm BL21 (DE) Ampicillin 20 °C 
srGAP1_Hs_FBAR BL21 (DE) kanamycin 28 °C 
srGAP1_Hs_GAP Bl21 (DE3) Ampicillin 28 °C 
srGAP1_Hs_Cterm BL21 (DE3) Ampicillin 18 °C 
srGAP1_PP_FBAR BL21 (DE3) kanamycin 28 °C 
Carom_Hs_FBAR Rosetta II (DE3) kanamycin + chloramphenicol 28 °C 
Cdc42_Hs Isoform 2 BL21 (DE3) Ampicillin 28 °C 
Cdc42_DR Isoform 2 BL21 (DE3) Ampicillin 28 °C 
RhoA_Hs BL21 (DE3) Ampicillin 28 °C 
Rac_Hs BL21 (DE3) Ampicillin 28 °C 
 
The cells were transformed with the plasmids and an overnight culture was set up. In addition 
to the overnight culture the needed antibiotics (34 µg/mg-100 µg/mg) and in case of the 
Lemo21 (DE3) cells 750 µM Rhamnose was additionally added to the medium. The cells 
were grown in 5 l glass flasks in a shaker (Infors Multitron Shajer, INFORS AG, Bottmingen) 
or in ventilated 1 l bottles at 37 °C up to an OD of 0.6, induced with 0.1 mM IPTG and 
harvested after 4 hours. The temperature was down regulated for each protein construct after 
induction, varying from 18-28 °C. For harvesting, the cells were centrifuged at 6000 rpm for 
10 min at 4 °C and the pellet was frozen at -20 °C. For purification harvested cells were lysed 
up to three times with either using the French Press (French Pressure Cell Press, American 
Thermal Instruments, Dayton, USA) or the sonicator (Branson Sonifier 250, G. Heinemann, 
Gmuend, Germany). The lysed cells were pelleted by centrifugation in an ultracentrifuge 
(Beckman Coulter Optima L-80 XP, Beckman Coulter, Krefeld) for 40 min at 104.630 g and 
4 °C. The supernatant was filtered (0.22 µM GP Millipore Express Plus Membrane, Millipore 
Cooperation, Billerica MA, USA) and used as the crude extract. 
 
6.2.2.2 Overexpression in M9-Medium 
15N and 13C-labelled recombinant human Cdc42 and Cdc42 from zebrafish were purified from 
BL21 E. coli strain overexpressing the proteins. Cells were grown in 4 l flasks at 37 ºC, after 
induction with 0.1 mM IPTG at 28 ºC, in minimal medium containing 13C glucose and 15N 
NH4Cl as carbon and nitrogen sources. The cells were grown overnight, harvested and stored 
at -20 ºC. 
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For selenomethionine labelling the Carom FBAR domain was expressed in M9-Medium with 
50 mg of selenomethionine and six additional amino acids (Leu, Ile, Thr, Phe, Lys and Val). 
Selenomethionine replaces the native methionines in the protein. Cells were grown in 2 l 
flasks at 37 ºC, after induction with 0.1 mM IPTG at 28 ºC. The cells were grown overnight, 
harvested and stored at -20 ºC  
 
6.2.2.3 Purification of 6-His-tagged proteins 
For the purification of each protein construct a P1 pump was used to load the crude extract on 
the specific column. Washing and elution steps were carried out on an Aekta FPLC system 
(GE Healthcare). Hexa-histidine tagged proteins (srGAP_FBAR_Hs, srGAP1_FBAR_DR 
and Carom_FBAR_Hs) were purified using an immobilized metal ion affinity 
chromatography (IMAC) column (GE Healthcare). Thereby the protein was eluted with 250 
mM imidazole. This purification step was followed by size exclusion on a Sephacryl 200 
column (GE Healthcare). At each step the purity of the proteins was examined by SDS-
PAGE. 
 
6.2.2.4 Purification of GST-tagged proteins 
GST-tagged proteins (srGAP1_GAP_DR, srGAP1_Cterm_DR, srGAP1_GAP_Hs, 
srGAP1_Cterm_Hs, Cdc42_Hs, zebrafish Cdc42, RhoA_Hs and Rac_Hs) were purified using 
a GSH affinity column (GE Healthcare). Here the protein was eluted with 50 mM GSH. The 
purification was generally followed by an overnight dialysis step for the cleavage of the GST-
tag with either 3C-Protease or Thrombin. This step was then followed by size exclusion on a 
Sephacryl 75 column (GE Healthcare). 
 
6.2.2.5 Purification of 13C and 15N labelled proteins for NMR 
Purification of 13C and 15N labelled human Cdc42 and Cdc42 from zebrafish were conducted 
in the same way as the respective unlabelled proteins. 
 
6.2.2.6 Preparation of nucleotide-free RhoGTPases 
6.2.2.6.1 Nucleotide-free RhoGTPases with alkaline phosphatase 
Preparation of nucleotide-free GTPase is carried out in two steps according to John et al., 
1990. In the first step, 1 U alkaline phosphatase and a 1.5 molar excess of GppNHp are added 
to approximately 1 mg of GDP-bound GTPase to degrade the bound GDP and replace it by its 
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non-hydrolysable analogue. GppNHp is resistant to alkaline phosphatase, but sensitive to 
phosphodiesterase. The protein solution is incubated at 4 °C overnight and the degradation 
process is analysed by a High Performance Liquid Chromatography (HPLC), using an HPLC 
buffer containing100 mM potassium phosphate pH 6.5, 10 mM tetrabutylammonium bromide 
and 7.5 % acetonitrile. After the complete degradation of GDP, 0.002 U snake venom 
phosphodiesterase per mg GTPase is added to the solution of the GppNHp-bound GTPase to 
cleave the nucleotide to GMP, G and inorganic phosphate (Pi). Here again, the protein 
solution was incubated overnight at 4 °C. The degradation process is analysed by HPLC. 
After the complete degradation of GppNHp, the snake venom phosphodiesterase is separated 
from the nucleotide-free protein with the help of an analytical gelfiltration. The nucleotide-
free proteins were stored at – 80 ̊C. 
 
6.2.2.6.2 Nucleotdie-free RhoGTPase with EDTA 
Another approach to remove bound nucleotide is to incubate purified protein sample (~100 
µM) in buffer containing 50 mM Tris, pH 7.5 and 20 mM EDTA for 20 min at 25 °C. This 
step is followed by centrifugation in a Centricon 10 concentrator at 4000 x g for 20 min. This 
was repeated four more times. Then the protein sample was exchanged into buffer containing 
50 mM Tris, pH 7.5, 150 mM NaCl and 1 mM DTE (Zhang et al., 2000). The protein sample 
was examined for the content of remaining nucleotide with 31P NMR spectroscopy before the 
experiment. 
 
6.2.2.7 SDS Polyacrylamide gelelectrophoresis (SDS-PAGE) 
The purity of the proteins was analysed with SDS-PAGE. A specific volume of the protein 
was mixed with 4x SDS buffer and heated up to 95 °C for 5 min. The samples were then 
loaded on 10 % SDS gels (see chapter 6.1.7.2). Additionally a protein marker (PageRuler 
Prestained Protein Ladder, Fermentas GmbH, St. Leon-Rot) was loaded. The gels were 
stained with Coomassie Brilliant Blue R-250 (SERVA Electrophoresis, Heidelberg, Germany) 
until protein bands became visible and then destained in a destaining solution. The gels were 
analyzed with the help of a gel documentation system (Fusion SL Vilber Lourmat, pEQLAB, 
Germany). 
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6.2.2.8 Silver staining 
For more sensitive detection of protein bands silver staining was used. All buffers (see chapter 
6.1.7.4) were prepared freshly at the day of use. The 10 % SDS gel was fixated overnight at 
room temperature. To remove the acetic acid the gel was washed three times with water, 50 % 
ethanol and again with water. Then the gel was incubated in the post-fixation buffer for 10 
min and quickly washed with water afterwards. The silver staining solution was applied to the 
gel for 0 min, then quickly washed off with water to reduce the staining intensity and 
developed for 5 min in the developing buffer. When bands started to appear the reaction was 
stopped by changing to the Stop II solution. The gel was transferred to water after 24 h and 
analysed with the gel documentation system.  
 
6.2.3 Biophysical Methods 
6.2.3.1 Circular Dichroismus Spectroscopy 
The secondary structure of purified proteins, was examined with Circular dichroismus (CD) 
spectroscopy (Jasco CD Spectropolarimeter J-810). Therefore an aliquot of the protein was 
dialyzed in buffer with 50 mM NaF. The measurement was blanked with buffer, then the 
protein was diluted to 0.5 mg/ml and then measured in a 1 mm cuvette (Tab. 6.22). 
Tab. 6.22: Parameter for examining the secondary structure 
Parameter  
band width 1 nm 
response 1 sec 
sensitivity Standard 
measurement range 260-190 nm 
data pitch 0.1 nm 
scanning speed 200 nm/min 
accumulation 10 
cell length  0.1 cm 
temperature 20 °C 
 
Additionally heat denaturation of the protein sample was carried out, to examine the melting 
temperature of the protein. The melting curve was recorded at 220 nm and the denaturation of 
the protein samples was followed over a temperature gradient from 20 °C- 90 °C. Curves with 
sigmoidal curvature indicated proper folding of the protein sample. 
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6.2.3.2 Nuclear Magnetic Resonance  
Samples for 1H and 31P Nuclear Magnetic Resonance (NMR) were prepared at concentrations 
of 0.15-0.25 mM in their specific buffers. 31P NMR was measured at 243 MHz (i.e. on a 600 
MHz spectrometer). Samples for 19F NMR were prepared at a total concentration of 0.15 mM 
in 20 mM Tris pH 7.5, 150 mM NaCl and 1 mM MgCl2 with addition of 120 µM AlCl3 and 5 
mM NaF. 19F spectra were recorded at 282 MHz (i.e. at a 300 MHz spectrometer). The 
binding site mapping for the Cdc42-AlFl4--GAP complex was recorded on 600 or 800 MHz 
spectrometers. All measurements were carried out at room temperature. Spectra were 
analysed with Sparky (version 3.113; Goddard/UCLA) or gsim (version 0.20.2b; 
Zorin/Durham University) and images arranged in Adobe Illustrator 6 (Version 16.0.0, Adobe 
System Incorporated, USA). 
 
6.2.3.3 Crystallography 
In order to determine the molecular structure of the target protein, it was subjected to 
crystallization. Therefore several screens in 96 well plates (Art-Robbins Intelli Plates, USA) 
were set up by mixing 0.3 µl of protein with 0.3 µl of the reservoir solution with the help of a 
Honeybee 963 crystallization robot (Genomic Solution). Images of the drop were obtained 
with the help of the RockImager 54 (Formulatrix, Waltham MA, USA) and manually 
inspected. Crystallization conditions were optimized by hanging drop screens varying protein 
concentration and concentration of the reservoir components. The following eight different 
crystallization screens (Qiagen Nextal) were applied on the proteins: Classic Suite I and II, 
PEGs Suite I and II, Protein Complex Suite, Joint Centre for Structural Genomics (JCSG) 
Suite, PACT Suite and the Cryos Suite. Additionally, heavy metal soaking experiments with 
platinum and mercury salts were carried out. Here, following platinum and mercury salts from 
the Hampton Research Heavy Atom Screens were applied to the proteins, according to their 
minimum pH: Pt1-Pt6, Pt8, Pt10, Pt12, Hg2 and Hg3. For the soaking experiments the 
crystals were transferred from the mother liquor to the solution with 10 mM of the heavy 
atom salt and incubated either for few hours or overnight.  
Protein crystals were picked with small nylon loops (Hampton) and either frozen in liquid 
nitrogen at once or immersed in cryo solution before freezing. Measurements of the frozen 
crystals were carried out at the Beamline PXII at the Swiss Light Source (SLS; Paul-Scherrer-
Institut, Villigen, Switzerland). 
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6.2.3.4 Mass Spectrometry Analysis 
For mass spectrometry analysis pulldown samples were submitted to a gel, run on a 1D SDS 
PAGE (NuPAGE 10 % BisTris gels, Invitrogen). The proteins were visualized by freshly 
made Coomassie blue staining. Destaining was performed with a destaining solution (see 
chapter 6.1.7.2). Each lane was divided into three to four sections for in-gel digestion. The gel 
pieces were dehydrated with acetonitrile (ACN), then swollen at room temperature by adding 
13 ng/ml sequencing-grade trypsin (Promega, Germany). The digestion was performed at 
37 °C overnight. The resulting peptides were extracted in three subsequent incubation steps 
with different concentrations of CAN. Supernatants were combined, ACN was evaporated in 
a vacuum centrifuge and peptides were desalted using C18 StageTips. The digested peptides 
were separated with the help of a nano-LC (Easy-nLC, Thermo Fisher Scientific, Germany), 
which is coupled to an LTQ-Orbitrap-XL (Thermo Fisher Scientific, Germany) through a 
nano-LC-MS interface (Proxeon Biosystems, Germany). Peptides were eluted using a 
segmented gradient of 5-90 % HPLC solvent B (80 % acetonitrile in 0.5 % acetic acid) at a 
flow rate of 200 nl/min over 43 min. The data acquisition was conducted in the positive ion 
mode. The mass spectrometer was operated in the data-dependent mode to automatically 
switch between MS and MS/MS acquisition. Survey full-scan MS spectra were acquired in 
the mass range of m/z 300–2000 in the orbitrap mass analyser at a resolution of 60,000. The 
five most intense ions were sequentially isolated and fragmented in the linear ion trap using 
collision-induced dissociation (CID) at the ion accumulation target value of 5000 and default 
CID settings. The ions already selected for MS/MS were dynamically excluded for 90 sec. 
The resulting peptide fragment ions were recorded in the linear ion trap. 
The raw data was analysed using the MaxQuant software version 1.2.2.9 (Cox et al., 2008) to 
generate peak lists that can be used for database search. A non-linear mass re-calibration for 
each pre-cursor ion and calculates precise masses as well as individual mass errors. The 
derived MS data were submitted to the Andromeda search engine (Cox et al., 2011).The 
acquired MS data was searched against a rat database and in the case of the second pulldown 
against a zebrafish database plus the sequences of GST_srGAP1_Hs_Cterm/GST-
srGAP1_DR_Cterm and 248 common contaminants. The Andromeda database scores 
calculated by MaxQuant were converted to posterior error probabilities (PEP) and false 
discovery rates were set to 1 % at peptide and protein group level (Elias et al., 2007). 
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6.2.4 Bioinformatics 
The bioinformatics toolkit of the MPI for Developmental Biology 
(http://toolkit.tuebingen.mpg.de/) served as a platform for a variety of sequence analysis.  
Homologs of the target protein sequence were found with PSI-BLAST (Altschul et al., 1997) 
by searching against a protein database, here the non-reduntant sequence database 70 (nr70). 
nr70 contains representative sequences, which are filtered for a maximum pairwise sequence 
identity of 70 %. The search was restricted to 2000 sequences at an E-value cut-off of 0.001, 
which is the threshold for including a sequence to the model created by PSI-BLAST to be 
used on the next iteration. The result of this search was then subjected to cluster analysis by 
pairwise BLAST P-values (Altschul et al., 1990) in CLANS (Frickey et al., 2004). Here, the 
sequences were clustered at a p-value of 10-15.  
Multiple sequence alignments were carried out with CLUSTALW. Coiled coil analysis was 
carried out with the help of the Coil/Pcoil tool (Parry et al., 1982; Lupas et al., 1991; Lupas et 
al., 1996). 
 
6.2.5 In vivo and in vitro Assays 
6.2.5.1 Pulldown 
The rat brain was weighed and buffer was added according to the weight. Then it was 
homogenized with a glass potter and centrifuged for 10 min at 3000 rpm. The supernatant was 
centrifuged again for 40 min at 164864 g in a Ti70 rotor. Approximately 1 ml of GSH beads 
were equilibrated with lysis buffer. To pre-clear the lysate, it was added to 600 µl of the 
equilibrated GSH beads and then rotated for 30 min at 4 ºC. This step was followed by a 
centrifugation step for 10 min at 13000 rpm and the supernatant was transferred into a new 
tube. 1 mg of the GST-tagged C-terminus was added to the 400 µl of equilibrated beads and 
incubated for 30 min at 4 ºC. Before adding 1 ml of the pre-cleared lysate to each bead 
condition, the beads were washed once with lysis buffer. The incubation took place overnight 
at 4 ºC. The beads were washed 4x with lysis buffer and then taken up in 60 µl 2x SDS-buffer 
and heated it up at 90 ºC for 10 min. This step was followed by another centrifugation step for 
10 min at 13000 rpm at 4 ºC and the supernatant transferred into a new tube. 10 µl were 
loaded on a BioRad TGX any kD gel (BioRad, Germany) and specific areas cut out and 
analysed by mass spectrometry. The pulldown with zebrafish embryos was carried out 
accordingly. 
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6.2.5.2 In-situ hybridization in zebrafish embryos 
6.2.5.2.1 Handling of the zebrafish embryos 
For the double in-situ hybridizations fish pairs from the albino strain were setup. After 2 h, 
laid eggs were picked in petri dishes and incubated at 28 °C.  1 mM of pronase was added to 
the medium to dechorinate the embryos. After 48 h the embryos were aliquoted à 100 each 
into 2 ml Eppendorf tubes and incubated overnight in 4 % Paraformaldehyde (PFA) at 4 °C. 
After that the embryos were transferred into 100 % MeOH in several steps (25 %, 50 %, 
75 %) and frozen at -20 °C. 
 
6.2.5.2.2 Generating template for in vitro transcription 
The DNA probe of the target domain was generated by PCR amplification from genomic 
DNA. The product was then cloned into a Topo vector (Invitrogen, Germany), which has a T7 
and SP6 recognition site before and after the insertion site (Tab. 6.23).  
Tab. 6.23: Different template primers for in vitro transcription 
Primer Sequence 
srGAP1_DR_insitu_fv CAAAATTAACCCTCACTAAAGGGGTCAAAGAGATTCGAGCTAA 
srGAP1_DR_insitu_rev TTGTTAACTCCCTATAGTGAGTCGTATTAGCAGCCGGATCTCAG 
Robo_fv GGATCCTAATACGACTCACTATAGGGAGGCCGTGATGGAGGTCGACGGCG 
Robo_rv ACAGGTGTCCACTCCCAGGTCCAAG 
 
The primers for generating the Robo samples are the same. After analysing the end product 
via sequencing, antisense RNA was generated for each sample with an in vitro transcription                              
kit (Roche, Germany). srgap1 was labelled with Digoxigenin (Roche, Germany) and robo1, 2 
and 3 with Fluorescin (Roche, Germany).  
 
6.2.5.2.3 Single in situ hybridization 
The single in situ hybridization assay was carried out at room temperature if not mentioned 
otherwise in the text. Embryos of different stages (16 hpf, 24 hpf, 30 hpf, 48 hpf and 72 hpf) 
were rehydrated in a MeOH series (100 %-25 %) and then washed twice in phosphate-
buffered saline (PBS) with 0.1 % 10 % Tween 20 (PBST). After digestion with 10 µg/ml 
proteinase K (Tab. 6.24) the embryos were washed twice in PBST and then incubated 20 min 
in 4 % PFA to refix the embryos.  
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Tab. 6.24: Embryonal stages and proteinase K digestion time 
Embryonal stages Time 
16 hpf 4 min 
24 hpf 7 min 
30 hpf 10 min 
48 hpf 12 min 
72 hpf 20 min 
 
After washing twice in PBST the embryos were divided into different vials and then pre-
hybridized in 200 µl Hyb+ buffer for 4 h at 65 °C. Embryos were hybridized overnight at 
65 °C with 1 µg RNA in 200 µl Hyb+ buffer. The RNA sample was taken out and the 
embryos were washed with 50 % Formamide/SSCT (twice for 30 min), 2 % SSCT (15 min), 
0.2 % SSCT (10 min) and then blocked with blocking buffer overnight. All washing steps 
were carried out at 65 °C in a water bath. For the detection of labelled RNA a 1:5000 dilution 
of Fab-AP (Roche, Germany) antibody was added overnight and kept at 4 °C. Then NTMT 
buffer was added to embryos and incubated 4x for 25 min. For staining BM-Purple was 
added. The embryos were incubated till all stages were stained to the same extent. The 
staining reaction was stopped with two PBST washing steps.  Then the embryos were 
transferred stepwise into 50 % glycerol for mounting. For microscopy of the embryos lateral 
and dorsal views were mounted on object slides (Roth, Germany) and then photographed with 
a Discovery microscope (Zeiss, Germany). The pictures were taken with the AxioVision 
Software (Zeiss, Germany) and edited with ImageJ 1.42 (National Health Institute, USA). 
 
6.2.5.2.4 Double in-situ hybridization 
All steps of this process were carried out at room temperature if not mentioned otherwise. 
48 h old zebrafish embryos were rehydrated in a stepwise series of MeOH and PBS washes 
and then washed 4x 5 min in PBST. Digestion of the embryos was performed with 10 µg /ml 
proteinase K in PBST for 15 min and washed 3x in PBST. After refixing the embryos in 4 % 
PFA for 20 min and washing 5x in PBST, the embryos were pre-hybridized in 300 µl of Hyb+ 
buffer for 4 h at 65 °C. Samples were prepared by adding 200 ng RNA to 200 µl hybridization 
buffer. Embryos were hybridized overnight in a 65 °C water bath.  Excess of the RNA sample 
was washed in several washing steps at 65 °C with 2x SSC and 50 % Formamide (15 min), 2x 
SSC (4x 15 min), 0.2 SSC (4x 15 min). The rest of the washing steps with 3x with PBST were 
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carried out at room temperature. For the detection of the labelled RNA the embryos were 
incubated in a western blot reagent, diluted 1:20 in PBST for 2 h at room temperature. The 
primary antibody sheep anti α-DIG (Roche, Germany) was diluted 1:5000 in western blocking 
buffer. The embryos were incubated at 4 °C overnight. The incubation step was followed by 
6x of 15 min washing steps with PBST. Then the embryos were re-blocked in western 
blocking buffer for 1 h at room temperature and the second antibody HRP-conjugated rabbit 
anti-sheep (Roche, Germany) was applied in a 1:200 dilution to the embryos overnight at 
4 °C. Again the embryos were washed 6x 15 min with PBST after this incubation step and 
visualized with TSA Alexa Fluor 647 (Life Technologies, Germany) with HRP goat anti- 
mouse IgG (Roche, Germany). Therefore the tyramide solution was diluted in 1x 
amplification buffer. The reaction was setup for 1 h in the dark under agitation and at room 
temperature. This was followed by 5x of 1 min washing steps with PBST, then the HRP was 
deactivated by incubating the embryos for 30 min with 6 % H2O2 and washed again 3x 10 min 
in PBST. After reblocking the embryos for 1 h in western blocking buffer, they were 
incubated in α-Fluorescin-POD (1:500 diluted) overnight at 4 °C. The tyramide signal 
amplification detection was repeated for the secondary antibody as described for the primary 
antibody. The fluorescence microscopy was carried out at a LSM 510 Meta (Zeiss, Germany). 
 
6.2.5.3 Assays with liposomes 
6.2.5.3.1 Generating the liposomes 
A mix of different lipids was used in the assays. Table 6.25 shows the lipid composition of the 
Endo-Mix liposomes with their molecular mass, stock solution and the used volume for a 
2.7 mg/ml (corresponding to 4 mM) lipid mix. The lipids were purchased from Avanti 
(Avanti, Alabama, USA). 
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Tab. 6.25:  Lipid composition of the Endo-mix liposomes 
Lipids Molar mass 
(g/mol) 
molar 
concentration 
[%] 
Lipid 
weight 
[µg] 
Cholesterol 386.65 35 541.32 
Sphingomyelin 760.22 10 304.08 
phosphatidylethanolamine (PE) 756.36 10 302.54 
phosphatidylserine (PS) 824.96 10 329.98 
phosphatidylinositol (PI) 902.13 5 180.42 
phosphatidylcholine (PC) 786.64 25 786.64 
phosphatidylinositol-4,5-
bisphosphate (PI(4,5)P2) 
1096.38 5 219.27 
    
Ø Molar mass 666.03 Total [µg] of lipids 2664.25 
 
To generate liposomes 1 ml of the lipid mix was transferred into a pear-shaped flask and 1 ml 
chloroform was added. The solution is then evaporated in a rotary evaporator for 60 min at 
90 rpm and 30 mbar. The dried lipid film is then re-suspended in a specific buffer (20 mM 
HEPES pH 7.5, 140 mM KCl, 10 mM NaCl, 1 mM MgCl2 to form multilamellar liposomes. 
The flask is then covered with parafilm and has to undergo a 10x freeze-thaw cycles in liquid 
nitrogen and 45 ºC water bath. The multilamellar liposomes are then aliquoted in Eppendorf 
tubes and stored at -80 ºC. 
 
6.2.5.3.2 Co-sedimentation with high speed centrifugation 
First the liposomes were brought to uniform size with a 3 min sonication step. For the co-
sedimentation assay 1 mg liposomes were incubated with 5 µM srGAP1 FBAR domain of 
zebrafish for 2 h in a table shaker (Eppendorf, Germany) at 37 ºC. This step was followed by 
a high-speed centrifugation step at 21000 g at room temperature for 30 minutes. Supernatant 
and pellet were analysed with a 10 % SDS gel. 
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6.2.5.3.3 Negative stain electron microscopy  
The liposomes were brought to uniform size with a 3 min sonication step. Then 1 mg of 
liposomes were incubated with 5 µM srGAP1 FBAR domain of zebrafish for 15 min. For the 
liposome assay electron microscopy (EM) carbon coated grids were used. The sample was 
pipetted on the grids, incubated for a while and then absorbed with a small tissue. The grids 
were washed 3x to remove probe excess and then stained with 1 % uranylacetate for 30 s. The 
grids were imaged with a Tecnai Spirit G2. 
 
6.2.5.4 Giant Unilamellar Vesicle (GUV) assay 
For the GUV assay different lipids were mixed in different concentrations to mimic the 
composition of the cell membrane (Tab. 6.26). Calculation of the used volume was done 
according to Tab. 6.25 in chapter 6.2.5.3.1. 
Tab. 6.26: Compositions of the GUVs 
Component  Molar concentration  
(%) 
Cholesterol 35 % 
Sphingomyelin 10 % 
PE 10 % 
PS 50 % 
PC 5 % 
PI 25 % 
PI(4,5)P2 5 % 
dicarbocyanine (DiD) 0.5 % 
 
The lipids were dissolved in chloroform to a concentration of 2.7 mg/ml and 15 µl of the 
solution were spread on platin (Pt) electrodes and dried in a desiccator for 30 min. The 
chamber was filled with a 300 osm sucrose solution and the Pt electrodes are connected to a 
pulse generator and an alternating voltage of 1.2 V and 10 Hz is applied for 1 h 50 min. To 
detach the GUVs from the electrodes a voltage of 1.2 V and 2 Hz is applied for 20 min. The 
vesicles are then transferred to an observation chamber, filled with an iso-osmolar buffer and 
let stay there to sink down to the bottom of the chamber. The proteins (5 µM) were added to 
the GUVs and inverse microscopy was carried out at an Olympus Fluoview 1000 with a 60x 
water objective at different time points.  To label the proteins with Alexa-488-C5-maleimide, 
the proteins were treated with 1 mM DTT and dialyzed in 20 mM Tris and 300 mM NaCl at 
pH 7.5. 100 µl of the dialysed protein sample was incubated with the dye for 2 h at 25 ̊C. To 
stop the reaction 1 M β-ME is added to the samples and incubated for another 1 h. This is 
followed by a centrifugation step at 13000 rpm for 5 min. To remove the free dye the sample 
was purified with a small G50 column, which was equilibrated with the dialysis buffer. 
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7. Results 
7.1 characterization of the srGAP1 protein  
The srGAP family was first mentioned by Wong et al. in 2001. To date four members 
(srGAP1-4) have been identified, of which mostly human srGAP1, srGAP2 and srGAP3 have 
been characterized (Couthino-Budd et al., 2012; Guerrier et al., 2009; Mason et al., 2010; 
Wong et al., 2001). Excepting the SH3 domain of srGAP1, there is no structural data available 
for the domains of any member of this protein family.  
 
7.1.1 Bioinformatical cluster analysis of the srgap family 
Homology, described as similarity through common descent, can be observed on a scale 
ranging from genetic sequence to anatomy. A high degree of protein sequence homology 
gives a strong expectation, that protein functions will be retained in different species (Tatusov 
et al., 1997). Here, the homology of the srGAP family to other protein families was analysed. 
Therefore, the full-length srGAP1 sequence was subjected to cluster analysis. Protein clusters 
are created using a BLAST p-value, which takes in the length of the hit versus the query and 
the subject. The top hits of the BLAST search are then clustered together. All sequence 
similarity searches were carried out in the MPI bioinformatics toolkit 
(http://toolkit.tuebingen.mpg.de; Biegert et al., 2006). 
In this query the full-length srGAP1 protein sequence was used to identify homologs of the 
srGAP proteins, which may help to predict structural and functional characteristics of the 
srGAP family. First, a PSI-BLAST search (Altschul et al., 1997) was carried out. Thereby, the 
amino acid sequence is searched against a protein database, here the non-redundant sequence 
database 70 (nr70), for similar sequences. PSI-BLAST performs iterative BLAST searches 
and builds an alignment from the best hits. This alignment is then used for the next search 
round. The nr70 data base contains sequences, which are filtered for a maximum pairwise 
sequence identity of 70 %. The search was restricted to 2000 sequences at an E-value cut-off 
of 0.001, which is the threshold for including a sequence to the model created by PSI-BLAST 
to be used on the next iteration. The result of this search was then subjected to cluster analysis 
by pairwise BLAST p-values (Altschul et al., 1990) in CLANS (CLuster ANalysis of 
Sequences, Frickey et al., 2004). P-values are defined as the probability that the score of an 
alignment of an evolutionarily unrelated sequence pair will be higher or at least the same as 
for a given alignment. Small p-values mean that the alignment of a given sequence pair is 
statistically relevant and is less likely by chance (Higgs and Atwood, 2005). Here, only 
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connections of a p-value of 10-15 or better were considered.  Clusters are formed based on 
attractive and repulsive forces according to the Fruchterman-Reingold algorithm (Frickey et 
al., 2004). Similar sequences (represented by dots) locate close together after a few iterations 
and form one cluster. 
The cluster map in Fig. 7.1 shows ten distinct clusters, some containing satellite-clusters. The 
clusters seem to be not closely related as indicated by the distance of the different clusters. 
Analysis of the domain composition of each protein family showed that all of them contain a 
FBAR domain and therefore belong to the BAR superfamily. The srGAP family cluster 
contains 239 sequences and is well separated from neighbouring clusters. It is connected to 
the FCH and double SH3 domain protein family as well as the RhoGAP containing protein 
family and the Tyrosine protein kinase Fer family. The FCH and double SH3 domain protein 
family consists of three sub-cluster which can be assigned to FCH and double SH3 domain 1, 
FCH and double SH3 domain 2 and Nervous Wreck, which can be only found in Drosophila. 
The RhoGAP containing protein family can be only found in Dictyostelium, whereas tyrosine 
protein kinase Fer family consists of two sub-clusters, which can be assigned to protein 
kinases found in insects and in mammals. The tyrosine protein kinase Fer family is an outlier 
group, which is only connected to the srGAP family and to a not annotated protein in the 
Cdc42 interacting family. It is also the only protein family with a SH2 domain and a Protein 
kinase C domain. All homologous protein families, besides the FCH domain only protein 
family, contain additional domains either SH3 domains or GAP domains.  The srGAP family, 
the RhoGAP containing protein family in Dictyostelium and the GTPase activating proteins in 
fungi are the only protein families with an annotated GAP domain. 
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Fig. 7.1: CLANS map of the srGAP family and their related protein families 
The sequences were clustered in CLANS at a p-value cut-off of 10-15, based on the all-against-all pairwise similarity as 
calculated by BLAST p-values. Dots illustrate protein sequences, whereas lines represent p-values. Darker lines represent 
lower p-values, whereas lighter lines represent higher p-values. Each colour represents one protein family, also indicated by 
the colour of the labels and each cluster is labelled with a number. A legend of the domains and the domain composition of 
each protein family is illustrated below the cluster map. 
 
In Tab. 7.1 all protein families found in the cluster map are listed with their known function. 
Interestingly, most of them are involved in the regulation of the cytoskeleton. 
 
 
 
 
FBAR GAP SH3 SH2 Protein kinase C WW 
1) Tyrosine proteinkinase Fer family 
2) Cdc42 interacting protein family 
3) Actin polymerization Bzz1 protein 
4) FCH and double SH3 proteins 
5) srGAP family 
6) GTPase activating protein family 
7) RhoGAP containing protein family 
8) FCH domain only proteins 
9) Growth arrest specific protein 
10) Protein kinase C and Casein kinase  
       substrate (PACSIN) 
(1) 
(2) 
(3) 
(4) 
(5) 
(6) 
(7) 
(8) 
(9) 
(10) 
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Tab. 7.1 Neighboring protein families with their known function  
 
 
A closer look at the srGAP family cluster (Nr. 5 in Fig. 7.1) shows that the previously 
compact cluster (at p-value cut-off of 10-15) disassembles and reveals six sub-clusters when 
edges with p-values above 10-200 are removed (Fig. 7.2).  
 
 
 
 
 
 
 
 
Fig. 7.2: Sub-clusters in the srGAP family cluster  
Cluster analysis of the srGAP protein cluster at p–value cut-off of 10-200 which separates into six sub-clusters: SRGAP1 from 
Caenorhabditis, srGAP 1,3, srGAP1 and 1-like, srGAP1, srGAP2 and srGAP3, srGAP4 and srGAP 4-like. 
 
The small cluster of the SRGAP1 proteins in Caenorhabditis (CBN-SRGAP1) is connected to 
the bigger cluster through the srGAP1 protein in the roundworm of pigs, which could be the 
evolutionary link between the C. elegans SRGAP1 and the other srGAP proteins. 
Interestingly srGAP1,3 can be only found in a few organisms: Yellow fever mosquito (Aedes 
aegypti), the southern house mosquito (Culex qinquefasciatus) and tick (Ioxedes scapularis). 
Protein family Function 
srGAP protein family  Regulation of actin dynamics, cell migration and differentiation 
Role in neuronal morphogenesis and migration 
FCH and double SH3 protein family Regulation of actin polymerization and cell migration 
Role in neuronal migration 
Actin polymerization Bzz1 protein Actin polymerization and endocytosis in yeast 
Cdc42 interacting protein family Reorganization of actin cytoskeleton 
Tyrosine protein kinase Fer family Regulation of actin cytoskeleton, microtubule assembly, 
lamellipodia formation and cell migration 
Growth arrest specific protein 
family 
Microtubule regulation 
FCH domain only protein family Clathrin-mediated endocytosis 
Protein kinase C and Casein kinase 
substrate family 
Reorganization of actin cytoskeleton and neuron 
morphogenesis 
RhoGAP containing protein family Unknown function in Dictyostelium 
GTPase activating proteins Unknown function in fungi 
srGAP 1,3  
srGAP 1 and 1-like 
CBN-SRGAP 1 
 srGAP4-like 
 srGAP4 
srGAP1 
srGAP2 
srGAP3 
srGAP 1 in 
roundworm 
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The separated part of srGAP1 and srGAP 1-like proteins can be found in some members of 
the insects. srGAP1, srGAP2 and srGAP3 are too similar and therefore did not collapse into 
different sub-clusters, whereas srGAP4 differentiates from the big cluster. Also the srGAP4- 
like proteins separate from the main srGAP4 cluster. Three main outlier sequences can be 
detected, which can be assigned to srGAP-4 like partial protein in common chimpanzee (Pan 
troglodytes), an unnamed protein in pufferfish (Tetraodon nigroviridis) and srGAP1 in 
atlantic salmon (Salmo salar) (dots from left to right). Members of srGAP1-4 have been only 
identified in eukaryotes. As many genomes, for example that of fish, are not fully sequenced 
yet, more srGAP proteins and their isoform containing organisms might emerge in the future.  
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7.1.2 Developmental and tissue-specific expression analysis 
of srgap1 in zebrafish embryos 
The bioinformatical analysis showed that srGAP1, srGAP2 and srGAP3 are highly similar, as 
they can be found in one cluster, which does not form subclusters. This also hints a possible 
conservation of the srGAPs in different organism. On a mRNA level, expression patterns of 
the srGAPs in rat, mice and human foetuses have been shown to be similar (Bacon et al., 
2009; Ip et al., 2011; Wong et al., 2001). Here, the expression pattern of srgap1 in zebrafish 
embryos was analysed for the first time. Zebrafish is an excellent model system for studying 
cellular, molecular and genetic developmental mechanisms of vertebrates (Streisinger et al., 
1981). So far, there is no information available regarding the mRNA expression pattern of the 
srgap family in developing zebrafish embryos. In the following section, the spatiotemporal 
gene expression patterns of srgap1 in different stages and tissues of zebrafish embryos is 
analysed and described. 
 
 
7.1.2.1 Gene expression pattern analysis in developing zebrafish embryos 
7.1.2.1.1 Expression of srgap1 in developing zebrafish embryos 
The expression of srgap1 has been studied previously in embryos and juvenile stages of rats, 
mice and in human foetuses and showed expression in the brain, specifically in retinal 
ganglion cells of E15 mouse embryos, the olfactory bulb of P2 mouse embryos, as well as in 
the anterior subventricular zone (SVZa) of the forebrain in P3 rats (Bacon et al., 2009; Ip et 
al., 2011; Wong et al., 2001). Expression in the spinal cord and the dorsal root ganglia of P2 
mouse is also described, though the expression levels are not specified. Human foetuses, 
ranging from 8-17 post-conceptional week (PCW), show expression in corticospinal axons. 
However, nothing is known about the expression of srgap1 in early embryonic and larval 
stages of zebrafish. In the following the expression of srgap1 was examined with whole-
mount in-situ hybridization experiments, which provide information about the timing and 
localization of the transcribed mRNA in the embryos. For this a 1425 bp long sense and anti-
sense probe of srgap1, corresponding to the FBAR domain of the srGAP1 protein was 
generated and labelled with digoxigenin before incubating it with fixed embryos. Figure 7.3 
shows lateral views of a 24 hours post fertilization (hpf) zebrafish embryo hybridized with the 
anti-sense (Fig. 7.3 A) and the negative control sense probe (Fig. 7.3 B). As seen in Fig. 7.3 
A, strong srgap1 expression is concentrated in the fore-, mid-, and hindbrain as well as in the 
retina, the spinal cord and the tail of the zebrafish embryo. No signal can be observed with the 
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sense RNA probe (Fig. 7.3 B), thus confirming the specificity of the signal of the anti-sense 
probe of srgap1 in Fig. 7.3 A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.3: Single in-situ hybridization experiment to analyse expression patterns of srgap1 in different developmental 
stages of zebrafish embryos  
For the single in-situ hybridization experiment the srgap1 RNA was Digoxigenin-labelled, detected with AP-conjugated α-
DIG antibody and developed with NBT-BCIP. The stages are indicated in hours post-fertilization. (A) Lateral view of a 
24 hpf zebrafish embryo with the anti-sense RNA probe. Labels indicate major expression areas for srgap1 in fore-, mid- and 
hindbrain as well as spinal cord and tail. (B) Lateral view of a 24 hpf zebrafish embryo with the sense RNA probe (labels 
indicate main parts of the embryo) Abbreviations: B, brain; FB, forebrain; HB, hindbrain; MB, midbrain; RT, retina; SC, 
spinal cord; T, tail. Images were taken with at a Discovery microscope (Zeiss) with 80x resolution. Scale bar: 5 µm 
 
These results fit well the expression patterns observed in rat and mouse embryos, as well as 
human foetuses (Bacon et al., 2009; Ip et al., 2011; Wong et al., 2001), leading to the 
conclusion that the expression sites of srgap1 are conserved in different vertebrate organisms. 
The expression of srgap1 in the central nervous system (CNS) correlates well with the 
predicted role of srgap1 in neuronal processes, such as axon guidance and neuron growth (Ip 
et al., 2011). Therefore, a possible correlation of srgap1 expression with the expression of its 
predicted interaction partners robo1, robo2, robo3 was investigated in the following. 
 
 
 
 
(A) 
(B) 
24 hpf 
24 hpf 
FB 
MB 
HB SC 
T 
RT 
B 
SC 
T 
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7.1.2.1.2 Comparison of the expression pattern of srgap1 with robo1-3  
The Robo family, cell-surface receptors for Slit ligands, represent possible interaction partners 
for the srGAP1 protein in vivo and play a major role in neuronal migration, axon guidance, 
vessel integrity and angiogenesis in case of Robo4. In this chapter, the comparison of the 
expression sites of three zebrafish robo genes (robo1-robo3) with srgap1 in zebrafish is 
described. While the extracellular domains of the robo 1-3 genes are conserved (see Tab. 7.2), 
robo4 shows less similarity with only 48 %-51 %. robo1, robo2 and robo3 show similar but 
distinct expression patterns in the zebrafish embryos (Campbell et al., 2007; Lee et al., 2001; 
Miyasaka et al., 2005; Thisse et al., 2001; Thisse et al., 2008 (direct Zfin database entry)), 
whereas robo4 has been described to be expressed in embryonic vasculature (Kaur et al., 
2007). This study concentrates on robo1-3, as based on literature data they seem to be 
involved in similar cellular functions as assumed for srgap1. 
 
Tab. 7.2: Comparison of the DNA sequence identities of the four robo genes of zebrafish 
Gene Sequence identity 
robo1-robo2 65 % 
robo1-robo3 63 % 
robo1-robo4 48 % 
robo2 –robo3 65 % 
robo2-robo4 51 % 
robo3-robo4 49 % 
 
To determine whether srgap1 expression is similar to one of the three robo receptors, 
zebrafish embryos at 16 hpf, 24 hpf, 30 hpf and 48 hpf were prepared and whole-mount in situ 
hybridization experiments were carried out, using the probes described above. Here, the 
probes were developed by using BM-Purple as substrate. Fig. 7.4 shows lateral views of 
16 hpf, 24 hpf, 30 hpf, and 48 hpf old zebrafish embryos. As seen in Fig. 7.4 column I, srgap1 
expression is detectable in neuronal tissues at all stages of development, with highest 
expression levels in the brain. The panels in column Fig. 7.4 II display the expression pattern 
of robo1. robo1 expression sites are in fore-, mid- and hindbrain as well as in the spinal cord. 
In the 48 hpf stage robo1 is also expressed in the branchial arches. The expression sites match 
the data for the robo1 expression sites in zebrafish published by Lee et al., 2001 and Thisse et 
al., 2008. For robo2 (Fig. 7.4 column III) expression sites can be seen in fore-, mid- and 
hindbrain, as well as in spinal cord (Fig. 7.4 C) and retina (Fig. 7.4 O). Overall, the expression 
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patterns of robo2 in the forebrain seem to be more spatially restricted than that of robo1, 
which is especially obvious at 24 hpf (Fig. 7.4 G). Similar observations for robo2 expression 
sites in zebrafish embryos were described before (Campbell et al., 2007; Lee et al., 2001 and 
Miyasaka et al., 2005). In Fig. 7.4 column IV the expression patterns for robo3 are shown in 
fore-, mid- and hindbrain, as well as in the retina (Fig. 7.4 P), spinal cord and tail. This pattern 
is reminiscent of the robo1 expression pattern. robo3 exhibits more ubiquitous expression in 
the brain than robo2. Other studies support these data showing similar expression patterns for 
robo3 (Campbell et al., 2007, Lee et al., 2001 and Thisse et al., 2001). The expression of 
srgap1 resembles that of robo1 and robo3. Absolute expression levels cannot be compared 
between individual images since signal intensities can vary due to the experimental 
conditions. For instance, all four genes (Fig. 7.4 row M-P) show weaker expression in the 
spinal cord at 48 hpf, which could be caused by lack of probe penetration due to insufficient 
permeabilization by proteinase K or due to further developed muscle tissue. Similar effects 
can be seen in the data published by Lee et al., 2001. Indeed, this effect is well-known for in-
situ hybridization experiments, and can be overcome by optimizing proteinase K digestion 
conditions. To more closely investigate whether srgap1 expression mimics that of robo1 and 
possibly robo3, the dorsal view of 30 hpf and 48 hpf heads were studied at higher 
magnification (Fig. 7.5). Figure 7.5 A shows a schematic view of the zebrafish brain in which 
fore-, mid- and hindbrain, as well as the retina are labelled in order to aid in the identification. 
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Fig. 7.4: Comparison of the gene expression patterns for srgap1, robo1, robo2 and robo3 at different developmental stages of zebrafish embryos 
(A-P) For the single in-situ hybridization assays the individual RNA probes were Digoxigenin-labelled, detected with AP-conjugated α-DIG antibody and developed with BM-Purple. The 
embryos are shown in lateral view. The stages are indicated in hours post-fertilization. Labels show distinct expression patterns of srgap1, robo1, robo2 and robo3 in brain and spinal cord. 
Abbreviations: BA, branchial arches; FB, forebrain; HB, hindbrain; MB, midbrain; RT, retina; SC, spinal cord; T, tail, TeO, tectum. Images were taken at a Discovery microscope (Zeiss) with 
80x resolution. Scale bars: 5 µm 
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Fig. 7.5: Gene expression patterns of srgap1, robo1, robo2 and robo3 in the brain of developing zebrafish embryos 
(A) Scheme of a zebrafish embryo head with labels of the main brain parts. (B-I) In the single in-situ hybridization assays the individual RNA probes are digoxigenin-labelled, detected with AP-
conjugated α-digoxigenin antibody and developed with BM-Purple. The heads of the embryos are shown in dorsal views. The stages are indicated in hours post-fertilization. Labels show specific 
expression sites for srgap1, robo1, robo2 and robo3 in the CNS. Abbreviations: FB, forebrain; HB, hindbrain; MB, midbrain; MHB, mid-hindbrain boundary; OB, olfactory bulb; OE, olfactory 
epithelium; OP, olfactory pit; PF, pectoral fin; RT, retina; TeO, tectum; VZ, ventricular zone. Images were taken at a Zeiss Discovery microscope with 160x resolution. Scale bar: 10µm 
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As seen in Fig. 7.5, even at higher magnification and from a different perspective, srgap1 
expression appears to be ubiquitous, but with higher expression levels in the region posterior 
to the mid-hindbrain boundary, as well as in the pectoral fins and the retina (Fig. 7.5 B and F). 
robo1 expression can be mainly observed in the fore-, mid- and hind brain, as well as in the 
tectum and the retina (Fig. 7.5 C and G). Especially at 48 hpf, the expression patterns of 
srgap1 and robo1 resemble each other. robo2 expression sites can be found primarily in fore- 
and hindbrain, as well as in the olfactory epithelium and the olfactory bulb (Fig. 7.5 D and H). 
robo2 shows distinct expression sites in specific nuclei of the fore- and hindbrain, whereas 
srgap1 and robo1 are ubiquitously expressed in fore- and hindbrain. robo3 appears to be 
expressed in fore-, mid- and hindbrain, the mid-hindbrain boundary, as well as in the retina 
and the olfactory pit (Fig. 7.5 E and I). This expression pattern resembles that of srgap1 and 
robo1. Table 7.3 shows a summary of all expression sites for srgap1, robo1, robo2 and robo3 
during early zebrafish embryonic development.  
 
Tab. 7.3: Summary of major expression sites for srgap1, robo1, robo2 and robo3 in developing zebrafish embryos 
(asterisks mark published expression sites, which are not visible here) 
 
 
  
 
 
 
 
 
 
The data shows simultaneous expression of all four genes in many areas of the brain. The 
examination at higher magnification strengthened the hypothesis that srgap1 and robo1 are 
expressed in the same tissues in the zebrafish embryos. To investigate the co-localization of 
srgap1, robo1 and possibly robo2 and robo3 in more detail, I continued with fluorescence 
double in-situ hybridization experiments. 
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7.1.2.2 srgap1 co-localizes with robo1 in developing zebrafish embryos 
In the previous section the expression of srgap1 and robo1 in overlapping domains in 
zebrafish embryos was shown. To identify, if both genes are co-expressed and co-localize to 
identical cells within overlapping expression domains, two-colour-fluorescent in-situ 
hybridization (FISH) was carried out. This method simultaneously visualizes expression 
patterns of multiple mRNAs in the same tissue or embryo preparation (Fig. 7.6 and Fig 7.7). 
For this experimental setup the srgap1 probe was labelled with fluorescein and the robo1 
probe with digoxigenin. Figures 7.6 A-C show dorsal views of the head of a 48 hpf zebrafish 
embryo. The first two panels (A and B) display the expression sites for srgap1 and robo1 
individually, whereas the last panel shows both expression sites merged in one image. Panel C 
in Fig. 7.6 indicates compatible expression sites for srgap1 and robo1 in specific nuclei of the 
fore- and hindbrain, visible through the orange colouring in these regions. 
Fig. 7.6: Double in-situ hybridization experiments for srgap1 and the robo1 receptor gene in 48 hpf zebrafish embryos 
Gene expression patterns of srgap1 and robo1 in 48 hpf embryos. srgap1 mRNA is labelled with fluorescein (green). The 
robo1 receptor mRNA is labelled with digoxigenin (red). (A-C) Dorsal views of a zebrafish embryo head with expression of 
srgap1 and robo1 in fore- and hindbrain. (D-F) Lateral view of the spinal cord shows expression for both genes. Single 
channels (A, B, D, E) and overlays of two channels (C and F) are shown. Abbreviations: FB, forebrain; HB, hindbrain; SC, 
spinal cord. Images were recorded at a Zeiss LSM510 Meta fluorescence microscope, with 40x resolution. Scale bars: 5 µm.  
 
The panels D-F in Fig. 7.6 show a lateral view of the spinal cord of a zebrafish embryo. Both 
mRNAs are expressed in the spinal cord and co-localize to a large extent here as well. The 
expression patterns visualized here with two-colour FISH fit well with my hypothesis of a co-
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localization of srgap1 and robo1 in zebrafish embryos and are consistent with the results in 
other vertebrates such as rat, mouse and human (Ip et al., 2011; Wong et al., 2001), 
suggesting an evolutionary conserved involvement of both partners. The expression pattern of 
robo1 is thought to be closely linked to its function in neural development, including neuronal 
migration and axonal growth. Therefore, it is likely that srgap1 is also involved in these 
processes.   
Next, the possible co-localization of srgap1 and robo2 was examined. For this experiment, a 
srgap1 probe labelled with digoxigenin and a robo2 probe labelled with fluorescein were 
used. Figures 7.7 A-C show dorsal views of a section of a 48 hpf embryo brain, focusing on 
the mid- and hindbrain regions. The first two panels (A and B) show the expression patterns 
for srgap1 and robo2, respectively. Expression of srgap1 in the tectum and large areas of the 
hindbrain appears to be very low in this double in situ experiment. Stronger expression can be 
seen in one of the rhombomeres, namely rhombomere 3 of the hindbrain. robo2 is expressed 
in the tectum and large parts of the hindbrain and shows specific expression confined to 
rhombomere 2. The rhombomeres were assigned based on comparisons with published 
studies (Maves et al., 2002; Moens and Prince., 2002; Prince et al., 1998). To ascertain the 
assignment, double in-situ experiments with rhombomere-specific markers are necessary. An 
overlay of both signals did not show overlapping expression of srgap1 and robo2 in the brain. 
In Fig 7.7 D-F lateral views of the spinal cord are displayed. srgap1 shows again very weak 
expression in this experiment, whereas robo2 shows a strong expression in the spinal cord. 
srgap1 seems to be generally expressed in a lower level than robo1-3. Here, in contrast to the 
srgap1/robo1 pair, no overlapping expression is observed. 
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Fig. 7.7: Double in-situ hybridization experiments for srgap1 and the robo2 receptor gene in 48 hpf zebrafish embryos 
Gene expression patterns of srgap1 and robo2 in 48 hpf embryos. srgap1 mRNA is labelled with digoxigenin (red). The 
robo2 receptor mRNA is labelled with fluorescein (green). Expression of srgap1 seems to be generally lower in two-colour-
fluorescent experiments. (A-C) Dorsal views of the hindbrain of a zebrafish embryo, (D-F) Lateral views of the spinal cord. 
Single channels (A, B, D, E) and overlays of the signals of both channels (C and F) are shown. Abbreviations: R2, 
rhombomere 2 R3, rhombomere 3, SC, spinal cord; TeO, tectum. Images were recorded at a Zeiss LSM510 Meta 
fluorescence microscope, with 40x resolution. Scale bars: 5 µm. 
 
Double in-situ experiments rely on the hybridization with a mixture of differently labelled 
RNA probes. Here, fluorescein-labelled srgap1 provided strong sensitivity as seen in Fig. 7.6, 
while digoxigenin-labeled srgap1 was significantly less sensitive in all performed 
experiments, as seen in Fig. 7.7 A and D. Therefore, it would be recommendable to use 
digoxigenin for the strongest expressed transcript, here the robo genes, and flourescein for the 
weaker srgap1 probe in two-colour-fluorescent hybridization experiments.  
Nevertheless, the results of the double in-situ hybridization of srgap1 and robo2 indicate that 
these genes have exclusive expression sites, which can be clearly observed in the differently 
confined rhombomere expression. This suggests srgap1 and robo2 are involved in different 
steps, at different places during neuronal development.   
Since robo1 and robo3 show similar mRNA expression patterns, it would have been 
interesting to determine if both of them also co-localize, hinting a possible interaction of both. 
However, multiple attempts to carry out double in-situ hybridization with robo3 were not 
successful, even when every component of the assay (see chapter 6.1.7.7) was exchanged. 
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The expression patterns of the single in-situ experiments for robo3 suggest possible co-
localization with srgap1.  
Overall, I was able to show that robo1 co-localizes with srgap1 in the brain and spinal cord, 
indicating that the respective proteins have the potential to interact in vivo, which is consistent 
with the results of previous studies (Bacon et al., 2009; Ip et al., 2011; Wong et al., 2001). 
robo2, however does not appear to be a potential interaction partner of srgap1, confirming 
different roles of the robo genes during embryonic development (Lee et al., 2001). The 
analysis of the srgap1 expression in developing zebrafish embryos confirmed its expression in 
neuronal tissues, as observed in other species, thus supporting its likely involvement in 
neuronal processes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
70 
 
7.1.3 Structural analysis of the srGAP1 FBAR domain 
Membrane sculpting and re-organization of the actin cytoskeleton are crucial steps during 
important cellular processes like endocytosis, cell migration and cell division. BAR domain 
containing proteins are central regulators of membrane remodelling. srGAP1 consists of a 
FBAR domain, a GAP domain, a SH3 domain and a C-terminal domain. As referred to in 
chapter 3.3 the srGAP family was described as being part of the recently emerged I-FBAR 
subfamily in the BAR domain superfamily, which are said to functionally mimic I-BARs  
(Guerrier et al., 2009). The structure of the I-BAR domain differs from the classical BAR and 
FBAR domains by its shape as it is more zeppelin-like and exhibits less curvature. The 
positively charged amino acids required for the binding to the negatively charged membrane 
are located at the convex surface of I-BARs and not on the concave side as for other BAR 
domains (Millard et al., 2005). This leads to an opposite effect when binding to membranes. 
The structural mechanism and the membrane binding activity of the I-FBAR domain 
subfamily has not been solved yet and it is not known how these domains promote membrane 
protrusions, instead of membrane invaginations in vivo. In order to understand this 
mechanism, I aimed to structurally characterize the FBAR domain of srGAP1.  
 
7.1.3.1 The human srGAP1 FBAR domain  
Initially, I started with FBAR fragments of the human srGAP1 protein, as there were already 
functional characterizations published for the human srGAP2 FBAR domain (Guerrier et al., 
2009; Mason et al., 2011). Various constructs of the human srGAP1 FBAR domain were 
overexpressed in BL21 cells. Table 7.4 summarizes the results achieved with all cloned 
human FBAR constructs.  
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Tab. 7.4: List of cloned human srGAP1 FBAR domain constructs with their expression vector and obtained results. 
The red-labelled construct was used for further analysis 
Human srGAP1 FBAR 
fragments 
vector Result 
GST-srGAP1_FBAR_1-468 
GST- 
        1                     468 
pGEX6P1 • weak expression  
 
His_srGAP1_FBAR_1-468  
6His- 
        1                     468 
pET47b • insoluble  
• refolding with guanidinium chloride, protein 
not stable  
 
• refolding with 8 M urea, degradation 
 
• detergent screen:  2.5 % N-lauryl-sarcosyl 
partly solubilizes the protein  
NusA_srGAP1-FBAR_21-468 
NusA 
           21                  468      
 
pET-NusA insoluble 
NusA-srGAP1-FBAR_31-510 
NusA- 
             31                   510       
pET-NusA insoluble 
His_srGAP1_FBAR_1-468_loop 
mutant  
6His- 
        1                     468 
pET47b insoluble 
 
The FBAR fragment (1-468 aa) fused to an N-terminal GST-tag showed weak expression in 
BL21 cells and was partly soluble. The collected fractions revealed a major protein band with 
a molecular weight of 55 kDa in the flow-through, but not in the elution fraction. This 
indicated that the N-terminal GST-tag is probably not accessible and therefore the protein did 
not bind to the GSH column. I continued with the cloning of a FBAR fragment (1-468 aa) 
with a N-terminal His-tag yielding a protein fragment that was insoluble as well. Several un- 
and refolding trials with guanidinium chloride or urea were not successful, as the protein 
precipitated in lower concentrations of the solubilizing reagents and was not properly folded. 
This was confirmed by 1D NMR (Dr. Murray Coles, personal communication). In order to 
identify conditions useful for purification, solubilisation trials with a series of detergents were 
performed. Among the examined detergents only sarcosyl, an anionic detergent, was able to 
partly solubilize the protein. Therefore, the purification scheme for the srGAP1 FBAR 
domain was adapted and the protein purified with a HisTrap column in the presence of 2.5 % 
sarcosyl, followed by a gelfiltration step with a S200 column in the presence of 0.5 % 
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sarcosyl in the final purification step. Figure 7.8 shows a protein band at approximately 
55 kDa on SDS-PAGE as assessed by Coomassie Blue staining. Several bands below the 
actual protein band suggest degradation of the protein during the course of purification. 
Sarcosyl represents a non-dialyzable detergent. Therefore, its interference in crystallization 
screenings makes the use of higher concentrations of the anionic detergent in the final 
purification step in order to increase the yield of pure protein not applicable. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.8: 10 % SDS gel after gelfiltration chromatography S75 of the human srGAP1 FBAR domain after detergent-
mediated solubilisation of His6-srGAP1-FBAR domain 
The 10 % SDS gel shows the eluted protein after a gelfiltration chromatography. Bands occurring lower than 55 kDa, show 
degradation of the protein. The SDS gel was stained with Coomassie Blue. (1) ProteinPage Plus Ruler, (2) elution fractions of 
the human srGAP1 FBAR domain (indicated with an arrow). 
Despite degradation, the purified His6-srGAP1 FBAR protein (Fig. 7.8) from independent 
purification attempts was subjected to multiple crystallization screenings, but even after 
extensive attempts no protein crystals could be obtained. In order to increase the stability of 
the protein construct further, the sequence of the human srGAP1 FBAR was re-assessed more 
closely. Proper determination of the N-terminal as well as the C-terminal boundaries is well 
known to play an important role in the solubility and expression properties of a protein 
(Graslund et al., 2008). Using the coils/pcoils tool from the Bioinformatic Toolkit of the MPI 
Tuebingen (http://toolkit.tuebingen.mpg.de) extended coiled coil parts were identified at the 
N-terminal part of the human srGAP1 FBAR domain (Fig. 7.9). Comparisons with known 
structures of BAR domains revealed the absence of these types of N-termini in most of the 
BAR domains starting from around amino acids number 20 (for example pdb: 2EFK, 
Shimada et al., 2007; 2EFL, Shimada et al., 2007; 3M3W, Bai et al., 2012). 
 
 
250- 
130- 
  95- 
  72- 
  
  55- 
   
 
  36- 
  
  28- 
   
  1                                     2 
   
73 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.9: Coiled coil sites in the human srGAP1 FBAR domain sequence 
Prediction of coiled coil sites in the human srGAP1 FBAR domain sequence with coiled coil areas at the N-terminal region 
from 1-50 aa, three smaller areas between 150-300 aa and another site at the C-terminus from 350-400 aa can be observed. 
The colours correspond to different sliding windows with 14 (green), 21 (blue) and 24 (red) residues 
(http://toolkit.tuebingen.mpg.de).  
 
Based on the results of this analysis, shorter constructs were designed and expressed. In 
addition, a FBAR fragment containing a mutation in the loop region from 190-220 aa, which 
is composed of a large fraction of hydrophobic residues, was cloned. However, no soluble 
protein was obtained from the cloned FBAR constructs again (see Tab. 7.4). Taken together, 
all types of constructs of the human srGAP1 FBAR domain did no yield soluble protein, 
which could be used for subsequent structural analysis of the domain. 
 
7.1.3.2 The SRGAP1 FBAR domain of Pristionchus pacificus 
As no structural data could be obtained from the human srGAP1 FBAR domain, the work was 
focused in the following on the FBAR domains of two other organisms: Pristionchus 
pacificus and Danio rerio. Table 7.5 shows a sequence comparison between the FBAR 
domains of all three organisms. 
Tab. 7.5: Comparison of the sequence identities of the srGAP1 FBAR domain of Homo sapiens, Pristionchus pacificus 
and Danio rerio 
Name Sequence identity for the FBAR 
domain 
Homo sapiens-Pristionchus pacificus 33 % 
Homo sapiens-Danio rerio 92 % 
Danio rerio-Pristionchus pacificus 32 % 
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Human srGAP1 FBAR domain and the SRGAP1 FBAR domain of Pristionchus pacificus 
share a mere sequence identity of 33 %, whereas then human and zebrafish FBAR domains 
are 92 % identical. The level of sequence identity of Pristionchus pacificus and zebrafish 
corresponds with 32 % to the grade of sequence identity between the human and Pristionchus 
srGAP1 FBAR domain. So, by choosing these organisms, highly similar and distantly related 
srGAP1 FBAR domains were covered with the intention to get protein fragments that can be 
more easily handled during purification and functional characterization of the srGAP1 FBAR 
domain. 
In a next step the SRGAP1 FBAR domain of Pristionchus pacificus was overexpressed and 
purified. The FBAR domain border was designed according to the results of the coils/pcoils 
analysis (Fig. 7.9). Hence, the FBAR domain was truncated at the N-terminus, resulting in a 
fragment from 20-460 aa with a molecular weight of 48 kDa. However, the FBAR fragment 
of Pristionchus pacificus was also not soluble. Solubilisation trials with a number of 
detergents were performed. The zwitterionic detergent CHAPS showed the best result and 
partly solubilized the protein. The purification was carried out with 1 % of the detergent. 
Unfortunately, the FBAR domain was degraded during the purification process. In order to 
yield properly folded protein and to reduce degradation, the protein was unfolded in 8 M urea. 
Subsequent refolding with lower concentrations of the solubilizing reagent, lead to 
degradation during the purification process as well. 
 
7.1.3.3 The srGAP1 FBAR domain of zebrafish 
In addition to the srGAP1 FBAR domain of Homo sapiens and Pristionchus pacificus, I 
overexpressed and purified the FBAR domain from zebrafish. Corresponding to the FBAR 
domain from Pristionchus pacificus, the first 25 aa at the N-terminal part of the domain were 
truncated, resulting in a fragment from amino acids 25-473 with a molecular weight of 
53 kDa. This protein construct was not soluble either. Therefore, a detergent screening was 
carried out. Similar to the human construct, here as well only the anionic detergent sarcosyl 
was able to solubilize the protein. Hence, 1 % of sarcosyl was used in the early purification 
steps. The concentration of the detergent was reduced to a final concentration of 0.25 % 
during the subsequent gelfiltration step. In a second approach the protein was unfolded with 
8 M urea and refolded by dialysis with stepwise reduction of the urea concentration. For both 
purified samples, the first in the presence of 1 % sarcosyl and the latter refolded, secondary 
structure determination was performed via CD spectroscopy. CD spectroscopy is defined as 
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the measurement of unequal absorption of left-handed and right-handed circularly polarized 
light. When light is polarized by passing through prisms or filters its electric field will 
oscillate sinusoidally in a single plane. When a molecule interacts with the light, it will absorb 
right and left handed circularly polarized light to different extents (Greenfield, 2006). Figure 
7.10 shows the secondary structure analysis after both purification methods. 
 
 
 
 
 
 
 
 
 
 
Fig. 7.10: Comparison of CD-spectra representing secondary structure of the FBAR domain from zebrafish purified 
by detergent or by Urea unfolding  
The blue line shows the CD spectrum of the srGAP1 FBAR domain after purification with sarcosyl. The final concentration 
of sarcosyl is 0.25 %. The red line shows the CD spectrum after refolding. For the measurement the srGAP1 FBAR protein 
was diluted to 1 mg/ml in 20 mM Tris pH 8.0 and 50 mM NaF buffer. 10 spectra were recorded on a Jasco Spectrometer J-
810 at room temperature. The resulting spectra were averaged.  
 
The CD spectrum of the protein purified in the presence of sarcosyl resembles a folded α-
helical protein with two minima at 208 and 222 nm (blue line), whereas the refolded F-BAR 
domain appears to be only partly folded, which becomes apparent by shifts of the two minima 
to 205 and 215 nm (red line). As mentioned in chapter 7.1.4.1 the protein sample containing 
sarcosyl did not yield any protein crystals for the human srGAP1 FBAR domain. Sarcosyl is 
also known to be a harsh detergent with possible interference in lipid-based in vitro assays, 
which are used to test the activity of the srGAP1 FBAR domain. As an alternative strategy 
and to obtain detergent-free protein, the protein was overexpressed in E. coli LEMO21 (DE3) 
cells. These cells are specifically designed for membrane proteins and proteins with solubility 
issues. The overexpression resulted in partly soluble protein, in the case that another, weaker 
detergent (1 % n-Dodecyl β-D-maltoside; β-DDM) was used after the cell lysis and during the 
purification process. β-DDM is a non-ionic, less harsh detergent, which does not interfere in 
crystallization setups and lipid-based in vitro assays. The concentration of β-DDM was 
reduced to 0.1 % in the final protein pool. The secondary structure analysis by CD 
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spectroscopy clearly shows α-helical secondary structure elements with two minima at 208 
and 222 nm (Fig. 7.11). Additionally, 1D NMR measurements confirmed proper folding of 
the FBAR domain (Dr. Murray Coles, personal communication). 
 
 
 
 
 
 
 
 
Fig. 7.11: Secondary structure analysis of the srGAP1 FBAR domain of zebrafish with CD-spectroscopy 
For the he secondary structure analysis of the srGAP1 FBAR domain of zebrafish 1 mg/ml of the srGAP1 FBAR protein was 
diluted in 20 mM Tris pH 8.0 and 50 mM NaF buffer. 10 spectra were recorded on a Jasco Spectrometer J-810 at room 
temperature. The resulting spectrum was averaged. 
 
In order to analyse the oligomeric state of this purified FBAR domain in detail, a static light 
scattering experiment was carried out (Fig. 7.12). Light scattering is an optical technique that 
measures the intensity of the scattered light in dependence of the scattering angle to obtain 
information on the molecular weight of a polymer. The protein was loaded on a size exclusion 
column and eluted in one peak with a calculated molecular weight of 110 kDa, indicating the 
presence of dimers.  
 
 
 
 
 
  
Fig. 7.12: Static light scattering profile of the srGAP1 FBAR domain of zebrafish 
For determining the molecular mass the protein (1 mg/ml) was loaded on a Wyatt SEC column and run with 0.5 ml/min at 
4 ºC. The FBAR domain of srGAP1 eluted in one peak with a calculated size of 100 kDa (green line), which indicates the 
presence of dimers. The chromatogram displays two graphs: in blue the refractive index and in the green the molecular 
weight. 
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The result of the light-scattering experiment confirmed that FBAR domains have the tendency 
to dimerize. In the next step, the purified recombinant protein was setup for several 
crystallization screenings, but all attempts to obtain crystals for the srGAP1 FBAR domain of 
zebrafish, were not successful. 
Taken together, the srGAP1 FBAR domain was proven to be a domain difficult to analyse 
structurally as proteins from different organisms and with different tags did not yield 
diffracting crystals. Screening more constructs with varying N- and C-termini might succeed 
in obtaining more stable protein fragments with an increased tendency to crystallize.  
In the following functional characterization of the srGAP1 FBAR domain of zebrafish were 
carried out, to examine the activity and the effect of the FBAR domain. 
 
7.1.4 Functional characterization of the srGAP1 FBAR 
domain of zebrafish 
Classical FBAR domains bind to the negatively charged membrane and lead to membrane 
invagination, whereas I-FBARs have a contrary effect by inducing membrane protrusion. 
When expressed in Cos7 or cortical neuron cells FBAR domains of the srGAP family led to 
filopodia formation (Coutinho-Budd et al., 2012; Guerrier et al., 2009), instead of 
invaginations, as it would occur for a classical FBAR domain like FBP17 (Kamioka et al., 
2004).  In a previous study it was also reported that the human FBAR domain of srGAP2 
binds to brain-derived liposomes and leads to the formation of tubules when it is introduced 
into liposomes through sonication (Guerrier et al., 2009). To understand how FBAR domain 
proteins interact with the membrane and how they are regulated, the membrane binding 
properties of the FBAR domain of srGAP1 from zebrafish was examined using different in-
vitro assays. For this purpose I used liposomes and giant unilamellar vesicles, both frequently 
employed as models for biological membranes in biochemical and biophysical studies (Hotani 
et al., 1999; Lasic et al., 1995). The effect of the FBAR domain was monitored by electron 
microscopy and later fluorescence microscopy. A co-sedimentation assay with negatively 
charged liposomes was also carried out, to determine the liposome binding activity of the 
srGAP1 FBAR domain.  
 
7.1.4.1 The srGAP1 FBAR domain of zebrafish co-sediments with negatively charged 
liposomes  
As mentioned above, liposomes are used as models of biological membranes, to examine in 
vitro effects of membrane-binding proteins. In order to analyse, if the purified FBAR domain 
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of srGAP1 can directly bind to liposomes a co-sedimentation assay was used. Co-
sedimentation assays are based on the sedimentation of interacting proteins with liposomes 
during high-speed centrifugation. This was previously shown for cofilin-1, which is involved 
in cell motility and endocytosis (Zhao et al., 2010). For this assay a lipid mix, which 
physiologically mimics the composition of the negatively charged cell membrane, called 
Endomix was used.  
The liposomes were made from cholesterol/sphingomyelin/PE/PS/PI/PC/PI(4,5)P2 in a ratio 
of 1:0.28:0.28:0.28:0.14:0.02 (Corbin et al., 2007). First, 5 µM of purified srGAP1 FBAR 
domain were incubated with 1 mg/ml of liposomes for 2 h at 37 °C. Then, the protein-
liposome mixture was centrifuged at high-speed (13000 rpm). The supernatants were removed 
and the pellets were resuspended in the original volume of 30 µl. As no sucrose layer was 
used, the liposomes should sediment to the pellet during the centrifugation step. Aliquots of 
the supernatant and pellet fraction were subjected to a 10 % SDS gel and stained with silver 
staining (Fig. 7.13). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.13: Binding of the srGAP1 FBAR domain of zebrafish to negatively charged liposomes  
The ability of the FBAR domain of srGAP1 to bind to liposomes was evaluated using co-sedimentation. The FBAR domain 
(5 µM) was incubated with 1 mg/ml of the liposome mix for 2 h at 37 ºC. After centrifugation at 13000 rpm for 10 min, 
supernatants and pellets were analysed by 10 % SDS PAGE. The gel was stained with silver staining. (S) Standard, (1) 1 
mg/ml liposomes alone, (2) 1 mg/ml liposomes with protein buffer (20 mM Tris, pH 8, 300 mM NaCl, (3) supernatant of the 
srGAP1 FBAR domain protein (5µM), (4) pellet of the srGAP1 FBAR domain protein (5µM), (5) supernatant of 1 mg/ml 
liposomes and 5 µM of the srGAP1 FBAR domain, (6) pellet with 1 mg/ml liposomes and 5 µM of the srGAP1 FBAR 
domain. Black label indicates molecular weight of the srGAP1 FBAR domain (54 kDa) 
 
As controls, liposomes alone (Fig. 7.13, lane 1-2) and the FBAR domain in buffer (Fig. 7.13, 
lane 3-4) were subjected to the same steps as the sample. Both controls serve to identify, if the 
liposomes alone or the protein itself have the tendency to precipitate. The strong band in lane 
3 indicates that the srGAP1 FBAR domain can be found in the supernatant. As shown in 
Fig. 7.13, lane 6 the FBAR domain of srGAP1 sedimented with the liposomes. A blurred 
band can be observed in the pellet fraction. This band is approximately at the molecular 
weight of the srGAP1 FBAR domain (54 kDa, indicated with black line). The blurred and 
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weaker band can be explained by the presence of the liposomes and the volume of the 
samples which were used on the SDS gel. The result of the co-sedimentation suggests that the 
FBAR domain of srGAP1 binds to negatively charged liposomes. With this first indication 
and to further support this result, the effect of the FBAR domain of srGAP1 on preformed 
liposomes was examined with negative stain electron microscopy. 
 
7.1.4.2 The srGAP1 FBAR domain of zebrafish leads to indentations of charged liposomes 
FBAR domains have been shown to bind to liposomes and lead to deformation or tubulation 
(Frost et al., 2008; Shimada et al., 2007). Multiple publications use negative stain electron 
microscopy to analyse the effect of FBAR domains on liposomes (Boucrot et al., 2012; 
Guerrier et al., 2009; Shimada et al., 2007).  To directly examine the membrane deforming 
properties of the srGAP1 FBAR domain the purified srGAP1 FBAR domain of zebrafish was 
incubated with preformed liposomes. The samples were pipetted on carbon coated grids and 
stained with 1 % uranylacetate to visualize them by negative stain electron microscopy 
(Fig. 7.14). 
 
 
 
 
 
 
Fig. 7.14: Deformation of negatively charged liposomes by the srGAP1 FBAR domain 
Negative stain electron microscopy of negatively charged liposomes incubated with (A) buffer, (B) liposomes incubated with 
DHPH domain of Intersectin as negative control and (C) liposomes incubated with the FBAR domain of srGAP1. All grids 
were stained with 1 % uranylacetate. Arrows indicate deformation. Scale bars: 2 µm. 
 
In Fig 7.14 A liposomes were incubated with buffer alone. When liposomes were incubated 
with the DHPH domain of the adaptor protein Intersectin, no deformation was observed. The 
DHPH domain is known to bind to membranes without inducing a deforming effect 
(Zamanian and Kelly, 2003). Figure 7.14 C displays liposomes incubated with the srGAP1 
FBAR domain. Interestingly, no tubulation of the liposomes can be seen as reported for the 
FBAR domains of FBP17, CIP4 and Syndapin  (Itoh et al., 2005; Shimada et al., 2010), but 
slight indentations of the preformed liposomes. This result supports an inverse FBAR activity 
of the srGAP1 FBAR domain, as suggested for IRSp53 and Missing in Metastasis (MIM) 
srGAP1 FBAR negative control buffer 
A B C 
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(Mattila et al., 2007, Millard et al., 2007; Saarikangas et al., 2009). Unfortunately, this 
experimental setup turned out to be not the best approach to examine indentations, as control 
liposomes without the incubation with the srGAP1 FBAR domain were sometimes also 
deformed during the experimental procedure, thus not facilitating the quantification of 
deformed liposomes. Therefore, I continued studying the effect of the srGAP1 FBAR domain 
in vitro, by using giant unilamellar vesicles, which allow a better observance of vesicle 
deformation in contrast to the smaller-sized liposomes. 
 
7.1.4.3 The srGAP1 FBAR domain of zebrafish causes invagination of giant unilamellar 
vesicles 
Giant unilamellar vesicles are cell-sized vesicles, which consist of a phospholipid bilayer and 
are large enough to be observed with optical microscopes. In recent publications an assay with 
giant unilamellar vesicles was described, to directly show invagination activities of the 
BAR/FBAR domains of Pinkbar and Nervous wreck (Becalska et al., 2013; Pykäläinen et al., 
2010). In order to visualize the effect of the srGAP1 FBAR domain, I established a GUV 
assay, with the help of Dr. Nathalie Eisenhardt (MPI for Developmental Biology, Tuebingen). 
To generate the GUVs, two different lipid-mixes labelled with 0.5 % dicarbocyanine were 
used, here DiD (DilC18), to examine if different lipid-mixes have an effect on the FBAR 
domain activity. The first lipid-mix consisted of lipids, which mimic the negatively charged 
composition of the cell membrane (as described in chapter 7.1.4.1). The second lipid-mix 
contained Folch I lipids, which are brain derived lipids with 5 % PIP2 as an additional 
component. The generated GUVs were incubated with the following components in different 
reaction chambers overnight: buffer alone (10 mM HEPES pH 7.5, 140 mM KCl, 10 mM 
NaCl and 1 mM MgCl2), DHPH domain of the adaptor protein Intersectin as a negative 
control, human Carom FBAR domain as a positive control (see chapter 7.2.2.1) and srGAP1 
FBAR domain of zebrafish (Fig. 7.15). 
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Fig 7.15: Invagination of giant unilamellar vesicles by the srGAP1 FBAR domain 
Deformation of DiD-labelled GUVs (red) after an overnight incubation with (A) buffer (10 mM HEPES pH 7.5, 140 mM 
KCl, 10 mM NaCl and 1 mM MgCl2), (B) DHPH domain of Intersectin, as negative control, (C) the human Carom FBAR 
domain and (D) the FBAR domain of srGAP1. Arrows point to deformation. Scale bars: 5 µm. 
 
As shown in Fig. 7.15 A incubation of GUVs with buffer alone has no effect. In Fig. 7.15 B 
the DHPH domain of Intersectin, with no membrane deforming activity is added to the 
vesicles as a negative control and shows no visible effect either. Fig. 7.15 C displays GUVs 
incubated with the Carom FBAR domain, the human homolog of the Drosophila Nervous 
wreck protein (Becalska et al., 2013). The FBAR domain of Carom is used as a positive 
control in this experimental setup as it has a scalloping effect on vesicles (see chapter 7.2.2.1 
for more detail). Here, invagination of the giant unilamellar vesicles were observed as 
expected. The FBAR domain of the srGAP1 protein also generates invaginations of the 
vesicles, though only 40 - 50 % of the vesicles were deformed (Fig. 7.15 D). Compared to the 
positive control, the invaginations induced by the srGAP1 FBAR domain are weaker, 
indicating the possibility of less induced curvature.  
 
7.1.4.4 Time-dependent invagination of giant unilamellar vesicles by the srGAP1 FBAR 
domain 
To determine the time-frame of the invagination process, images of the vesicles incubated 
with srGAP1 FBAR domain were taken after certain time points (0, 5 min, 40 min and 24 h). 
Figure 7.16 shows the respective images for the srGAP1 FBAR domain.  
 
 
 
 
 
 
 
buffer negative control Carom FBAR srGAP1 FBAR 
A B C D 
A B C D 
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Fig 7.16: Time-dependent deformation of giant unilamellar vesicles by the FBAR domain of srGAP1 
Deformation of DiD-labelled GUVs (red) over time, (A) GUV immediate after adding of the srGAP1 FBAR domain, (B) 
protein-GUV mix after 5 min of incubation, (C) GUV after 40 min of incubation and (D) after an overnight incubation at 4 ̊C 
with the FBAR domain of srGAP1. Arrow points to deformation. Scale bars: 5 µm. 
 
Taken together, the co-sedimentation assay, the negative stain EM assay and the GUV assay 
demonstrate, that unlike previously described FBAR domains of FBP17, CIP4 and Syndapin 
(Henne et al., 2007; Itoh and De Camilli, 2006; Peter et al., 2004; Shimada et al., 2007) the 
FBAR domain of the srGAP1 protein is not a classical FBAR domain, but rather belongs to 
the I-FBAR subfamily. Members of this subfamily cause invaginations, when incubated with 
liposomes and giant unilamellar vesicles, instead of forming tubules. Interestingly, the srGAP 
family is not the only family with a predicted functional I-FBAR domain: PSTPIP2 and Gas7 
have also been shown to induce filopodia in in vivo experiments (Chitu et al., 2005; She et al., 
2002). Therefore, more members of the I-FBAR family could emerge in the future.  
In summary the results of the functional analysis of the FBAR domain suggest an inverse 
FBAR function. In order to prove this hypothesis structural information for the srGAP1 
FBAR domain is essential, as it might give insight of how the structure and the function of the 
FBAR domains are related. At the same time, in an attempt to characterize the structural 
properties of I-FBARs, I concentrated on the FBAR domain of an analogous but distantly 
related protein, the human adaptor protein Carom (chapter 7.2). 
 
24 h 40 min 5 min start 
C D A B 
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7.1.5 Comparison of the binding specificity of the human 
srGAP1 GAP domain and its zebrafish homolog to three 
members of the RhoGTPases 
Many FBAR-containing proteins are involved in the regulation of Rho-GTP binding proteins 
(Habermann et al., 2004; Ho et al., 2004; Kanoh et al., 1997; Peter et al., 2004; Van Aelst et 
al., 1996). In addition to its FBAR domain, its SH3 domain and its C-terminal domain, the 
srGAP1 protein contains a GAP domain. Small guanine nucleotide-binding proteins, like the 
members of the Rho family of GTPases, act as molecular switches in cellular signalling 
pathways controlling cell proliferation, differentiation and apoptosis. Conversion from the 
GDP-bound to the GTP-bound state is controlled either positively or negatively by GEFs or 
GAPs, respectively (Corbett, and Alber, 2001, Vetter and Wittinghofer, 2001). GAP domains 
increase the intrinsic hydrolysis rate of GTPases by inserting a catalytic residue into the active 
site of the GTPase (Ahmadian et al., 1997, Mittal et al., 1996, Rensland et al., 1991). In a 
previous study with HEK cells it was reported, that the human srGAP1 GAP domain 
specifically inactivates Cdc42 and RhoA.  
In this present study, the human and zebrafish srGAP1 GAP domains were examined with 
different NMR methods to determine their activity towards three members of the Rho GTPase 
family, Cdc42, RhoA and Rac1. Attempts to measure this interaction with other methods, 
like, HPLC or fluorescence spectroscopy did not yield any results. First, the binding of the 
human srGAP1 GAP domain to the three members of the RhoGTPases was examined via 19F-
NMR spectroscopy, to analyse if there is aluminium fluoride-activated complex formation 
between the srGAP1 GAP domain and the RhoGTPase as this would indicate an interaction 
between both components. With 31P-NMR the activity of the srGAP1 GAP domain was 
examined, by following the acceleration of the intrinsic hydrolysis rate of the RhoGTPases. 
This experiment was carried out for the human srGAP1 GAP domain and its zebrafish 
homolog. In the last step, the binding sites of the GAP domain on 15N and 13C labelled Cdc42 
were mapped. All experiments were carried out in collaboration with Dr. Murray Coles (MPI 
for Developmental Biology, Tuebingen). 
 
7.1.5.1 The human srGAP1 GAP domain binds to the human Cdc42, but not to human RhoA 
and Rac1 
In a previous study srGAP1 and myc-tagged Cdc42, RhoA and Rac1 were co-transfected in 
HEK cells and interaction between srGAP1 and Cdc42 as well as RhoA was detected using 
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co-immunoprecipitation (Wong et al., 2001). Here, the interaction of the srGAP1 GAP 
domain with Cdc42, RhoA and Rac is analysed with a structural approach, using different  
NMR methods. Figure 7.17 displays the domain borders of the human srGAP1 GAP domain, 
the human Cdc42, RhoA and Rac1. 
 
 
Fig. 7.17: Domain boundaries of the human srGAP1 protein and the human RhoGTPases 
The human srGAP1 protein consists of a FBAR domain, a SH3 and a C-terminal domain with protein binding motifs. Its 
GAP domain (496-695 aa) is reported to bind to two members of the RhoGTPase family, Cdc42 and RhoA (Wong et al., 
2001). For RhoA and Rac the full-length protein was used, for Cdc42 the last 13 amino acids, which were highly 
hydrophobic, were truncated due to solubility issues. The red line indicates the domain boundary for the used Cdc42 
construct 
 
The srGAP1 GAP domain (496-695 aa) was cloned into a pGEX_6P1 vector with a N-
terminal GST-tag. The protein was purified with a GSH column, followed by the cleavage of 
the GST-tag with TEV-protease. The purification was finalized by a gelfiltration step with a 
S75 column (Fig. 7.18).  
 
 
 
 
 
 
 
 
Fig. 7.18: 10 % SDS gel after gelfiltration chromatography S75 of the human srGAP1 GAP domain  
The 10 % SDS gel shows the eluted protein after a gelfiltration chromatography. The SDS gel was stained with Coomassie 
Blue. 1) ProteinPage Plus Ruler, 2) fractions after cleavage with TEV-protease, 3) non-cleaved fusion protein, 4-5) GST 
protein, 6-12) elution fractions of the human srGAP1 GAP domain (22 kDa, indicated with an arrow). 
 
 
The human RhoGTPases, Cdc42 (1-178 aa), RhoA (1-193 aa) and Rac (1-192 aa) were 
purified following the same protocol.  
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An important finding in the studies regarding GAP binding was the application of AlFl4-. This 
compound mimics the transition state during the GTP hydrolysis process of heterotrimeric G-
proteins (Chabre, 1990). AlFl4- forms a complex with the GDP-bound α-subunit of 
heterotrimeric G-proteins by binding into the pocket that usually accommodates the γ-
phosphate of the bound GTP (Coleman et al., 1994; Sondek et al., 1994). This method was 
successfully used in a previous study to analyse the interaction of AlFl4- and α-transducin 
(Higashijima et al., 1991; Hoffmann et al., 1998). Figure 7.19 presents the possible binding 
mechanism of AlFl4- in the RhoGTPase-GAP complex. 
 
 
 
 
Fig. 7.19: Model of the potential AlFl4- -induced binding mechanism  
AlFl4- -induced transition state of a GDP-bound GTPase (brown) and a GAP domain (purple). Thereby, the AlFl4- binds into 
the pocket, which is usually occupied by the γ-phosphate of the bound GTP (modified, Hoffman et al., 1998). 
 
Here, 19F-NMR spectroscopy was applied to probe the fluoride binding directly and determine 
if the human srGAP1 GAP domain can form complexes with one of the three RhoGTPases. 
Figure 7.20 shows the obtained experimental data for the human GAP domain with human 
Cdc42, RhoA and Rac1. 
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Fig. 7.20: Analysis of AlFl4--induced complex formation between the RhoGTPases and the srGAP1 GAP domain 
19
F-NMR spectra (282 MHz) of protein samples in AlFl4-- containing NMR buffer. Spectra were measured at a Bruker 600 at 
room temperature. Chemical shifts were measured relative to free fluoride (-120 ppm). (A) Spectrum of AlFl4- alone (I), 
spectrum of GDP-bound Cdc42 with AlFl4 
-(II), spectrum of srGAP1 GAP domain with AlFl4 -(III), spectrum of GDP-bound 
Cdc42 (0.15 mM) with AlFl4- and equimolar concentration of human srGAP1 GAP domain (0.15 mM; IV). (B) Spectrum of 
GDP-bound RhoA and AlFl4
-
 alone (red) and spectra of GDP-bound RhoA with the srGAP1 GAP domain and AlFl4- (green). 
(C) Spectrum of GDP-bound Rac1 with AlFl4- alone (red) and Rac1 with the srGAP1 GAP domain and AlFl4-. 
 
 
The 19F-spectra of AlFl4- shows a sharp peak at -120 ppm (Fig. 7.20 A I). The spectrum of 
GDP-bound Cdc42 and AlFl4- shows no change in the signal at -120 ppm, suggesting that free 
GDP-bound Cdc42 did not bind to AlFl4- (Fig. 7.20 A II). The small peak at -160 ppm is an 
artefact of the measurement and can be disregarded. The spectrum of the srGAP1 GAP 
domain with AlFl4- also shows a peak at -120 ppm, indicating that the domain alone also does 
not interact with AlFl4- (Fig. 7.20 A III). In Fig. 7.20 A IV the 19F-NMR spectrum obtained 
when both GDP-bound Cdc42 and equimolar srGAP1 GAP domain are added together in the 
presence of AlFl4-, is shown. The disappearance of the signal at -120 ppm suggest stable 
complex formation between the GDP-bound form of the human Cdc42 and the human 
srGAP1 GAP domain. In contrast to the Cdc42 measurements, RhoA and Rac1 show weak 
signals and no binding to the srGAP1 GAP domain as the signal of AlFl4- does not disappear 
RhoA+GAP + AlFl4- 
RhoA+AlFl4- 
ppm 
(B) 
Rac1+AlFl4- 
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when the GAP domain of srGAP1 is added (Fig. 7.20 B and C). However, both proteins, 
RhoA and Rac1, show proper folding in 1H-NMR measurements, in which the hydrogen-1 
nuclei of a molecule are analysed. In a previous study, the AlFl4- signal does not disappear, 
but shifts instead. This could be due to the bigger size difference between the GAP domain 
and the GTPase or due to different measurement set up (Hoffmann et al., 1998). The first 
structural analysis confirmed the binding of the srGAP1 GAP domain to Cdc42, but not to 
RhoA, although both interactions were shown with HEK cell assays (Wong et al., 2001).  
 
7.1.5.2 The human srGAP1 GAP domain is active and increases the intrinsic hydrolysis rate 
of the human Cdc42 
As described in chapter 7.1.5.1, the human srGAP1 GAP domain specifically binds to the 
human GDP-bound Cdc42 in the presence of AlFl4-. To confirm this interaction and to 
examine the activity of the human GAP domain, 31P-NMR spectroscopy was carried out. With 
31P-NMR spectroscopy it is possible to probe the conformational states of nucleotide-binding 
proteins, dependent on the type of nucleotide present in their active centre (Spoerner et al., 
2005). Here, the state of GTP was followed overtime (Fig. 7.21). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.21: 31P-NMR spectra of GTP and GDP 
The 31P-NMR spectra (243MHz) were measured at a Bruker 600 at room temperature. For the measurements 1 mM of GTP 
and 1 mM GDP and inorganic phosphate were used. (A) The spectrum of GTP shows three peaks, which were assigned to γ-
phosphate at -22 ppm, β-phosphate at -11 ppm and α-phosphate at -6 ppm. (B) The spectrum of GDP and inorganic 
phosphate has three peaks as well, which were assigned to β-phosphate at -10 ppm, α-phosphate at -6 ppm and inorganic 
phosphate at -3 ppm. 
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For GTP three distinct peak positions were assigned as γ-phosphate (-22 ppm), β-phosphate (-
11 ppm) and α-phosphate (-6 ppm) (Fig. 7.21). The 31P spectrum of GDP and inorganic 
phosphate contains a new peak at 3 ppm, which was assigned as inorganic phosphate, while 
the resonance of γ-phosphate disappeared completely (Fig. 7.21 B). The signal of γ-phosphate 
is well resolved, therefore GTP hydrolysis can be unambiguously measured by analysing the 
decline of the γ-phosphate over time and steady increase of free inorganic phosphate and β-
GDP phosphate peaks (Fig. 7.21 B).  
For the measurements, nucleotide-free Cdc42 was used, which was obtained with two 
different methods. In the first approach nucleotide-free GTPase was prepared in two steps 
according to John et al., 1990. First, bound GDP was degraded by alkaline phosphatase and 
replaced by GppNHp, a non-hydrolysable GTP analogue, resistant to alkaline phosphatase, 
but sensitive to phosphodiesterase (Fig. 7.22). The completion of the degradation process was 
determined by a High Performance Liquid Chromatography (HPLC). After the complete 
degradation of GDP, snake venom phosphodiesterase was added to the solution to cleave 
GppNHp to GMP, G and Pi. The snake venom phosphodiesterase was then removed from the 
nucleotide-free protein by analytical gelfiltration. The second approach for removal of bound 
GDP is based on serial dilution (Zhang et al., 2000). The protein sample was examined for the 
content of the remaining nucleotide with 31P NMR spectroscopy before the experiment. 
 
 
 
 
Fig. 7.22: GTP and its non-hydrolysable analogue GppNHp 
(A) Chemical formula of GTP, (B) Chemical formula of GppNHp, the non-hydrolysable analogue of GTP, in which the 
oxygen atom bridging the β- to the γ-phosphate is replaced by a nitrogen atom. 
 
To assess the activity of the srGAP1 GAP domain, the intrinsic hydrolysis activity of Cdc42 
was measured first. Therefore, nucleotide-free Cdc42 and an excess of GTP were monitored 
over time till GTP was completely hydrolysed to GDP and inorganic phosphate. Then, an 
equimolar concentration of the srGAP1 GAP domain and additional GTP were added. Here 
again, the hydrolysis reaction was measured over time. Figure 7.23 presents a work chart for 
the measurement.  
 
(A) (B) 
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(A)
Cdc42+GTP
(reaction 1)
overnight
(B)
reaction 1
+ srGAP1 GAP+GTP
over 
day
(C)
reaction 1 
+srGAP1 GAP
+GDP
Fig. 7.23: Work chart for the 31P-NMR measurement 
(A) Intrinsic hydrolysis rate of Cdc42 was measured over time. Complete hydrolysis of added GTP after overnight 
incubation. (B) Addition of srGAP1 GAP domain and additional GTP to the overnight reaction and hydrolysis of GTP was 
monitored again over day. (C) After approximately 1 h complete hydrolysis of GTP to GDP and inorganic phosphate can be 
observed after the addition of GAP. 
 
In Fig. 7.24 the intrinsic hydrolysis rate of Cdc42 is shown over a time period of 12 h. Four 
signals can be observed, which correspond to γ-phosphate, β-phosphate, α-phosphate and 
inorganic phosphate.  
 
 
 
 
 
 
 
Fig. 7.24: Intrinsic hydrolysis activity of Cdc42 
31P NMR spectra (243 MHz) of 0.15 mM Cdc42 in 20 mM Tris pH 7.5, 150 mM NaCl and 1 mM MgCl2 buffer and 1 mM 
GTP were measured at a Bruker 600 spectrometer at room temperature. The signal of γ-phosphate, β-phosphate and α-
phosphate are followed over time (orange).  
 
 
At time point 0, no signal for inorganic phosphate can be observed. After 6 h the signal for 
inorganic phosphate is increasing, whereas the signal for γ-phosphate is decreasing gradually. 
After 12 h there is still a signal for γ-phosphate visible, implying a slow intrinsic hydrolysis 
rate for Cdc42. Therefore, Cdc42 and GTP were incubated overnight, which resulted in the 
complete hydrolysis of GTP to GDP and inorganic phosphate (Fig. 7.25 A). The labelling in 
Fig. 7.25 correspond to the labels used in the work chart (Fig. 7.23). Addition of the human 
srGAP1 GAP domain accelerated the GTP hydrolysis reaction. Within one hour newly added 
GTP was converted into GDP and inorganic phosphate, indicated by the decline of the γ-
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phosphate and the increase of the inorganic phosphate and the β-GDP phosphate (Fig. 
7.25 C). 
Fig. 7.25: 
31
P-NMR spectroscopy showing accelerated GTP hydrolysis by Cdc42 affected by the GAP domain of 
srGAP1 
31
P-NMR spectra (243 MHz) of samples in 20 mM Tris pH 7.5, 150 mM NaCl and 1 mM MgCl2 buffer were measured at a 
Bruker 600 spectrometer at room temperature. (A) Spectrum of 0.15 mM nucleotide-free human Cdc42 with 1 mM GTP. 
Slow intrinsic GTP hydrolysis activity of the human Cdc42 (blue). Complete conversion of GTP to GDP and inorganic 
phosphate after overnight incubation. (B) Addition of 0.15 mM srGAP1 GAP domain and additional 1 mM of GTP (green) to 
the human Cdc42. (C) Total conversion of GTP to GDP and inorganic phosphate after approximately 1 h after adding the 
srGAP1 GAP domain.  
 
For the calculation of the hydrolysis time the number of scans is multiplied by the time for 1 
slice, which corresponds to a single 1D experiment. In Fig. 7.26, a scheme of the calculation 
is presented.  
 
 
 
 
 
 
(A) 
(B) 
(C) 
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Fig. 7.26: Calculation scheme for calculating the accelerated hydrolysis time for Cdc42  
The number of scans are multiplied by the time which corresponds to the length of the scan. The resulting time is for one 
slice, which is one single 1D experiment. This is then multiplied by the number of scans for each slice. This results into the 
time constant in points, which then can be converted into the time constant in minutes. 
 
With this calculation scheme the time for the accelerated intrinsic hydrolysis reaction was 
calculated to be 16 min, whereas the value calculated for the intrinsic hydrolysis activity of 
Cdc42 is more than 12 h.   
 
7.1.5.3 The zebrafish srGAP1 GAP domain increases the intrinsic hydrolysis rate of the 
zebrafish Cdc42 
The srGAP1 protein can be found in various organisms. The srGAP1 protein from zebrafish 
has with 80 %, a high sequence identity to the human srGAP1 protein. To test if the 
interaction between the srGAP1 GAP domain and Cdc42 is conserved, analogous 31P-NMR 
measurements, were carried out with the zebrafish srGAP1 GAP domain and zebrafish Cdc42 
as described in the previous section. Figure 7.27 shows the domain boundaries for both 
proteins. 
 
Time constant in points  
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convert 
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(= one single 1D experiment) 
Number of slices x 
Number of 
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         (acquisition time + re-equilibration time) x 
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Fig. 7.27: Domain boundaries for the zebrafish srGAP1GAP domain and the zebrafish Cdc42 
The domain boundary for the zebrafish srGAP1 GAP domain was designed according to the boundary set for the human 
srGAP1 GAP domain (see Fig. 6.17). For the zebrafish Cdc42 the full-length protein was used. 
 
The zebrafish srGAP1 GAP domain (492-676 aa) was cloned into a pGEX6P1 vector with a 
N-terminal GST-tag. The protein was purified with a GSH column, followed by the cleavage 
of the GST-tag with TEV-protease and a second GSH column. The purification was finalized 
by a gelfiltration step with a S75 column (Fig. 7.28).  
 
 
 
 
 
 
 
 
Fig. 7.28: 10 % SDS gel after the second GSH column and gelfiltration chromatography S75 of the zebrafish srGAP1 
GAP domain  
The 10 % SDS gel shows the eluted protein after a gelfiltration chromatography. The SDS gel was stained with Coomassie 
Blue. 1) ProteinPage Plus Ruler, 3) fractions after cleavage with TEV-protease, 4) srGAP1 GAP domain in the flow-through 
of the second GSH column, 5) GST protein, 6-10) elution fractions of the zebrafish srGAP1 GAP domain (21 kDa, indicated 
with an arrow).  
 
 
The zebrafish Cdc42 was purified following the same protocol. Both proteins were analysed 
regarding their folding state with 1D NMR and proper folding was confirmed (Dr. Murray 
Coles, personal communication). For the 31P-NMR measurement, the intrinsic hydrolysis 
activity of the nucleotide-free Cdc42 with an excess of GTP was measured first (Fig. 7.29).  
 
 
 
 
 
 
 
 
 
                                  GAP                          
492                     676     
Cdc42           
1                          191            
1     2    3    4     5   6     7     8   9   10     
250- 
130- 
100- 
  75- 
  55- 
   
 30- 
  
 25- 
 15- 
   
93 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.29: Intrinsic hydrolysis activity of Cdc42 
31P NMR spectra (243 MHz) of 0.15 mM Cdc42 in 20 mM Tris pH 7.5, 150 mM NaCl and 1 mM MgCl2 buffer and 1 mM 
GTP were measured at a Bruker 600 spectrometer at room temperature. The signal of γ-phosphate, β-phosphate and α-
phosphate are followed over time (orange).  
 
Four signals can be observed in the graph, which correspond to γ-phosphate, β-phosphate, α-
phosphate and inorganic phosphate. Here, the signal for inorganic phosphate appears to be 
present from a very early time point. This can be attributed to a not complete nucleotide-free 
Cdc42. Therefore, the decline of the γ-phosphate and the increase of β-GDP phosphate was 
monitored. In comparison to the intrinsic hydrolysis rate of the human Cdc42, the intrinsic 
hydrolysis rate of the zebrafish Cdc42 seems to be very slow, as the signal for γ-phosphate is 
still clearly visible after 12 h (Fig. 7.29). A complete conversion of GTP into GDP and Pi 
cannot be observed even after an overnight measurement (Fig. 7.30 A). The zebrafish GAP 
domain and additional GTP were added to the overnight reaction and the hydrolysis process 
was monitored over time (Fig. 7.30 B).  No peak for free inorganic phosphate can be detected 
at 3 ppm, which could be explained by weaker signals and the high signal/noise ratio in 
contrast to Fig. 7.25.  
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Fig. 7.30: 
31
P-NMR spectroscopy showing accelerated GTP hydrolysis by the zebrafish Cdc42 affected by the GAP 
domain of the zebrafish srGAP1 
31
P-NMR spectra (243 MHz) of samples in 20 mM Tris pH 7.5, 150 mM NaCl and 1 mM MgCl2 buffer were measured at a 
Bruker 600 spectrometer at room temperature. (A) Spectrum of 0.10 mM nucleotide-free zebrafish Cdc42 with 1 mM GTP. 
(B) Addition of 0.15 mM srGAP1 GAP domain and additional 1 mM of GTP, (C) Conversion of GTP to GDP and inorganic 
phosphate 1 h after adding the zebrafish srGAP1 GAP domain.  
 
The basal GTP turnover for the zebrafish Cdc42 is lower than the human Cdc42, as the γ-
phosphate signal can be still detected after overnight incubation of the reaction. Within one 
hour, newly added GTP was hydrolysed to GDP and inorganic phosphate in the presence of 
equimolar concentration of the srGAP1 GAP protein (Fig. 7.30 C). This can be seen in the 
decline of the γ-phosphate (-21 ppm) and the increase of β-GDP (-10 ppm), indicating the 
srGAP1 GAP domain activity. Taken together, the results of the hydrolysis experiments 
indicate that both, the human and the zebrafish srGAP1 GAP domains are active and bind to 
Cdc42, increasing its intrinsic GTP hydrolysis rate.  
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7.1.5.4 No effect observed on the intrinsic hydrolysis activity of Cdc42 domains in cross-
organism 31P-NMR measurements 
As both human srGAP1 GAP domain and human Cdc42 as well as zebrafish srGAP1 GAP 
domain and zebrafish Cdc42 show interaction, which can be observed through the accelerated 
intrinsic hydrolysis activity of Cdc42, I examined if cross-organism measurements have an 
effect on the respective Cdc42 activity. The measurements were carried out analogous to the 
measurements described in 7.1.5.2 and 7.1.5.3.  
First the activity of the human Cdc42 with the zebrafish srGAP1 GAP domain was measured 
(Fig. 7.31). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.31: 
31
P-NMR spectroscopy showing GTP hydrolysis by the human Cdc42 affected by the GAP domain of the 
zebrafish srGAP1 
31
P-NMR spectra (243 MHz) of samples in 20 mM Tris pH 7.5, 150 mM NaCl and 1 mM MgCl2 buffer were measured at a 
Bruker 600 spectrometer at room temperature. 0.10 mM nucleotide-free human Cdc42 was measured with 1 mM GTP and 
0.15 mM zebrafish srGAP1 GAP domain.  
 
Signals for α-, β-, γ-phosphate and inorganic phosphate are observed. Compared to the results 
presented in Fig. 7.25 and 7.30 the signal for inorganic phosphate did not decrease even after 
8 h of incubation. The signal for inorganic phosphate starts to appear after almost 5 h. This 
would indicate that the zebrafish srGAP1 GAP domain has no effect on the intrinsic 
hydrolysis rate of the human Cdc42. 
In the next step zebrafish Cdc42 was measured with human srGAP1 GAP domain (Fig. 7.32). 
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Fig. 7.32: 
31
P-NMR spectroscopy showing GTP hydrolysis by the zebrafish Cdc42 affected by the GAP domain of the 
human srGAP1 
31
P-NMR spectra (243 MHz) of samples in 20 mM Tris pH 7.5, 150 mM NaCl and 1 mM MgCl2 buffer were measured at a 
Bruker 600 spectrometer at room temperature. 0.10 mM nucleotide-free zebrafish Cdc42 was measured with 1 mM GTP and 
0.10 mM zebrafish srGAP1 GAP domain.  
 
Here as well signals for α-, β-, γ-phosphate and inorganic phosphate can be observed. Signal 
for inorganic phosphate can be observed at early time points. One explanation for this could 
be a not complete nucleotide-free GTPase. The γ-phosphate decreases over time and the 
signal for inorganic phosphate increases steadily. After almost 4 h a complete turnover of the 
γ-phosphate can be observed indicating a low effect of the human srGAP1 GAP domain on 
the zebrafish Cdc42 compared to the measurement in Fig. 7.31. Species cross-over 
measurements showed either no effect on the acceleration of the intrinsic hydrolysis reaction 
of the RhoGTPase, in the case of human Cdc42 and zebrafish srGAP1 GAP domain (Fig. 
7.32), or a very low effect on the hydrolysis rate, in the case of human Cdc42 and zebrafish 
srGAP1 GAP domain (Fig. 7.31). These results lead to the assumption that both srGAP1 GAP 
domains are active and specific for Cdc42. But reach full activity in accelerating GTP 
hydrolysis only in the presence of Cdc42 proteins of their own species. 
 
7.1.5.5 Mapping of the srGAP1 GAP domain binding sites on the homologous Cdc42 proteins  
 
Cdc42 has a low intrinsic GTPase activity, which is significantly enhanced by the GAP 
domain, as seen in the 31P-NMR measurement series. To identify the regions of human and 
zebrafish Cdc42, which are involved in the binding of their respective GAP domains, 15N 
HSQC spectra were measured. HSQC measurements permit to obtain a 2D heteronuclear 
chemical shift correlation map between directly-bonded 1H and X-heteronuclei (commonly, 
13C and 15N). To assess the chemical shifts both Cdc42 proteins were measured alone and then 
with added GppNHp or GTP. The respective GAP domains were then added to the sample, 
until equimolar concentrations were reached. Chemical shifts were then recorded and mapped 
to a structural model of the RhoGTPase.  
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7.1.5.5.1 Mapping of the human srGAP1 GAP domain binding sites on the human Cdc42 
First the binding sites for human Cdc42 and srGAP1 GAP domain were examined. Therefore, 
15N and 13C labelled Cdc42 was prepared and 15N HSQC spectra were measured on a Bruker 
600 MHz spectrometer at room temperature. HSQC stands for Heteronuclear Single Quantum 
Coherence spectrum. It is a two-dimensional spectrum with one axis for 1H and the other for a 
heteronucleus 13C or 15N. The spectrum contains a peak for each unique proton attached to the 
heteronucleus being considered. The assignment of the backbone 1H, 13C, and 15N resonances 
of Cdc42 was carried out based on the already published assignment of human GDP-bound 
Cdc42 (Feltham et al., 1997) and additional HNCO (amide proton-to-nitrogen-to-carbonyl-
carbon correlation) and HNCA (amide proton-to-nitrogen-to-α-carbon correlation) 
experiments, which make it easier to distinguish between all Cαi and Cαi-1 peaks. Feltham et 
al. were not able to fully assign the GDP-bound human Cdc42. Several residues in the loops 
were not observed, presumably due to unfavourable water exchange, and residues at the C-
terminal end were missing due to proteolysis, as confirmed by mass spectrometry (Feltham et 
al., 1997). Also, the proline residues P32, P87 and P99 do not appear in 1H-15N correlation 
spectra, as they lack an amide proton. Nevertheless, 80 % of backbone amide resonances of the 
human Cdc42 could be assigned, providing good coverage of the protein surface. Figure 7.33 
A shows the sequence of the human Cdc42 protein with its P-loop, Switch I and Switch II 
binding sites. The secondary structure is indicated below the sequence. 
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Fig. 7.33: Structural motifs of the human Cdc42 and 15N HSQC spectrumof the bound complex human Cdc42 and 
human srGAP1 GAP domain  
(A) Sequence of the human Cdc42 protein with the potential binding sites, P-loop, Switch I and Switch II, for the srGAP1 GAP 
domain (shown with coloured boxes). The secondary structure is indicated below the sequence. α-helices are represented as 
green cylinders and β-strands as grey boxes. (B) 1H, 15N HSQC spectrum collected on human Cdc42-GTP (pink, I) and after 
addition of human srGAP1 GAP domain (blue, II). The box below (III) shows a zoomed view of the overlayed spectra, 
emphasizing the changes in the spectrum. Amino acid residue A176N is labelled as an example for an increasing and shifting 
signal, amino acid L70N for a disappearing signal after addition of the human srGAP1 GAP domain. Both amino acid residues 
are highlighted with red boxes in 7.33 (A). 
(B) 
(A) 
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Figure 7.33 B presents 1H-15N correlation spectra of the human Cdc42 before (Fig. 7.33 BI) 
and after adding the srGAP1 GAP domain (Fig. 7.33 BII). In Fig. 7.33 BIII a zoomed view 
of the overlayed spectra is presented to highlight the changes in the spectra after adding 
the srGAP1 GAP domain. This led either to increasing and shifting signals, as seen for 
A176N or disappearing signals, as seen for L70N. Based on the NMR spectra, it was 
attempted to map the binding sites of the srGAP1 GAP domain. This proved to be difficult 
as the complex was actively hydrolysing GTP. However, it was possible to narrow the 
binding site to the Switch I region. The same experiment was carried out with zebrafish 
Cdc42 and its respective GAP domain.  
 
7.1.5.5.2 Mapping of the zebrafish srGAP1 GAP domain binding sites on the zebrafish Cdc42 
protein 
As mapping of the binding sites for the human Cdc42 and human srGAP1 GAP domain proved 
to be difficult, due to the active complex and only implicated binding to the Switch I region. 
The same experiment was carried out for the zebrafish proteins to compare the results and 
examine if the binding sites are similar. Here, GppNHp was used instead of GTP to form a 
non-hydrolysable complex between the zebrafish Cdc42 and zebrafish GAP domain. Figure 
6.33 A shows the sequence of the zebrafish Cdc42 protein with its P-loop, Switch I and Switch 
II binding sites. The secondary structure is indicated below the sequence. The 1H-15N 
correlation spectrum of nucleotide-free zebrafish Cdc42 (1-191) is in good agreement with the 
data set published for human Cdc42 (pdb: 1GRN, Nassar et al., 1998). However, the spectrum 
shows considerable differences to that for the GTP/GDP bound protein. Signals for many 
residues assigned in the earlier analysis were not observed and others were of considerably 
lower intensity. Figure 7.34 B presents 1H-15N correlation spectra of the zebrafish Cdc42 
before (Fig. 7.34 BI) and after adding the srGAP1 GAP domain (Fig. 7.34 BII). In Fig. 7.34 
BIII a zoomed view of the superimposed spectra is presented to highlight the changes in 
the spectra after adding the srGAP1 GAP domain. This led either to increasing and shifting 
signals, as seen for T141N or disappearing signals, as seen for T138N. 
 
100 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.34: Structural motif of the zebrafish Cdc42 and 15N HSQC spectrum of the bound complex 
(A) Sequence of the zebrafish Cdc42 protein and its potential binding sites for the srGAP1 GAP domain are shown with 
coloured boxes. The secondary structure is indicated below the sequence. α-helices are represented as green cylinders and β-
strands as grey boxes. (B) 1H, 15N HSQC spectrum collected on zebrafish Cdc42-GppNHp (grey, I) and after addition of the 
zebrafish srGAP1 GAP domain (blue, II). Small box below (III) shows a zoomed view of the overlayed spectrum, emphasizing 
the changes in the spectrum. Amino acid residue T138N is labelled as an example for decreasing signal and amino acid T141N 
for a disappeared signal after addition of the zebrafish srGAP1 GAP domain. Both amino acid residues are highlighted with 
red boxes in 7.34 (A). 
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Figure 7.35 shows a model of the zebrafish Cdc42 highlighting the regions of the protein, which 
undergo conformational changes upon activation, as evidenced by chemical shift changes.  
Cdc42 consists of a central 6-stranded β-sheet. Helix α1 lies perpendicular to the β-strands at 
the concave side. The convex surface is flanked by α3 and α4, which are parallel to the 
β- strands. There is no structural evidence for an α2 helix, which cannot be found in Cdc42, in 
contrast to other GTP-binding proteins. αI is a less stable insert, forming a compact loop 
structure and lies adjacent to the loop between β4 and α3. Mapping the unobserved residues in 
white on to this structure (PDB: 1GRN) in Fig. 7.35 shows them to cluster on one face of the 
protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.35: Mapping the binding site for the GAP protein on the homologous RhoGTPase Cdc42 
Model of the zebrafish Cdc42 based on the pdb structure 1GRN.  The mapping of the binding site was acquired through 1H, 
15N HSQC spectra. Upon adding the non-hydrolysable analogue of GTP, GppNHp, which binds into the P-Loop between β1 
and α1, small/large shifts are observed in the near surroundings of the nucleotide binding site (coloured in orange and red). 
Dark blue regions at the C-terminal region of Cdc42 are not involved in the binding of the nucleotide or the GAP domain and 
are not affected by the short-termed complex formation. Light blue areas undergo quick signal changes, when the GAP domain 
is added. White regions, which include the Switch I, Switch II and P-loop region were barely visible. Grey areas were not 
detected at all. 
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For both organisms the hydrolysis complex seems to be very short-lived and instable as the 
interaction itself is very hard to detect when GTP is added instead of GppNHp. 
When nucleotide is added, small to large changes are observed in the orange/red coloured areas 
(residues 20-22, residues 84 and 90-91 and residues 157 and 159). When the srGAP1 GAP 
domain is added, further residues in α3, αI and β4 showed decreased intensity with increasing 
GAP concentration (e.g. T138N, see the enlargement to Fig. 7.34), many of them disappear 
completely (e.g. T141N, see Fig. 7.33). A large area on the C-terminal surface of Cdc42, which 
corresponds to the insert helix αI, is not involved in any interaction (dark blue). It is possible 
that this region has a role in mediating the binding of the target and regulatory proteins as it is 
relatively close to the switch surface (Feltham et al., 1997). Several residues in the Switch I, 
Switch II and the P-loop region are barely visible or have unassigned peaks. The switch binding 
regions are unstructured and very flexible, yet important for the interaction of Cdc42 with 
effectors. A possible explanation for the observed data is a dimerization of nucleotide-free 
Cdc42, leading to low intensities of the signals highlighted in white. Such dimerization was 
suggested by Zhang et al., 1998 and leads to a negative regulation of the RhoGTPase. Addition 
of GAP leads to complex formation utilizing a similar binding surface (light blue areas in the 
figure). It can be assumed that binding of GAP disrupts the dimerization, promoting the active 
form. 
Grey coloured regions were not detectable at all. This could be due to either unstructured 
flexible regions and/or internal dynamics, when the protein is in solution. This phenomenon 
was also described by Feltham et al., 1997, when the structure of the human GDP-bound Cd42 
was solved. Most of the potential affected residues lie on the surface of the protein.  
The results of the human and zebrafish proteins emphasize the importance of flexible regions 
in the N-terminus of Cdc42 in the interaction. At least one specific region of the flexible switch 
region contributes to the binding of the GAP domain, possibly Switch I (residues 31-40 aa). 
From the NMR data it can be expected, that the GAP domains bind primarily to those regions 
of Cdc42, which change conformation upon GTP/GppNHp binding. This result fits well with 
studies for other GAP domains with members of the RhoGTPase family (Feltham et al., 1997; 
Nassar et al., 1998; Dvorsky et al., 2004; Chandrashekar et al., 2011). 
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7.1.6 Possible new interaction partners for the human 
srGAP1 protein and its zebrafish homolog 
An essential step in understanding protein function is the identification of relevant interacting 
proteins. Based on structural and functional characteristics protein interactions can be 
classified as stable or transient, whereby the stable interaction will form protein complexes 
and the transient interaction will form signalling pathways (Rao et al., 2014). Only few 
binding partners for the srGAP1 protein are known so far. The RhoGTPase Cdc42 binds to 
the srGAP1 GAP domain, whereas Robo1 and possibly Robo3 bind to the srGAP1 SH3 
domain (Wong et al., 2001). The C-terminus of srGAP1 has received less attention so far, 
although it is expected to enable association of srGAP1 with other proteins. In a previous 
study it was shown that members of the srGAP family might interact with 14-3-3 proteins, 
though not much detail is provided about the interaction site (Blasutig et al., 2008). In this 
present study an approach to identify possible new interaction partners for the human and 
zebrafish srGAP1 C-terminal domains is described.  
 
 
7.1.6.1 Prediction of protein binding motifs in the human srGAP1 C-terminus 
 
The C-terminal domain of the human srGAP1 contains 286 residues (799-1085 aa) and is less 
conserved across different species, suggesting functional diversity (Fig. 7.36). However, no 
functional and biochemical data are available for the srGAP1 C-terminus. Comparison of the 
three human srGAP C-termini resulted in a sequence identity of 21 %. Compared with the 
sequence identities of the other domains, this region of the srGAP family has the highest 
sequence variation. Secondary structure analysis of the srGAP1 C-terminal domain does not 
reveal any elements of specific secondary structure, besides a short α-helical motif (955-
979 aa), which is conserved in all organisms. 
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Fig. 7.36: Sequence comparison for the C-termini of the three members of the human srGAP family 
The C-terminus is the less conserved domain of the srGAP family. Comparison of the C-termini of srGAP1, srGAP2 and 
srGAP3 resulted in a sequence identity of 21 %. 
 
To detect potential protein binding motifs in the C-terminal part of the srGAP1 protein, the 
primary sequence of the srGAP1 C-terminus was analysed. It is well known that protein-
protein interactions are mediated through binding of modular domains to characteristic short 
sequence motifs. For the analysis, Scansite, a program, developed to predict short sequence 
motifs (Obernauer and Yaffe, 2004; http://scansite.mit.edu/) was used. Several motifs likely to 
be phosphorylated or harbouring consensus binding sequences for proteins such as 14-3-3 and 
SH3 domains, were identified. In Fig. 7.37 specific binding motifs for potential binding 
partners in the C-terminal domain are shown. The binding motif search with Scansite was 
divided in three sections: the phosphoserine/threonine binding group, the SH3 group and 
different kinase binding groups. Here, the focus lies on the binding sites of 14-3-3 proteins 
and SH3 domains, as their possible relevance is indicated by previous publications (Blasutig 
et al., 2008; Tzivion et al., 2001; Weng et al., 1995). 
 
 
 
 
srGAP1 VQDMDDTFSDTLSQKADSEASSGPVTEDKSSSKD-MNSPTDR-HPDGYLARQRKRGEPPP 58
srGAP2 ------GVVERSSPKSEIEVISEPPEEKVTARAG-ASCPSGGHVADIYLANINKQRKRPE 53
srGAP3 ----------SLSQKADSEASSGPLLDDKASSKNDLQSPTEHISDYGFGGVMGRVRLRSD 50
                   * *:: *. * *  :. ::     ..*:       : .   :       
 
srGAP1 PVRRPGRTSDGHCPLHPPHALSNSSVDLGSPSLASH---PRGLLQNRGLNNDSPERRRRP 115
srGAP2 ------SGSIRKTFRSDSHGLSSSLTDSSSPGVGASCRPSSQPIMSQSLPKEGPDKCSIS 107
srGAP3 GAAIPRRRS-GGDTHSPPRGLGPSI---DTPPRAAACPSSPHKIPLTRGRIESPEKRRMA 106
               *         :.*. *     :*  .:        :       :.*::     
 
srGAP1 GHGSLTNISRHDSLK-KIDSPPIRRSTSSGQYTGFNDHKPLDPETIAQDIEETMNTALNE 
srGAP2 GHGSLNSISRHSSLKNRLDSPQIRKTATAGRSKSFNNHRPMDPEVIAQDIEATMNSALNE 
srGAP3 TFGSAGSINYPDKK-ALSEGHSMRSTCGSTRHSSLGDHKSLEAEALAEDIEKTMSTALHE 
        .**  .*.  ..     :.  :* :  : : ..: :*: :: *.:*:*** **.:**.* 
   
srGAP1 LRELERQSTAKHAPDVVLDTLEQVKNSPTPATSTESLSPLHNVALRSSEPQIRRSTSSSS 234
srGAP2 LRELERQSSVKHTPDVVLDTLEPLKTSPVVAPTSEPSSPLHTQLLKDPEPAFQRSASTAG 227
srGAP3 LRELERQNTVKQAPDVVLDTLEPLKNPPGPV-SSEPASPLHTIVIRDPDAAMRRSSSSST 224
       *******.:.*::********* :*. *  . ::*  ****.  ::. :  ::**:*::  
 
srGAP1 DTMSTFKPMVAPRM-GVQLKPPALRPKPAVLPKTNPTIG--PAPPP----------QGPT 28
srGAP2 DIACAFRPVKSVKM-AAPVKPPATRPKPTVFPKTNATSP--GVNSS--------TSPQST 276
srGAP3 EMMTTFKPALSARLAGAQLRPPPMRPVRPVVQHRSSSSSSSGVGSPAVTPTEKMFPNSSA 284
       :   :*:*  : :: .. ::**  **   *. : . :     .                : 
 
srGAP1 DKSCTM 287 
srGAP2 DKSCTV 282 
srGAP3 DKSGTM 290 
       *** *: 
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                                                                                                                              SH3 
799 VQDMDDTFSDTLSQKADSEASSGPVTEDKSSSKDMNSPTDRHPDGYLARQRKRGEPPP 
             
    PVRRPGRTSDGHCPLHPPHALSNSSVDLGSPSLASHPRGLLQNRGLNNDSPERRRRPG 
                            
                           14-3-3 
    HGSLTNISRHDSLKKIDSPPIRRSTSSGQYTGFNDHKPLDPETIAQDIEETMNTALNE 
 
                                                         14-3-3                                                  
    LRELERQSTAKHAPDVVLDTLEQVKNSPTPATSTESLSPLHNVALRSSEPQIRRSTSS 
 
                                           SH3                             
    SSDTMSTFKPMVAPRMGVQLKPPALRPKPAVLPKTNPTIGPAPPPQGPTDKSCTM 1085  
     
Fig. 7.37: Binding sites for putative interaction partners of the human srGAP1 C-terminus 
The C-terminal domain of srGAP1 contains several binding motifs for 14-3-3 proteins (orange) and various SH3 domains 
(blue). Sequence motifs are underlined. 
 
The results indicate that there are possible binding motifs for different proteins in the C-
terminal domain of the human srGAP1 protein. 14-3-3 protein binding was suggested in a 
previous study for the srGAP protein family (Blasutig, 2008). 14-3-3 proteins recognize two 
common recognition motifs containing phosphorylated serine or threonine residues: RSxpSxP 
(mode 1) and RxxxpSxP (mode 2). “pS” represents a phosphorylated serine residue and “x” 
represents any amino acid residue (Tzivion et al., 2001). Two potential mode 1 binding sites 
can be found in the C-terminal domain of srGAP1. Besides the binding sites for 14-3-3 
proteins, binding motifs for SH3 domains and different classes of kinases were also detected. 
SH3 domains recognize two classes of binding motifs: R/KxxPxxP (class I) and PxxPxR 
(class II). The binding motifs in the C-terminus of srGAP1 are class 2 motifs. Different types 
of kinase binding sites were also detected, with binding motifs containing serine or threonine 
residues. In this context it should be noted, that the predicted binding sites are exclusively 
base on the predictions using Scansite. In order to identify protein complexes associated with 
the human srGAP1, rat brain tissue pulldown assays were combined with mass spectrometry 
analysis. 
 
7.1.6.2 Rat brain pulldown with the human srGAP1 C-terminus hints to possible new 
interaction partners for srGAP1 
Previous studies indicate the involvement of srGAP1 in neuronal processes, as well as 
cytoskeletal regulation and endocytosis. As shown in previous studies and in this thesis 
(chapter 7.1.2), srGAP1 is mainly expressed in the brain during development (Bacon et al., 
2011; Couthino-Budd et al., 2012; Ip et al., 2010; Wong et al., 2001). To identify putative 
binding partners of srGAP1, a GST-fusion pulldown with brain tissue from rats at the 
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developmental stage P14 was carried out. First, the C-terminal domain of the human srGAP1 
(799-1085 aa) was cloned and purified as a GST-fusion protein. Then brain tissue from P14 
rats was homogenized in lysis buffer and the lysate pre-cleared with gluthathione-sepharose 
(GSH) beads. The GST-srGAP1 C-terminus was bound to GSH beads and incubated with the 
pre-cleared lysate overnight. GST protein alone was used as a negative control. After 
extensive washing steps, the beads were heated to 90 ºC, to release the proteins bound to the 
GSH beads, centrifuged and the supernatant was separated on a 10 % SDS gel (Fig. 7.38). 
The gel was stained with Coomassie Blue, destained and selected areas on the gel were cut 
out, digested with trypsin and the resulting peptides were submitted to nano-LC MS/MS. The 
acquired MS data were pre-processed with MaxQuant (v.1.2.2.9) to generate peak lists, which 
were submitted to the Andromeda search engine and searched against a rat protein database. 
In addition the data were analysed for the presence of peptides of the human srGAP1 C-
terminus as a positive control. Proteins identified with a minimum of one peptide were taken 
into consideration.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.38: GST-pulldown assay of human srGAP1 C-terminal fusion protein with P14 rat brain tissue 
The C-terminal GST-fusion protein of srGAP1 and GST protein alone were bound to GSH beads and incubated with rat brain 
lysate. The samples were washed and separated on a 10 % SDS gel. The gel was stained with Coomassie Blue and destained 
in destaining solution. (S) Standard, (1) negative control: GST (24 kDa). GST 1 and 2 correspond to the framed areas in lane 
1. (2) GST-srGAP1_C-terminus fusion protein (55 kDa). Similarly, GST-srGAP1_Cterm3-5 correspond to the specific 
framed areas in lane 2 on the 10 % SDS-gel. Framed and numbered areas (1-5) in the 10 % SDS gel were digested with 
trypsin and analysed with nano LC-MS. 
 
807 proteins were identified based on the MS/MS spectra of the peptides. To filter out non-
specific contaminants the results of the sample were compared to the GST negative control. A 
protein was not considered, if the negative control showed the same amount of identified 
peptides as the sample of the candidate protein. Proteins such as ribosomal proteins or heat 
shock proteins were identified in both samples to the same extent and thus were considered as 
background proteins. Proteins, which were detected in only one of two independent 
experiments, were also eliminated. To decide how reliable a protein is identified, the posterior 
     55-             
          S         1          2            
     25-             
3 
4 
5 
2 
srGAP1 C-term GST-fusion 
protein             
GST-protein              
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error probability (PEP) score in combination with the intensity and the number of identified 
peptides for the corresponding proteins was considered. The PEP score is calculated for each 
peptide. A PEP score lower than 0.01 indicates that the peptide was identified with a 
probability of more than 99 %.  Using this approach, 14 putative interaction partners with the 
lowest PEP scores and the highest number of detected peptides were selected and analysed 
regarding their domain composition and function. Table 7.6 shows the raw data of the mass 
spectrometry analysis for the 14 selected proteins. The labelling of the intensities in the table 
corresponds to the selected regions on the 10 % SDS in Fig. 7.38. 
Tab. 7.6: Raw data of the 14 putative interaction partners for the GST-srGAP1_C-terminus as identified in the rat 
brain pulldown experiment and mass spectrometry analysis, sorted with regard to the PEP score. Proteins of interest 
are highlighted in purple. 
Protein Names 
Peptides 
(negative 
control 
GST) 
Peptides 
(GST-
srGAP1 
Cterm) 
Sequence 
Coverage 
[%] 
PEP  Intensity  Intensity  Intensity  Intensity  Intensity   
 Score GST 1 GST 2 
GST-
srGAP1_Cterm3 
GST-
srGAP1_Cterm4 
GST-
srGAP1_Cterm5 
Dynamin-1-like 
protein 9 16 47,8 
7,13E-
269 3x106 0 1.2x107 0 0 
Dynactin subunit 1 1 12 38,6 
6,28E-
245 3x104 0 4.5x106 0 0 
Endophilin A1 2 7 58,8 
2,12E-
216 0 9.2x105 0 0 9.2x106 
Nck-1 1 23 36 
6,52E-
214 7x104 0 2.2x107 0 0 
Cyfip2 0 21 38,3 
1,26E-
210 0 0 3x107 0 0 
AP-2 complex 
subunit alpha-2 8 27 34,9 
2,72E-
188 2.9x106 1.6x105 3.8x107 0 0 
14-3-3 protein zeta 9 13 38,4 
5,04E-
96 0 2.1x107 0 0 4.8x107 
14-3-3 protein 
gamma 8 13 34,8 
4,48E-
76 0 2.3x107 0 0 6x107 
LIM and SH3 
domain protein 1 7 12 67,3 
5,54E-
66 0 6.5x106 0 0 3.1x107 
Synapsin 2 4 9 19,8 
1,67E-
60 2.7x106 0 0 1.2x107 0 
Neuronal 
migration protein 
doublecortin 1 5 27 
3,23E-
51 0 1.2x106 0 0 1.4x106 
Cortactin 0 4 23,3 
5,21E-
42 0 0 1.5x106 0 0 
14-3-3 protein 
theta 4 7 15,9 
2,23E-
29 0 2.8x106 0 0 5.2x106 
Abi1 protein 0 3 9,6 
1,54E-
25 0 0 0 1.8x106 0 
 
For some candidate proteins peptides were also detected in the negative control, but the 
number of the detected peptides and their measured intensity was lower in comparison to 
values obtained for the srGAP1 C-terminus, thus indicating specific binding to the C-terminal 
region. For other proteins, peptides were only detected in the sample. These proteins were 
also considered for further examination (not highlighted). In Fig. 7.39 the function of the 
identified binding partners are listed.  
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Fig. 7.39: Functional categorization of potential interaction partners of the C-terminal domain of srGAP1. Proteins 
were identified by nano LC-MS/MS analysis of a rat brain tissue pulldown with GST-tagged srGAP1 C-terminal fusion 
protein. The biological functions were assigned as referred to in the universal protein resource database (http://uniprot.org) 
and protein- specific publications. 
 
Many SH3 domain containing proteins as well as subunits of the 14-3-3 proteins, which 
binding sites were indicated in the analysis of the primary sequence of the srGAP1 C-
terminus, were found in the mass spectrometry analysis. Interestingly, most of the identified 
candidates seemed to be involved in actin cytoskeleton regulation (39 %), vesicle transport 
(22 %) or neuronal processes (26 %). A lower number of proteins are involved in endocytosis 
(9 %) and cell cycle regulation (4 %).  
In the following table (Tab. 7.7) proteins belonging to the different categories are analysed 
regarding their domain composition and function: 
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Tab. 7.7: Identified potential interaction partners for the human srGAP1 protein with their domain 
composition and detailed function  
category domain composition function 
Vesicle transport 
Dynamin-1-like 
protein 
               
                
                    dynamin              ?               GED 
Key player in fission process of 
mitochondria (Froehlich et al., 
2013) 
Dynactin subunit 1  
                                                    
                      CAP-Gly             dynactin 
Organization of microtubules 
and transport of vesicles 
(Zhapparova et al., 2009) 
Endophilin A1  
 
                     FBAR                            SH3 
Synaptic vesicle transport (Bai 
et al.,2010) 
actin cytoskeleton regulation 
Nck-1 
                   
    SH3     SH3      SH3                               SH2 
Binding of to effector proteins 
involved in cytoskeletal 
dynamics (Jones et al., 2009) 
Cyfip-2  
                                         Cyfip 
Scaffolding protein for  
complexes associated with Rac 
pathway (Jackson et al., 2007) 
Lasp1  
                
LIM                nebulin1   nebulin2            SH3 
Involvement in cell migration, 
signalling and stabilization of 
cytoskeleton (Pappas et al., 
2011). 
Cortactin  
  NTA                 repeats                  helical   p-rich  SH3 
Regulation of cortical actin 
assembly (Weed et al., 2001) 
Abi1  
   
homeo-box like  p-rich                           SH3 
Involvement in actin 
reorganization, lamellopodia 
formation and part of WAVE2 
complex  (Echarri et al., 2004) 
Endocytosis 
Assembly protein-2 
complex subunit 
alpha 2  
 
 
    adaptin-N                               α-adaptin C 
Involvement in clathrin-
mediated endocytosis and 
cargo recognition (Nakatsu et 
al.,2003) 
Neuronal processes 
Synapsin-2 Isoform 
a 
 
A             B                   C                     G       H          E 
Modulation of neurotransmitter 
release at the presynaptic 
terminal (Medrihan et al., 2013) 
Neuronal migration 
protein 
doublecortin 
 
                  
                   DCX1               DCX 2 
Neuronal migration and neurite 
branching (Gleeson et al., 
1999) 
Cell cycle control 
14-3-3 proteins  
         14-3-3- gamma or zeta or theta 
 
Mitotic signal transduction, 
apoptose and cell cycle control 
(Meek et al., 2004; Tzivion et 
al., 2001) 
In order to determine if the srGAP1 C-terminus from zebrafish has similar or different 
putative interaction partners, a pulldown with whole zebrafish embryos at the developmental 
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stage of 48 hpf was carried out on the basis of the data obtained from the pulldown with the 
C-terminal domain of the human srGAP1 protein. Similar results would indicate a conserved 
role for the human and zebrafish srGAP1 in multiple pathways besides the Slit-Robo 
pathway, like endocytosis or the regulation of the actin cytoskeleton.  
 
7.1.6.3 Prediction of protein binding motifs in the C-terminal domain of the zebrafish srGAP1  
 
As described in chapter 7.1.6.1 proteins recognize specific linear binding motifs for binding to 
other proteins in signalling pathways. To assess the existence of such motifs in the C-terminal 
domain of the zebrafish srGAP1 protein, I analysed the primary sequence with Scansite. In 
Fig. 7.40 the predicted binding motifs are highlighted and the putative interaction partners are 
indicated. The binding motif search with Scansite was divided in three sections: the 
phosphoserine/threonine binding group, the SH3 group and different kinase binding groups. 
The focus of the analysis was put on binding sites for 14-3-3 proteins and SH3 domains as 
kinase motifs are too abundant. 
                                                                                                                      14-3-3 
782 DMDDTFSDTLSQKADSEASSGHGGEEKCSSRDMGSPTDSRLPDAYISRHRKRSDP 
        SH3  
    PTRRPPARPTDTHCLVHPSHHSSHTNPDLGSPVMGHYSPRDMLRGRGHMPMDSPE 
                         SH3     14-3-3            
   RRRRTGHGSLTNISRHESIKKMESPPIRRSTSSGQYSSFNEPHVKSLDPESIAQD 
 
   IEETMNTALNELKELERQSSAKHAPDVVLDTLEQMKNAPTPASSTESLSQLHGLL 
                                       14-3-3                           SH3                                 SH3 
    LRPAGTELHMRRSTSSSSDTMSTFKPAVAPRMGVQLKPPTLRPKPMVPVPKTGAA 
    
    QHPAAPPQDPLDKSCTM 1073 
Fig. 7.40: Binding sites for putative interaction partners of the zebrafish srGAP1 C-terminus 
The C-terminal domain of srGAP1 contains several binding motifs for 14-3-3 proteins (orange) and various SH3 domains 
(blue). Sequence motifs are underlined. 
 
The results of the binding motif search indicate several possible short sequence motifs that 
might be recognized by different proteins. The identified sequence motifs are similar to them 
of the human srGAP1 C-terminal domain and indicate a possible conserved binding region 
(see chapter 7.1.6.1). Although, for the srGAP1 C-terminus of zebrafish more SH3 and 14-3-3 
binding motifs in comparison to its human equivalent are predicted. In order to identify 
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potential binding partners for the srGAP1 C-terminal domain, as pulldown assay with whole 
48 hpf zebrafish embryos. 
 
7.1.6.4 No relevant hints for potential interaction partners for the zebrafish srGAP1 C-
terminus 
In chapter 7.1.6.1 the pulldown with P14 rat brain tissue revealed several potential binding 
candidates for the human srGAP1. Here, I searched for potential interaction partners for the 
C-terminal domain of the zebrafish srGAP1 with a zebrafish embryo pulldown followed by a 
mass spectrometry analysis. The experimental design of the pulldown followed the protocol 
of the rat brain tissue pulldown with GST-tagged srGAP1 C-terminus as bait. First, the C-
terminal domain of the zebrafish srGAP1 (782-1083 aa) was cloned and purified as a GST-
fusion protein. 48 hpf embryos were collected, removed from their chorion, washed and 
homogenized in lysis buffer. The lysate was pre-cleared with gluthathione-sepharose (GSH) 
beads. The GST-fusion protein of the srGAP1 C-terminus was bound to GSH beads and 
incubated with the pre-cleared lysate overnight, while GST alone was used as a negative 
control. After several washing steps, the beads were heated at 90 ºC, to release bound proteins 
from the GSH beads. The samples were centrifuged and the supernatant separated with SDS-
PAGE (Fig. 7.41). The gel was stained with Coomassie Blue and destained in destaining 
solution. As seen on the 10 % SDS gel the sample of the srGAP1 C-terminus (Fig. 7.41, lane 
2) was apparently degraded during the pulldown process. Despite the degradation the samples 
were analysed by the mass spectrometry facility after trypsin digest as it was considered that 
the amount of the bait protein might be enough to identify possible interacting proteins. The 
resulting peptides were submitted to nano-LC MS/MS. Identified peptides were pre-processed 
by MaxQuant (v.1.2.2.9) to generate peak lists, which were then submitted to the Andromeda 
search engine and searched against a zebrafish protein database. In addition, the data were 
analysed for the presence of the zebrafish srGAP1 C-terminal peptides as a positive control.   
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Fig. 7.41: GST-pulldown assay of the C-terminal fusion protein of srGAP1 with 48 hpf zebrafish embryos. 
The GST-fusion protein of the C-terminal srGAP1 protein and GST protein alone were bound to GSH beads and incubated 
with zebrafish embryo lysate. The samples were washed and separated on a 10 % SDS gel. The gel was stained with 
Coomassie Blue and destained in destaining solution. (S) Standard, (1) negative control: GST (24 kDa) (2) GST-srGAP1_C-
terminus fusion protein (55 kDa). Framed and numbered areas (1-6) on the 10 % SDS gel were digested with trypsin and 
analysed with nano LC-MS. 
 
Based on the MS/MS spectra analysis 571 proteins were identified. From them 141 proteins 
with the lowest PEP score were selected and examined for their peptide coverage in 
comparison to the GST negative control. Figure 7.42 shows a chart with the identified 
proteins. Unlike the pulldown with the rat brain tissue for the human srGAP1 C-terminal 
fusion protein, the majority of the proteins are non-specific contaminants, like ribosomal 
proteins (13 %), yolk-derived proteins (6 %), proteins from the eyes (3 %) or muscle tissues 
(8 %) as they were detected in the negative control and the sample to the same extent. The 
annotation of the zebrafish genome is not complete yet, which might explain the 21 % of 
uncharacterized proteins. Furthermore, proteins with unknown function were detected (34 %). 
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Fig. 7.42: Categorization of identified proteins in the zebrafish embryo pulldown.  
Proteins were identified through a pulldown with zebrafish embryos, using GST-tagged srGAP1 C-terminal fusion protein 
and analysed by nano LC-MS/MS. The categorization was assigned according to the Universal protein resource database 
(http://uniprot.org). 
 
In conclusion, no specific interaction partner could be identified by the GST-pulldown with 
zebrafish embryos. One obvious reason for this might be the degradation of the bait protein by 
contamination with proteases. srGAP1 is mainly expressed in the brain, a pulldown with 
zebrafish brain tissue should be considered. This might be more successful in the assessment 
of similar candidates as it was done for the human srGAP1 C-terminus. So far, it can be 
assumed that the srGAP1 protein is not only a crucial factor in the Slit-Robo pathway, but 
possibly also in multiple other pathways, like actin cytoskeleton regulation, endocytosis and 
vesicle transport. 
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7.2 Structural and functional characterization 
of the FBAR domain of the human Carom protein 
As mentioned before the BAR superfamily contains three subfamilies. Recently, the subfamily 
of I-FBARs was described (Couthino-Budd et al., 2011; Guerrier et al., 2009). Though several 
FBAR containing proteins have been solved (Syndapin (PDB: 3I2W, Edling et al., 2009), CIP4 
(PDB: 2EFK, Shimada et al., 2007), FPB17 (PDB: 2EFL, Shimada et al., 2007), the structural 
properties of I-FBAR domains have not been determined yet. Furthermore, the mechanism of 
how they induce membrane invagination remains unknown. A recent study about the to the 
srGAP family phylogenetically related Nwk protein, which also contains a N-terminal FBAR 
domain, reported inverse FBAR activity (Becalska et al., 2013). To understand the difference 
between “classical” FBAR domains and inverse FBAR domains structural and functional 
studies were performed on the human homolog of Nwk, Carom.  
 
7.2.1 Biochemical characterization of the FBAR domain of 
the human Carom protein 
carom encodes a protein, composed of a conserved FBAR domain and two SH3 domains. The 
protein is so far poorly characterized, but its function seems to be connected to endocytosis and 
cell migration. According to a study of its Drosophila homolog, Nwk, this FBAR domain is 
assumed to have a membrane deforming activity differing from previously described BAR and 
FBAR proteins and sharing similarity to the activity described for the srGAP protein family 
(Becalska et al., 2013).  
 
7.2.1.1 Purification and biochemical analysis of the FBAR domain of the human Carom protein 
The recombinant FBAR domain of the human Carom protein comprising amino acid residues 
1-424, was overexpressed in E. coli Rosetta DE3 cells (Fig. 7.42). This construct contains a C-
terminal α-helical extension, which has been shown to be dispensable for filopodia formation 
in S2 cells in a previous study (Becalska et al., 2013). To be able to compare the results of the 
functional analysis of the Carom FBAR domain with them obtained for the srGAP1 FBAR 
domain containing this extension, the longer FBAR fragment was chosen. 
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Fig. 7.42: Domain composition of the full-length human Carom protein  
The human Carom protein consists of a FBAR domain and two SH3 domains. Its FBAR domain (1-424 aa, highlighted with a 
red box) is presumed to bind to membranes and induce membrane protrusions. 
 
The Carom FBAR domain, with a molecular weight of 54 kDa, was purified in a two-step 
purification by affinity chromatography using NiNTA and size exclusion S75 (Fig. 7.43). 
 
 
 
 
 
 
 
 
 
Fig. 7.43: Gelfiltration chromatography profile and 10 % SDS gel of the FBAR domain of the human Carom protein  
The Carom FBAR domain elutes in one peak. This corresponds to the band on the 10 % SDS gel at a molecular weight of 54 
kDa (indicated by an arrow). The 10% SDS gel was stained with Coomassie Blue. Insert 1) ProteinPage Plus Ruler, insert 2) 
concentrated fraction from the elution peak. 
In order to analyse the oligomeric state of the FBAR domain in detail, a chromatography-mode 
static light scattering was performed. The protein (1 mg/ml) was loaded on a size exclusion 
column and subjected to analysis. The Carom FBAR domain eluted in two peaks, the first one 
at 100 kDa and the second one at 51 kDa, implying that it probably exists as a mix of monomers 
and dimers in solution (Fig. 7.44).  
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Fig. 7.44: Static light scattering profile for the human Carom FBAR domain 
For determining the molecular mass, the protein (1 mg/ml) was injected on a Wyatt size exclusion column and run with 0.5 
ml/min at 4 ºC. The FBAR of the Carom protein eluted in two peaks: the first one with a calculated size of 100 kDa (green 
line) and the second with a size of 51 kDa (red line). The chromatogram displays two graphs: in blue the refractive index and 
in green and red the molecular weight.  
 
Using published structures of the FBAR domains of CIP4 (PDB: 2EFL, Shimada et al., 2007) 
and FBP17 (PDB: 2EFK, Shimada et al., 2007) as templates, a structural model of the Carom 
FBAR domain has been built (Fig. 7.45). This suggests that the Carom FBAR domain shows 
the typical FBAR domain fold with six anti-parallel α-helices. 
 
 
 
 
 
Fig. 7.45: PDB-based model for the human Carom FBAR domain 
The PDB-based model shows the potential structure of the human Carom FBAR domain, based on the structural data of the 
FBAR domain of CIP4 (PDB: 2EFL, Shimada et al., 2007) and FBP17 (PDB: 2EFK, Shimada et al., 2007). The sequence data 
base research was conducted with HHpred and the model created with Modeller and edited with OpenSource Pymol 1.3. 
 
The model coincides with the secondary structure analysis performed by CD spectroscopy (Fig. 
7.46). The CD spectrum was recorded at room temperature at a wavelength ranging from 190 
to 260 nm.   
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Fig. 7.46: Secondary structure analysis of the human Carom FBAR domain by CD-spectroscopy 
For the measurement the Carom FBAR protein (0.5 mg/m) was diluted in 20 mM Tris pH 8.0 and 50 mM NaF buffer and 10 
spectra were recorded on a Jasco Spectrometer J-810 at room temperature. The resulting spectrum was averaged. 
The obtained spectrum shows a curve with two minima at 208 and 222 nm that is typical for α-
helical proteins. 
 
 
7.2.1.2 First crystals for the human Carom FBAR domain 
Since the biophysical characterization of the Carom FBAR domain showed the protein to be 
properly folded, it was set up for crystallization. This was done using the following Qiagen 
Nextal Screens: Classic Suite I and II, PEGs Suite I and II, Protein Complex Suite, JCSG Suite, 
PACT Suite and the Cryos Suite. The crystallisation set up yielded small rectangular native 
crystals. Analysis of the crystals presented the best data set at 2.8 Å in 0.1 M Bis-Tris pH 5.5, 
25 % PEG 3350 and 0.1 M NH4OAc (highlighted in Tab. 7.8). 
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Tab. 7.8: Crystallization conditions with Carom FBAR domain crystals 
Crystallization conditions Diffraction 
0.1 M HEPES 
1.4 M tri-sodium citrate 
no diffraction 
0.1 M sodium cacodylate 
5% PEG 800 
40% 2-methyl-2.4-pentanediol 
3.5 Å 
 
0.1 M Bis-Tris pH 5.5 
25% PEG 3350 
0.1 M NH4OAc 
2.8 Å 
30% PEG 1500 6 Å 
0.1 M Bis-Tris pH 6.5 
0.2 M NaCl 
25% PEG 3350 
no diffraction 
0.1 M HEPES pH 7.5 
0.1 M NaOAc 
22% PEG 4000 
no diffraction 
2.1 M DL-malic acid pH 7.0 no diffraction 
 
To increase the quality of the diffracting crystals, the purified Carom FBAR domain was 
subjected to extensive crystallisation screens with different buffers, salts as well two differently 
sized PEGs (Tab. 7.9). The initial condition is highlighted in Tab. 7.8 and was varied in its 
buffer concentrations (0.1 M - 0.4 M), its pH range (pH 5 - 7.2) as well as in the precipitant 
concentration (18 % - 33 %). All conditions were set up as duplicates at room temperature and 
at 4 °C. Despite this effort, no better diffracting crystals were obtained by varying the initial 
condition. 
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Tab. 7.9: Variation of the crystallization conditions for initial set up of the Carom FBAR domain 
 
Buffer Bis-Tris Acetate Phosphate Citrate 
Concentration 0.1 M-0.4 M 0.1 M-0.4 M 0.1 M-0.4 M 0.1 M-0.4 M 
pH range 5.0-7.2 3.6-5.6 5.0-8.0 3.0-6.2 
 
 
 
 
 
 
 
An attempt was made to resolve the 2.8 Å crystal data set by molecular replacement with the 
help of the available structures of the FBAR domains of CIP4 (PDB: 2EFK, Shimada et al., 
2007) and FBP17 (PDB: 2EFL, Shimada et al., 2007) as search models. Both proteins are 
related FBAR domains to the human Carom FBAR domain, with a mere sequence identity of 
12 % and 17 % and a shorter length compared to the FBAR domain of Carom. Unfortunately, 
the molecular replacement effort did not lead to any results.  
Another approach to solve the structure of the Carom FBAR domain was applied by soaking 
experiments with platinum and mercury salts with reproduced crystals from the native 
condition, which originally yielded the 2.8 Å data set.  Heavy metal soaking relies on the fact 
that molecules diffuse into the protein crystal and bind to the crystal lattice. Typically, 
numerous heavy atom salts must be screened before one is found to bind to the crystal without 
damaging the crystal lattice. Here, platinum and mercury salts form the Hampton Research 
Heavy Atom Screens were applied, according to their minimum pH (Tab. 7.10). This screen 
was designed to offer convenient sets of popular heavy atom compounds. For the soaking 
experiments the crystals were transferred from the mother liquor to the solution with 10 mM of 
the heavy atom salt and incubated either for few hours or overnight.  
 
 
SALT NH4OAc NaOAc Mg(OAc)2 
Concentration 0.1 M-0.4 M 0.1 M-0.4 M 0.1 M-0.4 M 
Precipitant 18%-33%  
PEG 3350 
28%-32% PEG 
1500 
28%-32%  
PEG 6000 
Temperature room 
temperature 
4 °C 
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Tab. 7.10: Heavy atom screen for the Carom FBAR domain 
Heavy atom screen Diffraction 
Platinum 
 
Pt1  4.5 Å 
Pt2 7 Å 
Pt3 4-5 Å 
Pt4 3.5-4 Å 
Pt5 no diffraction 
Pt6 no diffraction 
Pt8 5-6 Å 
Pt10 no diffraction 
Pt12 no diffraction 
Mercury 
 
Hg2 no diffraction 
Hg3 no diffraction 
 
Even though several platinum salts bound to the protein and crystals were obtained, the 
structure could not be solved from the resulting crystallisation data.  
Therefore, selenomethionine-labelled protein was purified and subjected to crystallization 
screenings for experimental phasing. The protein was overexpressed in bacteria, grown in 
medium containing selenomethionine as the only source of methionine. This allows for the 
complete replacement of the methionine residues by selenomethionine in the protein. 
Selenomethionine-substituted proteins can be solved with the multi-wavelength anomalous 
dispersion (MAD) method. This method resulted in the growth of small rectangular crystals in 
different crystallization setups (Tab. 7.11).  
Tab. 7.11: Crystallization conditions of the selenomethionine-substituted Carom FBAR domain and the obtained 
diffraction data sets 
Crystallization conditions Diffraction Result 
0.2 M Ca(OAc)2 
0.1 HEPES pH 7.5 
10% PEG 8000 
10 Å could not be solved  
0.2 M CaCl2 
0.1 M HEPES pH 7.5 
28% PEG 400 
3 Å 
too small cell? 
could not be solved  
0.1 M Tris pH 8.5 
0.2 M MgCl2 
15% PEG 4000 
9 Å could not be solved  
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Crystals from 0.1 M Tris pH 8.5, 0.2 M MgCl2 and 15 % PEG 4000 diffracted to a resolution 
of 9 Å. Another crystal from 0.2 M CaCl2, 0.1 M HEPES pH 7.5 and 28 % PEG 400 diffracted 
to a resolution of 3 Å. But processing of the data set resulted in a small unit cell, which did not 
fit the Carom FBAR domain. However, performed mass spectrometry analysis of the 
selenomethionine crystals showed that the crystals were indeed composed of the Carom FBAR 
domain. Additional screenings did not lead to any crystals providing better diffraction by using 
the selenomethionine labelled crystals.  
Finally, the obtained native crystals were identified with molecular replacement as tetrameric 
E. coli beta carbonic anhydrase, a contaminating protein co-purified from the expression host. 
This was also confirmed with mass spectrometry analysis.  
By varying the crystallization conditions more precisely for the selenomethionine labelled 
protein, it may be possible to define the structure of the Carom FBAR domain. This information 
would give new insight into the structural properties and functional mechanism of I-FBAR 
domains. 
 
7.2.2 Membrane deforming activity of the human Carom 
FBAR domain 
The FBAR domain of Nervous Wreck from Drosophila has been shown to have a negative 
membrane deforming activity (Becalska et al., 2013). This deforming activity is similar to that 
of the srGAP family. Both FBAR domains functionally mimic I-BAR domains though they do 
not bear any detectable sequence homology. To determine the role of the Carom FBAR domain 
and to compare its function with that of the FBAR domain of srGAP1, in vitro assays with 
GUVs in cooperation with Dr. Aleksander Czogalla (Hertie Institute, Dresden) and Dr. Nathalie 
Eisenhardt (MPI for Developmental Biology, Tuebingen) were performed. 
 
7.2.2.1 The Carom FBAR domain induces scalloping of giant unilamellar vesicles 
The main characteristic of FBAR domains is to bind and bend membranes. In chapter 7.1.3.3 it 
is shown that the FBAR domain of the zebrafish srGAP1 induces membrane deformations of 
giant unilamellar vesicles (see Fig. 7.11). The human Carom FBAR domain is implicated to 
have a similar functional role. To confirm this assumption a GUV assay was performed by Dr. 
Aleksander Czogalla. GUVs were incubated with the FBAR protein overnight and the reaction 
chambers were examined with confocal fluorescence microscopy. Figure 7.47 shows the effect 
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of the human Carom FBAR domain on 0.5 % DiD-labelled, vesicles in comparison to a buffer 
control. 
                                                    Buffer                              Carom FBAR domain 
 
 
 
 
Fig. 7.47: Scalloping of giant unilamellar vesicles by the human Carom FBAR domain 
Deformation of DiD-labelled giant unilamellar vesicles (red) after overnight incubation with  (A) buffer (20 mM Tris pH 7.5, 
300 mM NaCl) and with (B) Carom FBAR domain. Arrows point to deformation. Scale bars: 20 µm. 
 
When incubated with the Carom FBAR domain, vesicles show a strong scalloping (Fig. 7.47 B), 
compared to the buffer control showing circular GUVs (Fig. 7.47 A). After an overnight 
incubation at 4 °C, almost 80 % of the giant unilamellar vesicles were deformed in comparison 
to the control vesicles in buffer. This result supports the assumption that the Carom FBAR 
domain, like the FBAR domain of the srGAP family, belongs to the novel  
I-FBAR domain subfamily. 
 
 
7.2.2.2 The Carom FBAR domain binds to giant unilamellar vesicles 
By varying the experimental set up, I wanted to examine if the deformations of the GUVs are 
specifically induced upon binding of the Carom FBAR domain. For this I performed an 
additional GUV assay with Alexa-488-labelled FBAR protein with the help of Dr. Nathalie 
Eisenhardt. Two different kind of vesicles were generated: first using vesicles from the Endo-
Mix, containing negatively charged lipids, (Fig. 7.48) and secondly vesicles containing Folch I 
+ 5 % PIP2 (Fig. 7.49). Both were labelled with 0.5 % DiD. I then used Alexa-488-C5-
maleimide to label the thiol groups of the 7 cysteine residues in the Carom FBAR domain. The 
protein was incubated with the dye for 2 h at 25 °C. Then the reaction was inhibited with 1 M 
β-ME and free dye was separated from the labelled protein by a Sephadex G50 column. The 
vesicles were incubated overnight at 4 ºC with buffer or the Carom FBAR domain. The reaction 
chambers containing the vesicles were imaged with two channels, Alexa-488 and DiD. 
  
 
A B 
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Fig. 7.48: The Carom FBAR domain deforms giant unilamellar vesicles composed of negatively charged lipids 
For the GUV assay Endo-Mix DiD-labelled giant unilamellar vesicles (white) were incubated with (A) buffer (20 mM Tris pH 
7.5, 300 mM NaCl) as negative control and (B) the Alexa-488 labelled FBAR domain of the human Carom protein (green). 
Binding of the Carom FBAR domain to vesicles is accompanied by slight deformation effects, indicated with an arrow. Scale 
bars: 20 µm. 
 
Control vesicles generated from negatively charged lipids show no signal in the Alexa-488 
channel (Fig. 7.48 A). Incubation with the FBAR domain lead to slight deformations of the 
vesicles (Fig. 7.48 B). This can be attributed to the FBAR domain, which is observed as a clear 
signal in the Alexa-488 channel. In the next step, the effect of the Carom FBAR domain on 
vesicles generated from Folch I with 5 % PIP2 was examined, in order to determine if vesicles 
composed of a different lipid mix show the same effect when incubated with the human Carom 
FBAR (Fig. 7.49). 
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Fig. 7.49: Scalloping of giant unilamellar vesicles composed of Folch I and 5 % PIP2 by the human Carom FBAR domain 
Giant unilamellar vesicles were generated from Folch I + 5 % PIP2 and labelled with 0.5 % DiD. (A) Vesicles incubated with 
buffer (20 mM Tris pH 7.5, 300 mM NaCl) (B) Vesicles incubated with Alexa-488 labelled Carom FBAR domain. Arrows 
point to deformation. Scale bars: 20 µm. 
GUVs containing labelled Carom FBAR domain a clearly visible in the Alexa-488 channel 
showing severe deformation (Fig. 7.49 B), whereas the control is not the affected (Fig. 7.49 A). 
The results indicate that the FBAR domain binds to the vesicles and induces scalloping. The 
higher level of deformation for the Folch I and 5 % PIP2 generated GUVs can be explained by 
the higher amount of PIP2 in the vesicle preparation and a higher affinity to Folch I lipids. With 
the Alexa-488-labelled protein it could be clearly shown, that the deformation of the vesicles is 
indeed induced by the FBAR domain of the human Carom protein.  
 
7.2.2.3 Time-dependence of the deformation of giant unilamellar vesicles by the Carom FBAR 
domain  
In the following, the time frame, in which the deformations of the GUVs become apparent was 
examined. The assay was carried out by Dr. Aleksander Czogalla. Vesicles were generated from 
negatively charged lipids. The assay was performed in a time frame of 24 h and images were 
taken after 5 h, >5 h and 24 h incubation with the Carom FBAR domain (Fig. 7.50). 
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Fig. 7.50: Time-dependent deformation of giant unilamellar vesicles by the Carom FBAR domain 
Vesicles (red), generated from negatively charged lipids and labelled with 0.5 % DiD were incubated with the Carom FBAR 
domain for 5h (A), >5h (B) and overnight (C) at 4 ºC. Deformation are indicated with an arrow. Scale bars: 20 µm. 
 
 
Strong deformation was observed after an overnight incubation (Fig. 7.50 C). Figure 7.50 A 
shows a slight deformation after 5 h, though it is possible that the deforming processes start 
earlier. It seems that the Carom FBAR domain induces deformations of vesicles in a time-
dependent manner. 
Taken together, the functional analysis of the FBAR domain of the human Carom protein 
implicated a negative membrane deforming activity. I was able to show this in in vitro assays 
with GUVs. The different degree of scalloping in the performed experiments could be attributed 
to different stocks of lipids used for generating the vesicles. All results indicate an inverse 
FBAR activity for the FBAR domain of Carom, similar to the results of the Nervous Wreck 
FBAR domain scalloping and the srGAP1 FBAR domain. The membrane deforming activity 
of the Carom FBAR domain seems to be stronger, than the activity of the srGAP1 FBAR 
domain and more comparable to the scalloping induced by the FBAR domain of Nervous Wreck 
(Becalska et al., 2013). Determination of the structure of the Carom FBAR domain would have 
supplemented detailed information about the shape of the FBAR domain. The current findings 
indicate a potential new member in the inverse FBAR subfamily.  
A B C 
5 h                                   >5 h                                   24 h 
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8. Discussion 
The srGAP family is known to be involved in Slit-dependent axon repulsion as well as in the 
regulation of neuronal migration, neuronal morphology, spine maturation and synaptic 
plasticity (Bacon et al., 2011; Carlson et al., 2011; Charrier et al., 2012; Guerrier et al., 2009; 
Soderling et al., 2002; Soderling et al., 2007, Wong et al., 2011). Two members of the srGAP 
family, srGAP2 and 3 have been implicated in severe mental illnesses, such as mental 
retardation and the neurodevelopmental syndrome, indicating a crucial role of this protein 
family during brain development (Carlson et al., 2011; Saitsu et al., 2011). The FBAR domain 
of this family shares functional properties with the I-BAR domains of IRSp53 and MIM by 
inducing membrane protrusion instead of membrane invaginations as observed for classical 
FBAR domains (Couthino-Budd et al., 2011; Frost et al., 2007; Itoh et al., 2005; Mattila et al., 
2007; Millard et al., 2007; Saarikangas et al., 2009). Recent studies functionally define the 
srGAP family as part of a new subgroup in the BAR superfamily, the I-FBAR domain 
containing proteins (Carlson et al., 2011; Couthino Budd et al., 2011).  
In this thesis, I focused on the biochemical, structural and functional characterization of 
human and zebrafish srGAP1 proteins as well as on the FBAR domain of human Carom. In 
the following chapters the role of the srGAP1 protein and the resulting function will be 
highlighted and critically analysed. 
 
8.1 srgap1 is expressed in neuronal tissues of 
zebrafish embryos 
Members of the srGAP family are involved in neuronal processes, such as repulsive axon 
guidance and neuronal migration (Endris et al., 2011). Few studies show information about 
the expression and distribution of srgaps, though this might provide us with new clues to the 
function of this family. In this thesis, the expression sites of srgap1 were analysed for the first 
time in zebrafish embryos. The developmental and tissue-specific expression analysis showed 
that srgap1 is mainly expressed in neuronal tissues in zebrafish embryos supporting its 
involvement in neuronal processes. In previous studies the expression patterns of srgap1 were 
analysed in mouse and rat embryos as well as human foetuses, showing preferential 
expression in neuronal tissue as well, indicating a conserved expression pattern for srgap1 
(Tab. 8.1) (Bacon et al., 2009; Ip et al., 2011; Wong et al., 2001). 
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Tab. 8.1: Summary of known expression sites of srgap1 
 zebrafish 
(this thesis) 
Mice rats Human 
 
 
 
 
 
 
Expression 
sites 
Forebrain 
 
Hindbrain 
 
Midbrain 
 
Olfactory bulb 
 
Pectoral fins 
 
Retina 
 
Spinal cord 
 
Ventricular 
zone 
 
Tail 
Cerebellar plate 
 
Cortical plate 
 
Dorsal root 
ganglia 
 
Olfactory bulb 
 
Spinal cord 
Subventricular zone 
(forebrain) 
 
 
Subventricular 
zone 
 
Intermediate zone 
 
Corticospinal 
axons 
 
 
In this work it is shown that in early hours of the zebrafish development (16 hpf) srgap1 is 
expressed more broadly, whereas in later stages (24 - 48 hpf) the expression sites concentrate 
to the head region. The expression of srgap1 appears to be evenly distributed and not to be 
localized to specific areas, such as in the olfactory epithelium and specific nuclei in the 
hindbrain, as it could be shown for robo2. When later stages than 48 hpf were analysed the 
expression sites of srgap1 were hardly detectable. This can be either caused by less 
penetration of the mRNA probe or a reduced level of srgap1 expression. Analysis of co-
localization with robo1, robo2 and robo3 resulted in distinct overlapping expression sites 
with robo1 in the fore- and hind brain area as well as in the spinal cord. This might be an 
indication for a possible interaction of both proteins or at least the participation of srGAP1 in 
pathways in which Robo1 is involved in, such as axon pathfinding and axon branching.  
 
8.2 The srGAP1 FBAR domain belongs to the Inverse-
FBAR subfamily 
An important aspect of neuronal migration including motility, cell division and cell 
communication is the remodelling of membranes. Proteins can bind to membranes, impose, 
stabilize or preferentially bind specific membrane curvatures. Besides this, they can recruit 
additional effector functions to specific regions of the cell (Henne et al., 2007). There are 
several known membrane binding domains C1, C2, PH, FYVE, PX and ENTH (Hurley et al., 
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2006). Lately, proteins with a membrane binding BAR domain have emerged (Chitu and 
Stanley, 2007; Itoh and De Camilli, 2006; McMahon and Gallop 2005). BAR domain 
containing proteins bind to membranes and induce in dependence of the type of the BAR 
domain membrane invaginations or membrane protrusions (Fig. 8.1). BAR, N-BAR and 
FBAR domains induce tubular membrane invaginations, whereas I-BAR domains lead to 
membrane protrusions.  
 
 
 
 
 
 
 
Fig. 8.1: Model of membrane deformation 
Possible mechanism for membrane deformation by BAR/FBAR domains and I-BAR domains. The membrane is depicted in 
brown and the membrane binding domain in blue. Classical BAR or FBAR domains bind with their concave surface to the 
membrane and thereby lead to membrane invagination, whereas I-BAR domains bind to the inner-leaflet of the membrane 
with their convex interface and lead to membrane protrusion (modified, Scita et al., 2007).  
 
In this thesis, the FBAR domain of srGAP1 has been characterised biochemically and 
functionally. Using a GUV-based in vitro system, a negative regulation of membrane 
deformation by the FBAR domain of srGAP1 has been demonstrated. When incubated with 
GUVs the srGAP1 FBAR domain leads to inward deformations of the vesicles. This 
observation coincides with functional in vivo studies concerning other members of the srGAP 
family, which show that the srGAP FBAR domain acts not in its classical way by inducing 
membrane invagination, but rather leads to membrane protrusions upon binding. A recent in 
vivo study in cortical neuron and Cos7 cells with all three members of the srGAP family, 
demonstrated that the degree of membrane protrusion varies among the members. In this 
context it was shown that srGAP2 seems to induce stronger filopodia formation compared to 
srGAP1 and 3 (Couthino-Budd et al., 2012; Endris et al., 2011; Guerrier et al., 2009). In 
general it was noted, that srGAP1 is less potent in inducing filopodia like structures when 
expressed in cells. Therefore, it seems to be more important for membrane stabilization as 
opposed to membrane deformation during expression in cortical neuron cells (Couthino-Budd 
et al., 2012). The ability of the srGAP1 FBAR domain to induce membrane invagination, 
when incubated with liposomes or giant unilamellar vesicles, is reminiscent of the activity of 
the presumably structurally related I-BAR domain containing proteins (Mattila et al., 
2007, Millard et al., 2007,Saarikangas et al., 2009 and Scita et al., 2008). The I-BAR domain 
BAR/FBAR I-BAR 
Cytosol 
Cytosol 
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of Pinkbar induces planar or gently curved membrane structures similar to the srGAP1 FBAR 
domain. It was suggested that the Pinkbar I-BAR domain oligomerizes, thus deforming 
cellular membranes (Pykäläinen et al., 2011). This result is consistent with the proposed 
mechanism of coat formation of F-BAR domains, in which multiple interactions, including 
lateral and tip-to-tip contacts, contribute to the stabilization of F-BAR domain coats on 
membranes (Frost et al., 2008). If this is also the case for the srGAP1 FBAR domain has to be 
examined.  
One explanation for the behaviour of the srGAP FBAR domains, deviating from other BAR 
domains could be a different curvature of the FBAR domains, which lead to a different 
distribution of positively charged residues on the surface, similar to that of the I-BARs 
(Guerrier et al., 2009). The extent of membrane deformation seems to be also dependent on 
the flanking sequences of the FBAR domain. For Amphiphysin it was reported that it 
performs different functions in cellular context depending on its flanking sequences (Itoh and 
Camilli, 2006). To analyse this in more detail, structural data of the srGAP1 FBAR domain 
are necessary. In a previous study a structural model for the srGAP3 FBAR domain was 
created based on alignments with the FBAR domains of FBP17, CIP4, and FCHo2. 
Divergence from the canonical FBAR domains was suggested through multiple sequence 
alignments, which showed that residues which were identified to interact with membrane 
lipids were not conserved in the srGAP3 FBAR domain. The structural model provides an 
estimation of the srGAP3 FBAR domain, which seems to be less curved compared to the 
solved FBAR domains (Carlson et al., 2011). From the obtained functional data in this thesis, 
it can be assumed that this FBAR domain, therefore, might be less curved and more planar 
than other characterized FBAR domains.  
Another factor, which could influence the membrane binding activity of the FBAR domain, is 
a potential autoinhibition. A mutation in the SH3 domain of srGAP2 reduced neurite 
branching. A complete lack of the SH3/C-terminal part restored the ability to inhibit neurite 
branching. This contradictory finding suggested that the SH3 and C-terminal domain could 
block the srGAP2 FBAR dimerization and thus prevent binding to the membrane (Coutinho-
Budd et al., 2011) (Fig. 8.2). This autoinhibitory mechanism is observed for FBAR domain-
containing proteins, like syndapin 1, endophilin and amphiphysin (Meinecke et al., 2013; Rao 
et al., 2010), as well as RhoGAP proteins, like GRAF and Oligophrenin-1 (Eberth et al., 
2009). For the FBAR domain of syndapin 1 crystallographic analysis revealed a basic 
interaction surface on the FBAR domain, which interacts with the acidic surface on the SH3 
domain.  Also cell assays with Cos7 cells showed that the full-length syndapin 1 shows no 
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membrane tubule formation in contrast to the truncated syndapin 1, containing only the FBAR 
domain. Binding of dynamin to the SH3 domain releases the inhibition of the SH3 domain on 
the syndapin 1 FBAR domain (Rao et al., 2010). Similar results were described for the FBAR 
domains of endophilin and amphiphysin, which also contain a C-terminal SH3 domain 
(Meinecke et al., 2013). Oligophrenin-1 and GRAF contain a GAP domain instead of a SH3 
domain. Here, a fluorescence-based GTP-hydrolysis assay showed that the GAP domains 
alone increased the intrinsic hydrolysis rate of the GTPase Cdc42, whereas a longer protein 
construct with the FBAR and the GAP domain reduced the stimulation of the intrinsic 
hydrolysis rate of the GTPase by 50-fold. In this case the BAR domain itself is the inhibiting 
factor, though it is also suggested that the GAP domain binding stabilizes the dimerization 
state of the FBAR domain (Eberth et al., 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8.2: Possible autoinhibition mechanism for the srGAP FBAR domain 
Model for the auto-inhibition mechanism of the srGAP FBAR domain by SH3 and C-terminal domain. The autoinhibition is 
abolished upon binding of an effector X to the SH3 domain (modified, Guerrier et al., 2012).  
 
For the srGAP family it is assumed that the autoinhibition is probably abolished through 
effector binding to the SH3/C-terminal domain. Whether the proposed mechanism is indeed 
the case for the srGAP1 has to be investigated. It would be also interesting to examine if the 
FBAR of the srGAP1 protein has an inhibitory effect on its GAP domain, like it is described 
for GRAF and Oligophrenin-1 (Meinecke et al., 2013). 
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The GUV-based in vitro analysis of the FBAR domain of the human Carom protein, led to 
scalloping of the GUVs upon incubation with the FBAR domain. When the srGAP1 FBAR 
domain was incubated with GUVs under same condition a lower extent of deformation could 
be observed, which would confirm the assumption that the srGAP1 FBAR domain might be 
less curved and might have a weaker affinity to the vesicles. For both proteins the GUV assay 
was more suitable than EM assays with liposomes. The bigger size of the vesicles in the GUV 
assay, allowed a better observation of the deformation than it was possible in the EM assays 
with the much smaller liposomes. Liposomes are more suitable to visualize outward 
tubulation than inward deformation. Early 2013, a novel study described the FBAR domain of 
the Drosophila protein-Nwk, which is phylogenetically closely related to the srGAP family 
and which is an orthologue of Carom. It reported flattening and scalloping of GUVs, when 
incubated with the FBAR domain of Nwk (Becalska et al., 2013). This suggested a novel 
higher order structure and membrane-deforming activity for the Nwk FBAR domain 
separating it from previously described FBAR proteins and demonstrating relation to the 
activity of the FBAR domain of the srGAP family and the Carom protein. 
In my in vitro assays using a higher amount of PIP2 led to a stronger deformation of the 
vesicles in contrast to assays with a lower amount of PIP2. Previous in vitro studies with BAR 
domain containing proteins, suggested a high affinity of BAR domains to phospholipid-
containing liposomes (Itoh et al., 2005). Association with PIP2 is highly favoured by BAR 
domains and the extent of tubulation is dependent on the PIP2 concentration. Based on the fact 
that PIP2 shows a 25fold higher abundance in the plasma membrane, the latter is most likely 
the physiological binding partner of FBARs in the cell (Mattila et al., 2007). For the FBAR 
domains of srGAP1 and Carom this specificity has not been confirmed so far by measuring 
dose-dependent binding of both FBAR domains to PIP2 containing membranes.  
The BAR domain is a dimerization, membrane-binding and curvature-sensing domain, which 
can be found in many different protein contexts. Its ability to sense membrane curvature led to 
the assumption of a specific mechanism for spatial and temporal compartmentalisation of 
proteins to specific membrane domains. With the results obtained in this project an I-FBAR 
activity for the srGAP1 FBAR domain as well as for the Carom FBAR domain could be 
shown. The observation that both proteins do not exhibit inward tubulation on GUVs as 
shown for IRSp53 (Saarikangas et al., 2009) and also do not show the outward tubulation 
typical for other FBAR domains, makes them unique in their membrane binding activity. 
However, the mechanism of the FBAR assembly and the way, they control membrane 
deformation, is still unknown and needs further investigation. 
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8.3 The srGAP1 GAP domain binds to the RhoGTPase 
Cdc42 and increases its intrinsic hydrolysis rate 
GTPases are low molecular weight guanine nucleotide binding proteins, which function as 
binary switches by cycling between an active and an inactive state. The activity of the 
GTPases is dependent on the GTP/GDP ratio in the cell and can be influenced by different 
regulatory proteins (Schmidt and Hall, 2002). It has been reported that BAR domain 
containing proteins interact with GTPases through their BAR domains. The GTPases Arf and 
Rac, both bind to the BAR domain of Arfaptin (Habermann et al., 2004;  Kanoh et al, 1997;  
Peter et al., 2004; Van Aelst et al., 1996). Members of the Toca family, CIP4 and Toca-1, 
contain a Cdc42 binding module, called HR1 at the C-terminal part of the FBAR domain (Ho 
et al., 2004). Several BAR domain containing proteins, like PACSIN2, IRSp53, MIM and 
Abba show interaction with GTPases as well. However, it is reported that the binding sites for 
GTPases overlap with the site for PIP2 binding, hinting towards a competing interaction (Lee 
et al., 2007; Matilla et al., 2007). There are also several BAR domain-containing protein 
families having flanking domains, which specifically bind to GTPases. The srGAP family 
contains a GAP domain next to the FBAR domain. In a previous study using HEK cell assays 
it was shown that the srGAP1 GAP domain tends to interact with Cdc42 and RhoA (Wong et 
al., 2001).  
In my experiments the srGAP1 FBAR domain does not show any signs of interaction with 
RhoGTPases, Cdc42, RhoA and Rac1, in GST-pulldown analysis as well as co-expression 
and co-purification experiments, indicating a specific role for the GAP domain. Several 
methods were applied, to examine whether a RhoGTPase exists which is specific for the 
srGAP1 GAP domain. This included the stopped-flow method, fluorescence spectroscopic 
measurements and HPLC. Unfortunately, none of them showed a clear effect of the GAP 
domain on the acceleration of the intrinsic GTP hydrolysis activity of any of the RhoGTPases. 
An explanation for this could be that the used rhodamine labelled nucleotides are not suitable 
as no significant change of the fluorescence signal could be detected. To determine the 
activity and specificity of the srGAP1 GAP domain a structural approach based on different 
NMR methods, here 19F and 31P-NMR, was applied. Using this approach, activity of the 
srGAP1 GAP domain and a specific interaction with Cdc42 could be shown. Table 8.2 
summarizes the specificity of all three members of the srGAP family for one of the three 
RhoGTPases, Cdc42, RhoA and Rac. 
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Tab. 8.2: Summary of RhoGTPase family specificity and their detection method for the three members of 
the srGAP family 
 
The specificity for Cdc42 seems to be conserved in different organisms as both, the zebrafish 
and the human srGAP1 GAP domains show the same specific interaction with Cdc42. It 
seems that both GAP domains show full activity only in the presence of species specific 
Cdc42. The human srGAP1 GAP domain affects the intrinsic hydrolysis rate of the zebrafish 
Cdc42 to a lower extent with less than 10 % activity compared to the human Cdc42, while the 
zebrafish srGAP1 GAP domain shows no effect on the intrinsic hydrolysis rate of the human 
Cdc42. The species specific binding is surprising as the sequence identity between the human 
and zebrafish Cdc42 is 98 %. Whether this is caused by the last 13 aa, which are missing at 
the C-terminus of the human Cdc42 protein construct is unclear. Due to its flexibility the C-
terminal region of the zebrafish Cdc42 cannot be observed in the HSQC spectrum. This is 
consistent with a previous published result (Feltham et al., 1997). No peaks emerge in this 
region after we added the srGAP1 GAP domain. Therefore, it might be assumed that the 13 aa 
are not important as they are beyond the binding site, which was narrowed down to the Switch 
I region. In a previous study, in which the crystal structure of Cdc42 was solved, it was noted 
that the C-terminal region of the protein was disordered and only partly visible in the electron 
density map. Therefore, it has been assumed that the C-terminal part of the protein is only 
providing a tail, which anchors the protein in the membrane compartment, a prerequisite for 
its biological function (Rudolph et al., 1999).  
The interaction with Cdc42 possibly connects srGAP1 to processes taking place during cell 
polarity determination, cell cycle regulation and spine formation. Moreover, through this 
interaction srGAP1 would be involved in severe illnesses, like cancer by affecting cell 
migration and invasion and also mental retardation, which is caused by abnormalities during 
spine formation (Newey et al., 2004; Ramackers et al., 2002; Schmidt and Hall, 2002;). 
srGAP family member RhoGTPase Detection method 
srGAP1 Cdc42, RhoA 
only Cdc42 
• HEK cell assay (Wong et al., 2001) 
• 31P-NMR, 19F-NMR (this thesis) 
srGAP2 Rac1 • fluorescent-based GAP assay with 
purified srGAP2 GAP protein 
(Guerrier et al., 2009) 
srGAP3 Rac1 • 32P labelled GTPase assay (Soderling 
et al., 2002) 
• cerebellar granular neuron assay 
(Soderling et al., 2002) 
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Affiliation of members of the srGAP family in mental retardation has already been shown for 
srGAP3 (Endris et al., 2002). 
 
8.4 Identification of Potential new pathways for 
the srGAP1 protein 
The function of the C-terminal domain of srGAP1 has not been characterized so far. It is 
assumed that it might act as a protein binding anchor, connecting srGAP1 to other unknown 
pathways. Bioinformatical analysis of the C-terminal domain of the srGAP1 protein predicted 
several protein binding motifs for SH3 domains or 14-3-3 proteins. In this study, a screen with 
GST-tagged srGAP1 C-terminus was performed, to find novel interaction partners for 
srGAP1. The pulldown was carried out with rat brain tissue and was analysed by mass 
spectrometry, to identify potential binding partners for the human srGAP1 protein.  
Several potential candidates involved in neuronal processes, endocytosis, vesicle transport, 
cell cycle and actin cytoskeleton regulation have been identified (Fig. 8.3). Some of these 
proteins have been already reported as potential binding partners for members of the srGAP 
family. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8.3: Potential pathway involvements for the srGAP1 protein 
The pulldown with rat brain tissue and the analysis of the pulldown with mass spectrometry identified several potential 
binding partners for srGAP1, which are involved in neuronal morphogenesis and migration, endocytosis, regulation of actin 
polymerization, cell cycle control and microtubule assembly and regulation. 
 
Many FBAR containing proteins, like FBP17, CIP4, Nwk, Syndapin 1 and PSTPIP bind to N-
WASP and Dynamin (Coyle et al., 2004; Itoh et al., 2005; Kessels et al., 2002; Merilainen et 
al., 1997; Qualmann et al., 1999 and 2000; Tsujita et al., 2006; Wu et al., 1998). Previous 
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studies also indicated interaction of srGAP2 with the WASP complex, which is involved in 
filopodia formation (Miki et al., 1998). For srGAP3 an interaction with the related WAVE1 
protein was reported (Endris et al., 2011). In this pulldown, members of the WAVE complex, 
Nck1 and Abi1, have been identified. Although a direct interaction of srGAP1 with both 
proteins has to be confirmed, it appears to be likely. WAVE is a small G-protein effector that 
has been shown to be important for actin nucleation, branching of the actin meshwork in 
lamellipodia (Suetsugu et al., 2003, Yamazaki et al., 2005), which activates the RhoGTPase 
Rac and the Arp2/3 complex. Other possible interaction partners are different subunits of the 
14-3-3 protein family, which are mostly involved in mitotic signal transduction, apoptosis and 
cell cycle control (Fu et al., 2000; Meek et al., 2004; Tzivion et al., 2001). Here, the subunits 
gamma, theta and zeta have been identified. For all selected proteins (Tab. 7.6) the identified 
interaction has to be verified with other methods to show direct interaction. In comparison, 
the pulldown with zebrafish embryos did not yield a conclusive result as most of the identified 
proteins were contaminants. One reason for this high number of contaminants might be the 
degraded target protein. An explanation for this rapid and almost complete degradation of the 
target protein, can be the presence of mere concentrations of pronase that is applied to the 
zebrafish embryos for dechorination. Although the embryos are washed afterwards 
extensively, this does obviously not completely remove the protease. A control gel with the 
purified fusion protein appeared to be stable. For a future experiment it should be considered 
to carry out a pulldown with adult zebrafish brains to avoid pronase treatment as well as 
contamination with muscle tissue and eye- associated proteins as well as yolk-specific 
proteins. A classical problem of protein mass spectrometry in the assessment of protein 
complexes is, the difficulty to distinguish real from adventitious protein associations. To 
verify in vivo interaction of the selected mass spectrometry candidates identified in this 
project, several approaches can be pursued. Performance of co-expression and co-
immunoprecipitation assays in HEK or Cos7 cells represent one possibility to eliminate false 
positive candidates. In such experiments, srGAP1 and its potential interaction partner will be 
tagged with two different markers, for example GFP and mCherry, and their localization can 
be analysed with the help of fluorescence microscopy. Co-expressing candidates can then be 
verified by co-immunoprecipitation experiments or the proteins can be purified and binding 
affinities could be determined with isothermal titration calorimetry (ITC) or microscale 
thermophoresis (MST). 
In Fig. 8.4 a model showing the possible functions of each domain of the srGAP1 protein is 
presented. The data obtained within this project clearly show that the FBAR domain of the 
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srGAP1 protein differs in its membrane binding activity clearly from classical FBAR 
domains. The extent of the invagination observed in in vitro assays, is indicative for a less 
curved shape of the FBAR domain. This is confirmed with the results obtained for the Carom 
FBAR domain, showing a complete deformation of giant unilamellar vesicles in contrast 
pointing to a probably highly curved FBAR domain. The srGAP1 GAP domain specifically 
binds to Cdc42 and increases its intrinsic hydrolysis activity. The binding site was mapped to 
the Switch I region of the Cdc42 protein. An additional involvement of the srGAP1 protein in 
other pathways, like cell migration, signal transduction process, vesicle transport and 
organization of microtubules besides the Slit-Robo pathway are indicated by the potential 
binding partners identified by mass spectrometry.  
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Fig. 8.4: Role of the individual srGAP1 FBAR domains 
The members of the srGAP family contain a FBAR, GAP, SH3 and C-terminal domain. The SH3 domain (orange circle) 
binds to the cytosolic domain of the Robo receptor, thus activating the srGAP1 protein and involving it in the Slit-Robo-
pathway, leading to axon repulsion during neuronal development. Activation of the srGAP1 protein leads to an increased 
activity of its GAP domain (yellow box), which specifically binds to a member of the RhoGTPase family, Cdc42, and 
increases its intrinsic GTP hydrolysis rate, thus inhibiting all downstream processes and preventing actin polymerization. The 
FBAR domain (blue half moon) binds with its negatively charged concave surface to the positively charged membrane and 
leads to membrane bending/deformation. The C-terminal domain contains a PxxP motif and additional other protein binding 
motifs and is assumed in protein-protein interaction and thus involving the srGAP1 protein in new pathways (modified, 
Wong et al., 2001; Hohenester et al., 2008).   
 
The srGAP proteins can be linked to different signal cascades. This is supported by their 
distinct expression sites in neuronal tissue of mouse and rat embryos as well as human 
foetuses (Bacon et al., 2009; Ip et al., 2011; Wong et al., 2001) and as shown for srgap1 in 
zebrafish embryos in this thesis. The different protein domains of the protein, not only the 
FBAR domain but also the GAP and C-terminal  domain, might work together to implement 
the srGAP1 protein in signal cascades downstream of Slit and Robo1, as well as connect it to 
other, related pathways; allowing the control of membrane deformation during neuronal 
migration.  
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8.5 Outlook 
The results of this thesis confirm and complement previously published data about the 
srGAP1 protein, which indicated a different membrane binding activity for this protein, and 
provide new data about the Carom FBAR domain. Here, in contrast to previous studies 
different types of in vitro approaches with GUVs were performed to visualize differences in 
the membrane binding activities of the srGAP1 and Carom FBAR domain. Both FBAR 
domains lead to inward vesicle deformation instead of tubule formation. Additional in vivo 
assays with Cos7 cells or neuronal cells and the structural characterization of these FBAR 
domains would help to get a deeper understanding of this complex mechanism of membrane 
binding and deformation, which differs from other examined FBAR domains, such as FBP17 
and CIP4. A differently shaped FBAR domain, in contrast to the already known canonical 
FBAR domains could explain the membrane protruding activity of the srGAP family 
members. Also the possible autoinhibition of the FBAR domain should be analysed in cell 
assays with full-length srGAP1 protein and a truncated srGAP1 protein with the FBAR 
domain only. Similar experiments should be carried out for the Carom protein. When an 
autoinhibitory effect, possibly indicated by less tubulation of the cells, which express the full-
length protein, is observed, direct binding of the FBAR domain to the SH3/C-terminal domain 
should be examined. Additionally, the effect of the srGAP1 FBAR domain on the activity of 
its GAP domain should be examined. Therefore, a protein construct with both domains should 
be purified and its activity tested with the already established 31P-NMR measurements. It can 
be assumed that the activity of the srGAP1 protein relies on the cooperation of its different 
domains. Furthermore, the characterization of the potential interaction partners, which were 
identified by mass spectrometry analysis, regarding their binding affinity to srGAP1 would 
provide new information about possible unknown functions of the srGAP1 protein and 
contribute to a better understanding of the complex protein network in the cell.  
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